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In the present study, in vivo investigations were carried out to identify the role of 
medial septum (MS) in nociception about which little was known.  Experiments were 
performed using the formalin model of persistent inflammatory pain.  Hind paw 
injection of formalin induces a biphasic pattern of nociceptive licking and flinching.  
These nociceptive behaviors are accompanied by parallel change in animal agitation 
(ambulation) and hippocampal theta wave activity.  Interestingly, hippocampal theta, 
which is modulated by septal GABAergic neurons, is most prominent during 
formalin-induced agitation rather than during licking and flinching behaviors.   
 
In the present study, MS GABAergic mechanisms were manipulated with intraseptal 
injection of (a) bicuculline (0.125g/0.5l), a GABAA receptor antagonist, (b) 
muscimol (1 or 2g/0.5l), a GABAA agonist, and (b) zolpidem (8 or 12g/0.5l), a 
positive allosteric modulator of GABAA receptor.  The neural effects of intraseptal 
bicuculline were first characterized on hippocampal theta wave activity and related 
changes in CA1 pyramidal cell synaptic excitability in anaesthetized rat and later on 
formalin pain.  On the other hand, both muscimol and zolpidem are known to inhibit 
MS neurons at the selected doses, muscimol being much more efficacious than 
zolpidem in inhibiting MS neural activity.   
 
The results showed that in anaesthetized rat, intraseptal microinjection of bicuculline 
selectively attenuated hippocampal theta rhythm to (a) direct MS activation with 
intraseptal microinjection of the cholinergic agonist, carbachol, (b) reticular 
viii 
 
stimulation and (c) hind paw injection of formalin.  However, the drug did not affect 
the suppression of CA1 population spike accompanying reticular stimulation and 
formalin injection.  The effects of bicuculline are consistent with the notion that the 
drug attenuated septal GABAergic mechanisms without preventing excitation of MS 
neurons to external inputs.   
 
In awake rat intraseptal bicuculline selectively enhanced formalin-induced ambulation 
but did not affect nociceptive licking and flinching.  Further, the ambulation was no 
longer parallel to the biphasic sensory experience.  On the other hand, intraseptal 
microinjection of muscimol in behaving rat attenuated nociceptive licking and 
flinching, especially in the second and more persistent phase of the formalin test, but 
had little or no effect on formalin-induced ambulation.  The behavioural effects of 
muscimol were accompanied by inhibition of spinal nociceptive processing.   
 
In contrast to muscimol, intraseptal zolpidem evoked a weak antinociceptive effect 
and, like muscimol, did not affect formalin-induced ambulation.  Correspondingly, 
intraseptal zolpidem had a weak effect on formalin-induced hippocampal theta 
activation and did not affect formalin-induced spinal nociceptive processing.  The 
effect of zolpidem was precluded with co-administration of bicuculline which is 
consistent with the notion that the antinociceptive effect of zolpidem is mediated via 
GABAA receptors in the MS.  
 
Taken together, the foregoing findings indicate that MS normally facilitates persistent 
nociception such that blocking septal neural activity is antinociceptive.  Moreover, 
disrupting GABAergic inhibition, rather than blocking information outflow per se 
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from MS, evoked a greater effect on ambulation suggesting that MS modulates, rather 
than drives, the ongoing ambulatory motor behaviors.  Indeed, the selective effect of 
bicuculline on ambulation suggests a role of MS GABAergic mechanism in formalin-
induced agitation distinct from mechanism(s) underpinning nociceptive licking and 
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1 INTRODUCTION 
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1.1 Hippocampal formation and the hippocampus 
The hippocampal formation consists of several cytoarchitectonically distinct regions – 
namely the entorhinal cortex, dentate gyrus (DG), hippocampus proper (also known as 
Ammon’s horn, Cornu Ammonis or CA) and the subicular complex – that are 
uniquely linked by excitatory unidirectional projections.  In the rat, the hippocampal 
formation is an elongated C-shaped structure extending from the septal nucleus 
(rostrodorsally) to the temporal lobe (caudoventrally) (Amaral and Lavenex, 2007).  
The long axis and the orthogonal axis are referred to as the septotemporal axis and the 
transverse axis respectively.  The hippocampus is an allocortical structure and is 
further divided into three fields based on cellular differences, which are the fields 
CA1, CA2 and CA3.  The hippocampal focus of this thesis is field CA1, which is 
among the most studied areas of the hippocampus.  Interestingly, of the three fields, 
the field CA2 is the smallest and the least characterized.  Nonetheless it is 
distinguished from others by selective innervations from the hypothalamic 
supramammillary nucleus and the selective presence of genetic markers, such as the 
Purkinje cell protein 4 and vasopressin 1b receptor (Vertes and McKenna, 2000; Lein 
et al., 2005; Young et al., 2006). 
 
1.1.1 Hippocampal cytoarchitecture 
The hippocampal fields are demarcated into multiple regions that are, in a dorsal to 
ventral order in the transverse plane, the alveus, the stratum oriens, stratum 
pyramidale, stratum radiatum, stratum lacunosum-moleculare, and the fissure (Witter 
and Amaral, 2004).  The principal cells of the CA subfield are the pyramidal cells 
while the granule cells are the principal cells of the dentate gyrus.   
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In hippocampal field CA1 of humans, approximately 90% of the cells are pyramidal 
neurons (Olbrich and Braak, 1985) while the remaining non-principal cells are mostly 
GABAergic interneurons (Freund and Buzsaki, 1996).  The soma or cell bodies of the 
pyramidal cells are located in the stratum pyramidale and that of the DG granule cells 
in the stratum granulosum of the dentate gyrus.  Pyramidal cells have two dendritic 
trees with the basal dendritic tree extending into the stratum oriens and the apical 
dendritic tree extending towards the hippocampal fissure.  The soma of CA1 
pyramidal cells are relatively small and averages about 15 μm in diameter with a 
dendritic tree length of approximately 13.5 mm on average (Ishizuka et al., 1995).  
The apical dendrites branch profusely in the stratum radiatum with some dendrites 
entering and branching in the stratum lacunosum-moleculare (Ishizuka et al., 1995).  
 
In contrast to the pyramidal neurons, the GABAergic interneurons are found in all 
layers of hippocampal subfields and play an inhibitory role.  Among the different 
interneurons type, the chandelier or axo-axonic cells are found within or immediately 
adjacent to the principle cell layer.  In the hippocampus, the dendritic tree of these 
interneurons consists of radially oriented branches that penetrate all layers indicating a 
possibility of receiving inputs from afferents terminating in these layers.  A 
characteristic feature of the chandelier cell is the termination of its axon with rows of 
2–30 boutons lined up with the axon initial segments of the principal cells 
transversing the principal cell layers and stratum oriens in CA1 (Freund and Buzsaki, 
1996).   
 
Another type of hippocampal interneuron is the pyramidal basket cell.  This is a 
heterogeneous group of neurons with different afferent connections but with a 
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common morphological feature, which is that the interneuron axon mainly innervates 
the perisomatic region of the principal cells.  The pyramidal basket cell is named as 
such because of its dendritic tree morphology which is predominantly pyramidal-
shaped in the hippocampus (Freund and Buzsaki, 1996).  The basal dendrites 
penetrate the entire layer of the stratum oriens, whereas the apical dendrites originate 
from one to three dendrites from the apical pole of the soma and ascend through 
stratum radiatum to penetrate the stratum lacunosum-moleculare (Freund and Buzsaki, 
1996).  The axonal arbors originates from the cell body or a primary dendrite and is 
restricted to their respective hippocampal subfield boundaries (Freund and Buzsaki, 
1996). 
 
In addition, there is a group of interneurons that predominantly synapse with dendrites 
of the pyramidal or granule cells.  These interneurons are collectively known as 
dendritic inhibitory cells.  One hippocampal cell type belonging to this group is the O-
LM cell whose axon terminates in conjunction with entorhinal afferents in the stratum 
lacunosum-moleculare.  Interestingly, the location of the dendritic tree of the O-LM 
interneruons differs between CA1 and CA3.  The soma and dendritic tree of O-LM 
cells are confined to the stratum oriens in CA1 where they receive input from axon 
collaterals of the CA1 pyramidal cells.  In contrast, the dendrites of O-LM neuron 
traverses all strata, except stratum lacunosum-moleculare, in CA3 which is in parallel 
with the distribution of recurrent collaterals of the CA3 pyramidal cells (Freund and 
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1.1.2 Intrinsic connections 
The well-studied trisynaptic pathway of the hippocampus refers to the successive 
unidirectional feed-forward excitatory projections starting from the entorhinal cortex 
to the dentate gyrus granule cells which, in turn, project to the pyramidal cells of the 
hippocampal subfield CA3.  And, finally, the pyramidal cells of CA3 project to CA1 
pyramidal cells.  Hippocampal information processing is mostly considered to occur 
along this trisynaptic circuit.  The entorhinal cortical projection to the dentate gyrus is 
known as the perforant pathway and is the major cortical input to the dentate gyrus 
(Witter, 2007), and thus, to the hippocampus.   
 
The entorhinal cortex is a six layered structure and is subdivided into the lateral and 
medial entorhinal cortex.  The origin of the entorhinal – dentate projection is mainly 
from layer II of the entorhinal cortex (Steward and Scoville, 1976; van Groen et al., 
2003).  These afferents terminate in an orderly fashion in the molecular layer of the 
dentate gyrus such that the afferents from the lateral entorhinal cortex terminate in the 
outer one-third, while the afferents from the medial entorhinal cortex terminate in the 
middle one-third of the molecular layer.  In addition, the afferents of the perforant 
pathway exhibit a septo-temporal organization of termination whereby: i) the afferents 
from the most lateral and caudal-medial parts of the entorhinal cortex terminate in the 
septal dentate gyrus, ii) the more medial part of the lateral entorhinal cortex and the 
more rostral area of the medial entorhinal cortex terminates in the mid-septotemporal 
levels of the dentate gyrus, and finally, iii) the afferents from the most medial portion 
of the lateral entorhinal cortex and the most rostral portion of the medial entorhinal 
cortex terminate in the most temporal quarter of the dentate gyrus (Dolorfo and 
Amaral, 1998; van Groen et al., 2003).   
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Besides the entorhinal-dentate afferents, the entorhinal cortex projects to hippocampal 
subfield CA3 and CA1 (Steward and Scoville, 1976; Yeckel and Berger, 1990; van 
Groen et al., 2003).  Similar to dentate gyrus, the entorhinal projection to CA3 
originate from layer II of the entorhinal cortex.  In contrast, the origin of the 
projection to subfield CA1 is from layer III of the entorhinal cortex (Steward and 
Scoville, 1976).  The direct entorhinal-CA projection terminates in the stratum 
lacunosum-moleculare of the CA3 and CA1, making a monosynaptic contact with 
pyramidal cell apical dendrites and interneurons (Yeckel and Berger, 1990; Witter, 
1993).   
 
The second limb of the trisynaptic circuit consists of the afferents from the dentate 
gyrus to field CA3 of the hippocampus.  These afferents comprise the mossy fiber 
pathway and is the only extrinsic connection of the dentate gyrus.  Interestingly, the 
mossy fibers (i.e. axons that project to the CA3) arise solely from the granule cells of 
the dentate gyrus and the entire population of granule cells in the dentate gyrus project 
to field CA3 (Amaral and Lavenex, 2007).  Tract tracing with the anterograde tracer, 
Phaseolus vulgaris leucoagglutinin (PHA-L), revealed that the mossy fibers terminate 
in the narrow stratum lucidum which is situated just above the pyramidal cell layer of 
field CA3 (Amaral and Witter, 1989).   
 
The third and last limb of the trisynaptic circuit, from field CA3 to field CA1 of the 
hippocampus, is known as the Schaffer’s collateral pathway.  Axons of CA3 
pyramidal cells innervate both the stratum radiatum and stratum oriens of CA1 
heavily where they terminate on the apical and basal dendrites of CA1 pyramidal cells, 
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respectively (Hjorth-Simonsen, 1973).  The anterograde tracing studies with PHA-L 
indicates that the distribution and termination pattern of the fibers differ with relation 
to the origin of the fibers in CA3 whereby: i) CA3 pyramidal cells located close to the 
dentate gyrus project preferentially to the area of CA1 nearer to the subiculum with 
axons terminating in the superficial stratum radiatum, and ii) CA3 pyramidal cells 
located closer to the CA1 region project to the CA1 area increasingly closer to CA3 
with axonal terminations in the deeper stratum radiatum and oriens (Amaral and 
Witter, 1989). 
 
In turn, the hippocampal CA1 pyramidal cells project to the subiculum.  Axons of 
CA1 pyramidal cells course through the stratum oriens or the alveus towards the 
subiculum.  The CA1 projection to the adjacent subiculum is also topographically 
organized whereby CA1 cells located near the boundary of the adjacent subiculum 
project just across the boundary to the subiculum, the middle area of the CA1 projects 
to the middle area of the subiculum, and the area of CA1 furthest away from 
subiculum (near to CA2 region) project to the portion of subiculum furthest away 
from the CA1 (Amaral and Lavenex, 2007). 
 
Besides the Schaffer’s collateral projections, which are associational connections, the 
CA3 pyramidal cells also project via commissural projections to the contralateral 
hippocampal fields CA1, CA2 and CA3.  In the rat, commissural connections are 
abundant whereas it is much less so in the monkey and thought to be absent in 
humans.  The CA1 commissural projections are weak and limited (Amaral and 
Lavenex, 2007).   
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1.1.3  Pyramidal cell physiology 
In relation to the present study, the following review on hippocampal pyramidal cell 
physiology will focus on dorsal field CA1 of the hippocampus.  Hippocampal 
pyramidal cell activity, both spontaneous and evoked, has been well studied.  With 
regards to the former, the hippocampal pyramidal cells have been shown to discharge 
spontaneously in two distinct patterns, single spike firing or burst firing (Kandel and 
Spencer, 1961).  The burst firing is further classified into three patterns: i) brief bursts 
of two to four spikes, ii) moderate bursts of five to eight spikes, and iii) prolonged 
bursts whereby depolarization lasts up to 100 of milliseconds.   
 
Interestingly, in vitro experiments suggest that the burst firing depends, at least in part, 
on a relatively prolonged and large spike after-depolarization potential (ADP) that is 
observed with intracellular recording both in vivo and in vitro (Azouz et al., 1996; 
Jensen et al., 1996; Yue et al., 2005).  The ADP is mediated by a low voltage-gated, 
persistent sodium current located at or near the soma and, indeed, blocking the 
persistent sodium current with the anti-epileptic, phenytoin, the neuro-protectant, 
riluzole, or the protein kinase C activator, phorbol-12,13-dibutyrate (PDB) suppressed 
spike ADP and also bursting activity in a hippocampal slice preparation.  On the other 
hand, an influx of Ca
2+
 may underlie the burst discharge of CA3 pyramidal neurons in 
the guinea pig brain slice (Wong and Prince, 1978; Wong et al., 1979).    
 
The burst firing is often observed as a ‘complex spike’ when recorded extracellularly 
in-vivo.  A complex spike is a burst discharge of 2 to 11 action potentials (spikes) with 
short interspike intervals of 1.6 to 6ms.  The spike amplitude in the burst exhibits a 
decrement from the first to the last (Fox and Ranck Jr, 1975).  Interestingly, Buzsaki 
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et al., (1996), showed that the intra-burst spike decrement is seen with extracellular 
recording from the proximal dendrites but not in extracellular recordings from the 
perisomatic region.  Thus, the progressive spike decrement of spikes in the burst was 
proposed to be due to dendritic processing of the back-propagating action potentials 
of the burst (Buzsáki et al., 1996). 
 
The CA1 pyramidal cells are also excited on afferent stimulation and typically 
discharge with a single spike on single shock afferent stimulation (Fox and Ranck, 
1981; Buzsa`ki and Eidelberg, 1983).  On the other hand, tetanic stimulation of the 
Schaffer collaterals can induce rhythmic burst firing of CA1 pyramidal cells in-vitro 
(Bonansco et al., 2002).  Interestingly, the single pulse stimulation-evoked excitation 
exhibits a relationship with relatively large field potentials in the hippocampus that 
are also evoked by such afferent stimulation.  For example, stimulation of Schaffer’s 
collaterals afferent evoked a large negative going extracellular field potential in the 
apical dendrites of CA1 pyramidal cells.  This field correlates with intracellular 
excitatory post synaptic potential (EPSP) recorded from pyramidal cells and is thus 
known as a field EPSP and represents an excitatory dendritic sink generated on 
synaptic excitation at dendrites of pyramidal cells (Andersen et al., 1966; Amaral and 
Lavenex, 2007).  This negative field potential reverses in the pyramidal cell layer 
where a positive field potential is observed which represents a somatic source.  
Increasing the intensity of Schaffer’s collaterals stimulation past a certain threshold 
evoked a negative waveform superimposed on the positive field EPSP in the 
pyramidal cell layer.  The negative waveform is known as the population spike and 
the amplitude of the population spike corresponds to the population of pyramidal cells 
discharging (spiking) synchronously to synaptic excitation (Andersen et al., 1971).  
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Following the population spike, a large positive waveform is recorded from the 
pyramidal cell layer which represents the intracellular inhibitory postsynaptic 
potential (IPSP) in the pyramidal cells. 
 
Using current source density (CSD) analysis, the Schaffer-collateral stimulation-
evoked population spikes was shown to be generated at the proximal apical dendrites 
in vivo in the urethane anaesthetized rat (Herreras, 1990; Kloosterman et al., 2001).  
The afferents were stimulated at near threshold and supra-threshold stimulation 
intensities to evoke a population spike.  In contrast, the location of the trigger zone for 
the generation of population spike in vitro depended on the intensity of stimulation.  
Local tetrodotoxin (TTX) application at the somatic region blocked the initiation of 
population spike to threshold stimulation of afferents in the stratum radiatum of 
hippocampal slices.  However, with stimulation at supra-threshold intensity, the site 
of population spike generation shifted to the proximal apical dendrites (Turner et al., 
1991).   
 
Interestingly, CSD analysis indicated that the population spike was generated near the 
cell body or initial segment of the pyramidal cells in vivo in the urethane 
anaesthetized rat on afferent stimulation-induced excitation of the basal dendrites of 
CA1 pyramidal cells (Kloosterman et al., 2001).  
 
The activity of hippocampal pyramidal cells is modulated by local inhibitory 
interneurons via feed-forward and feed-back inhibition.  In feed-forward inhibition, 
the activation of the interneuron by excitatory afferents suppresses the firing of the 
pyramidal cells (Buzsáki, 1984).  Indeed, the threshold for excitation of an 
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interneuron, including identified basket cells, on stimulation of 
Schaffer/Commissural- afferents is lower as compared to the threshold for excitation 
of pyramidal cells (Fox and Ranck, 1981; Buzsaki and Eidelberg, 1982; Sik et al., 
1995).  Accordingly, Schaffer-collateral stimulation at intensities sub-threshold for 
exciting pyramidal cells lead to the induction of intracellular IPSPs in these neurons 
(Turner, 1990).  Furthermore, afferent stimulation-induced activation of an 
interneuron almost always precedes the extracellular population spike of the 
pyramidal cells (Buzsaki and Eidelberg, 1982; Sik et al., 1995; Ylinen et al., 1995).  
The feed-forward inhibition is suggested to play a role in improving the “signal-to-
noise” information processing by restricting the excitation of pyramidal cells to 
relatively strong excitatory inputs (Buzsáki, 1984).  
 
In feed-back inhibition, the excited pyramidal cells activate inhibitory interneurons 
through axon collaterals.  In turn, the activated interneurons inhibit the group of 
pyramidal cells it impinges on, including those which initially activated the 
interneurons.  Accordingly, in a paired recording of an interconnected interneuron and 
pyramidal cell, excitation of the pyramidal cell elicited excitatory postsynaptic 
potential (EPSP) and action potentials in the interneuron, which in turn produced 
hyperpolarization in the pyramidal cell (Knowles and Schwartzkroin, 1981; Lacaille 
et al., 1987).  Furthermore, in the paired-pulse depression evoked on twin-pulse 
Schaffer collateral stimulation, the suppression of the paired population spike is 
attenuated by bicuculline, a GABAA receptor antagonist, in the hippocampus.  Among 
the different interneurons type, the O-LM interneuron are suggested to be excited by 
stimulation of the pyramidal cells (Gulyas et al., 1993).  For example, strong but not 
weak commissural stimulation produce an action potential in the O-LM interneuron 
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that followed the generation of the extracellular CA1 population spike suggesting a 
feed-forward activation of the interneuron (Sik et al., 1995).   
 
1.1.4 Extrinsic connections 
The review here provides a brief overview of the subcortical extrinsic connections of 
the hippocampus.  In general, the brain regions with input to the dentate gyrus and the 
hippocampus include the septum, hypothalamic region, amygdaloid complex and 
selected brainstem structures.  The major subcortical input to the hippocampus is from 
the medial septum.  An in-depth review of this connection is given in the following 
chapter (see chapter 1.2.2) since the medial septum is the focus of this study.  The 
supramammillary nucleus (SuM) is the main hypothalamic region projecting to the 
hippocampal formation, specifically the dentate gyrus and the hippocampus (Vertes, 
1992; Vertes and McKenna, 2000).  Anterograde tracing studies with PHA-L 
indicates that the SuM projects to the granule cell layer and the adjacent molecular 
layer of the dentate gyrus, and to stratum oriens, stratum pyramidale, and stratum 
radiatum of the hippocampal field CA2 and CA3a (Vertes, 1992).  There is no 
evidence of any direct projection from the DG and hippocampus back to the SuM.   
 
In contrast, there exist reciprocal connections between the amygdala and the 
hippocampus proper, but not the dentate gyrus.  The basal nucleus of the amygdala 
sends projections which terminate in stratum oriens and stratum radiatum of 
hippocampal subfields CA1, CA2 and CA3 with heavier projection to the latter.  In 
context of field CA1, projections from the lateral nucleus of the amygdala terminate 
in stratum lacunosum-moleculare (Pikkarainen et al., 1999).  The hippocampal-
amygdaloid connections arises mostly from the temporal region of subfield CA1 
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(PitkÄNen et al., 2000).  As regards connections with the brainstem, the dentate gyrus 
and hippocampus both receive noradrenergic and serotoninergic inputs from the 
pontine nucleus locus coeruleus and the raphe nuclei, respectively.  In addition, the 
dentate gyrus also receives dopaminergic projections from the ventral tegmental area 
(Amaral and Lavenex, 2007). 
 
1.2 The Medial Septum 
1.2.1 Neuroanatomy of the septal region 
The septum or septal region of the rat is a subcortical forebrain structure beneath the 
anterior region of the corpus callosum and dorsal to the anterior commissure (Jakab 
and Leranth, 1995).  It is flanked by the anterior horns of the lateral ventricles.  The 
region is classified into four groups of nuclei: the lateral, medial, posterior and the 
ventral group.  The triangular nucleus, bed nuclei of the anterior commissure and the 
stria medullaris make up the posterior group, while the ventral group consists of the 
bed nuclei of the stria terminalis.  Of particular interest here is the medial septal 
complex comprising the medial septal nucleus and the nucleus of the diagonal band of 
Broca (DB) which form the medial group.  Lastly, the lateral group includes the 
lateral septal (LS), septofimbrial, and the septohippocampal nuclei.  In relation to the 
present study, the following review will focus on the medial septum (MS).   
 
1.2.2 Cytoarchitecture and chemoarchitecture of the medial septum 
It is notable that there are no distinct cytoarchitectonic boundaries between the medial 
septal nucleus and the DB.  The distinction is only arbitrary and they share similarities 
with regards to their chemoarchitecture, connectivity and functions (Jakab and 
Leranth, 1995).  Because of this, the term medial septum (MS) used in this study 
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encompasses both the medial septal nucleus and the nucleus of the diagonal band of 
Broca.  Based on cytoarchitectonic features, at least five neuronal cell types can be 
distinguished in the medial septum and most of them, except one cell type, possess 
varicose, spine-free dendrites.  The neuronal diameter is variable and the dendritic 
length can vary from 100 – 200 μm to about 400 – 500 μm (Dinopoulos et al., 1988; 
Jakab and Leranth, 1995).   
 
Medial septal neurons are commonly classified into three non-overlapping 
populations based on their cytochemical properties, namely (a) cholinergic, (b) 
GABAergic and (c) glutamatergic.  The enzyme choline acetyltransferase (ChAT), 
which joins Acetyl-CoA to choline to produce acetylcholine, is commonly used as a 
marker for cholinergic neurons.  Structurally, the ChAT immunoreactive neurons are 
ovoid or round in shape and their diameter ranges from 15–20μm (with a larger 
indented nucleus) to 20–30μm (with a small indented nucleus) (Milner, 1991).  The 
septal cholinergic neurons are the major source of cholinergic afferents to the 
hippocampus (McKinney et al., 1983).  The GABAergic neurons are also 
heterogeneous and they can be broadly classified into two subpopulations.  Of these, 
the GABAergic projection neurons express the calcium-binding protein parvalbumin 
(PV), whereas the PV-negative cells are likely local inhibitory neurons (Jakab and 
Leranth, 1995).  The glutamatergic neurons, expressing the vesicular glutamate 
transporters (VGLUT1 and VGLUT2), are also projection neurons, at least in part.  
Thus, many are retrogradely labeled from the hippocampus (Sotty et al., 2003; Colom 
et al., 2005).  Immunohistochemical staining with anti-glutamate indicated that the 
medial septal glutamatergic neurons are generally smaller in size (5–21μm) and 
heterogeneous in cell body shape (Colom et al., 2005).   
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Within MS, the cholinergic and parvalbumin-containing neurons exhibit distinct 
topographical organization.  Generally, the parvalbumin-containing neurons are 
located around the midline in the MS, whereas the cholinergic neurons are located 
more laterally and surround the parvalbumin-containing neurons (Risold, 2004).  The 
glutamatergic neurons, however, are distributed amongst the cholinergic and the 
parvalbumin-containing neurons (Kiss et al., 1990; Colom et al., 2005).  Other 
neurotransmitters or neuropeptides that are expressed by medial septal neurons 
include the gonadotropin releasing hormone (GnRH), calcium-binding proteins 
calbindin D-28k and calretinin, substance P and somatostatin (Jakab and Leranth, 
1995; Risold, 2004).  The cholinergic and GABAergic neurons may co-express other 
neurotransmitters and/or neuropeptides.   
 
1.2.3 Intrinsic septal connections 
The neurons within the medial septum are interconnected.  In this context, Brauer et al. 
(1998) selectively destroyed medial septal cholinergic neurons by microinjecting the 
immunotoxin, 192 IgG-saporin, into the region.  Electron microscopic examination of 
immunohistologically stained sections revealed that degenerating axons terminal were 
in close contact with parvalbumin-positive neurons and other neurons in the medial 
septum, suggesting that MS cholinergic neurons influence diverse population of MS 
neurons including the GABAergic neurons (Brauer et al., 1998).   
 
Furthermore, evidence suggests that local glutamatergic neuron within the medial 
septum synapse with both cholinergic and GABAergic neurons in the region.  In this 
regard, immunocytochemical analysis indicated that vesicular glutamate-2 transporter 
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(VGLUT2)-positive terminals are in close proximity with the cell bodies and 
dendrites of glutamic acid decarboxylase-67 isoform (GAD67)-labelled GABAergic 
and ChAT-labeled cholinergic neurons in organotypic mini-slices of the medial 
septum (Manseau et al., 2005).  It is notable that the organotypic slice culture lacks 
extrinsic input.  Interestingly, the VGLUT2-positive terminals were also found 
adjacent to glutamatergic neuronal cell bodies (Manseau et al., 2005).  Further, using 
electron microscopy, Hajszan et al. (2004) showed that VGLUT2-positive boutons 
made synaptic contacts with parvalbumin labeled neurons in brain sections.  These 
VGLUT2-containing axons remained unaffected following fimbria/fornix transection 
and septal undercut indicating that these axons originated from putative glutamatergic 
neurons within the MS (Hajszan et al., 2004).  Thus, all three major groups of neurons 
in the medial septum, the GABAergic, cholinergic and glutamatergic receive putative 
synaptic input from local glutamatergic neurons.   
 
The septal GABAergic neurons also establish synaptic contacts with neurons within 
the MS.  In this context, MS neurons with electrophysiological characteristics similar 
to GABAergic neurons (see below) were found to make contacts with neuronal cell 
bodies that also parvalbumin-positive (Henderson et al., 2004).  The parvalbumin-
positive neurons in MS are GABAergic in nature.  Indeed, parvalbumin-positive 
boutons were also found to make synaptic contacts with the soma of parvalbumin-
positive neurons within the medial septum in perfusion-fixed brain slices (Henderson 
et al., 2004).  
 
The intrinsic medial septal connections vis-à-vis the septo-hippocampal reciprocal 
connections is illustrated in figure 1.1.   























Fig. 1.1.  Simplified diagram illustrating the interactions within the medial septum 
(MS) and between the MS and the hippocampus.  Orange and blue lines indicate 
septo-hippocampal cholinergic and GABAergic projections respectively. Black lines 
indicate glutamatergic innervations and green lines indicate local inhibitory 
GABAergic connections.  Red lines indicate the intra-hippocampal projections from 
hippocampal pyramidal cells and purple lines show the hippocampal-septal 
GABAergic projections.  Black solid triangle and square indicate GABAA receptors 
and muscarinic acetylcholine receptors respectively. In addition, known α1-subunit 
and α3-subunit containing GABAA receptors is represented by the yellow solid 
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1.2.4 Efferent and afferent connections of the medial septum 
The medial septum has connections with various regions of the central nervous 
system, including regions of the telencephalon, diencephalon, brain stem and the 
spinal cord.  In many instance, the connections are of reciprocal nature.  The 
reciprocal septo-hippocampal connection has been the subject of numerous studies.  
The properties and significance of this connection are reviewed in the following 
chapters.  Here, I have summarized the overall afferent and efferent connections of the 
MS.   
 
Autoradiographic and PHA-L anterograde tracing studies indicate that the medial 
septum sends topographically organized ascending projections to various cortical 
regions of the brain.  The different cortical regions are: the entorhinal cortex, 
cingulate cortex, medial prefrontal cortex, olfactory cortex, insular cortex, occipital 
cortex, somatosensory cortex and the orbital area of the cortex (Swanson and Cowan, 
1979; Woolf et al., 1986; Záborszky et al., 1986; Gaykema et al., 1990; Jakab and 
Leranth, 1995; Risold, 2004).  Among the sub-cortical regions, the region projects to 
the basolateral nucleus of the amygdala and the hypothalamus (Woolf and Butcher, 
1982).  The hypothalamus is a major target of the descending projections from the 
medial septum.  In this context, retrograde and anterograde tracing methods indicated 
that the majority of the projections terminate in the lateral hypothalamic area 
(Meibach and Siegel, 1977b; Swanson and Cowan, 1979; Tomimoto et al., 1987; 
Jakab and Leranth, 1995).  Furthermore, terminations are also observed in the 
mammillary complex, namely the pars posterior of the medial mammillary nucleus, 
lateral mammillary nucleus and the supramammillary nucleus (SuM) (Meibach and 
 - 19 - 
Siegel, 1977b; Swanson and Cowan, 1979; Jakab and Leranth, 1995).  The other areas 
of the midbrain where the medial septum projects to include: the ventral tegmental 
area, the interpeduncular nucleus, the medial and lateral habenula, and the 
mesopontine rostromedial tegmental nucleus (Swanson and Cowan, 1979; Jakab and 
Leranth, 1995; Jhou et al., 2009).  Finally, the medial septum has also been shown to 
project to areas of the brainstem such as the periaqueductal grey (PAG), and the 
dorsal and medial raphe nuclei.  The MS projection to the latter is non-cholinergic 
(Swanson and Cowan, 1979; Kalén and Wiklund, 1989; Jakab and Leranth, 1995).  
 
In turn, the MS receives reciprocal afferents from the hippocampus, entorhinal cortex, 
hypothalamic areas including the SuM and the lateral hypothalamic area, midbrain 
regions such as the interpeduncular nucleus and the ventral tegmental area, and the 
raphe nuclei of the brain stem (Swanson and Cowan, 1979; Cullinan and Záborszky, 
1991; Jakab and Leranth, 1995; Risold, 2004; Haghdoost-Yazdi et al., 2009).  
Interestingly, anterograde PHA-L and retrograde fluorogold tracing indicated that the 
medial septum also receives direct spinal input from deep dorsal horn (Burstein and 
Giesler Jr, 1989; Cliffer et al., 1991; Li et al., 1997).  In addition, the laterodorsal 
tegmental nuclei, locus coeruleus of the brainstem, posterior hypothalamic nucleus, 
and the lateral preoptic area also project to the medial septum (Swanson and Cowan, 
1979; Cullinan and Záborszky, 1991; Jakab and Leranth, 1995; Risold, 2004).   
 
The projection from the lateral septum to the medial septum is an area of contention.  
In one of the first comprehensive evaluation of the connections of the septal region, 
Swanson and Cowan (1979) reported massive intraseptal projections from the lateral 
septum to the medial septum.  This view was subsequently disputed by Leranth et al. 
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(1992), who demonstrated weak afferent projection to the medial septum with 
microinjection of the anterograde tracer PHA-L into the lateral septum (Leranth et al., 
1992).   
 
1.2.5 Septo-hippocampal connections 
The MS is reciprocally connected with the hippocampus.  The hippocampal targets of 
the medial septal afferents include the dentate gyrus and hippocampal fields CA1 and 
CA3 (Crutcher et al., 1981; Jakab and Leranth, 1995; Risold, 2004; Amaral and 
Lavenex, 2007).  In return, the medial septum receives direct projections from 
hippocampal field CA1, and possibly field CA3 (Gaykema et al., 1991; Toth et al., 
1993; Haghdoost-Yazdi et al., 2009).   
 
The medial septal efferents project to the hippocampus via 4 routes: the fimbria, 
dorsal fornix, supracallosal striae, and a ventral route through and around the 
amygdala (Gaykema et al., 1990; Peterson, 1994; Jakab and Leranth, 1995; Amaral 
and Lavenex, 2007).  The fimbria and dorsal fornix pathway are taken by the majority 
of the septohippocampal efferent from the MS, though the DB efferent may also reach 
hippocampus via the latter two routes (Peterson, 1994; Jakab and Leranth, 1995).  The 
MS projection is topographic whereby neurons around the medial region of the medial 
septum project to dorsal/septal part of the hippocampus and neurons from more lateral 
part of the MS project to the ventral/temporal aspects of the hippocampus (Gaykema 
et al., 1990). 
 
Interestingly, the cholinergic and GABAergic septo-hippocampal projecting neurons 
target different cell types in the hippocampus.  Fibers of the MS GABAergic neurons 
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selectively target GABAergic neurons, including hippocampal interneurons and 
hippocampal – medial septal (HS) projection neurons, whereas cholinergic efferent 
innervate both hippocampal pyramidal cells and interneurons without any particular 
preference for either neuron type (Frotscher and Léránth, 1985; Freund and Antal, 
1988; Gulyás et al., 1991; Jakab and Leranth, 1995; Takács et al., 2008).  As regard to 
the glutamatergic septo-hippocampal neurons, details on the hippocampal neuronal 
targets are scarce.  
 
The feedback from the hippocampus to the MS via the HS cells is also GABAergic 
(Toth et al., 1993).  The HS neurons mostly innervate MS parvalbumin-positive 
GABAergic projection neurons that project back to the hippocampus (Toth et al., 
1993).  However, some contacts between the HS projections and MS cholinergic 
neurons has also been reported (Toth et al., 1993).  The HS cells receive a substantial 
convergent excitatory input from the local collaterals of the hippocampal pyramidal 
cells and locally target both hippocampal interneurons and pyramidal cells (Gulyás et 
al., 2003; Takács et al., 2008).  Interestingly, almost all (> 95%) hippocampal neurons 
projecting to the medial septum express the neuropeptide somatostatin (SST).  In 
addition, a subset of the parvalbumin containing MS GABAergic neurons, but not the 
cholinergic neurons, express the SST receptor sst2A (Gulyás et al., 2003; Bassant et 
al., 2005).  Electrophysiological investigations indicate that microiontophoretic 
application of SST or the SST receptor sst2A agonist, octreoride, blocked the unit 
activity of medial septal neurons in the urethane anaesthetized rat (Bassant et al., 
2005).  
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The hippocampal formation, especially the subiculum also projects to the lateral 
septum.  The hippocampal-lateral septum projection consists of excitatory 
glutamatergic afferents that course through the fimbria and fornix to reach the lateral 
septal nucleus (Meibach and Siegel, 1977a; Swanson and Cowan, 1979; Jakab and 
Leranth, 1995; Risold and Swanson, 1997; Risold, 2004).   
 
1.2.6 Electrophysiological properties of septal neurons 
The electrophysiological properties of MS neurons vary with cytochemical nature of 
the neuron.  For example, putative cholinergic neurons, identified post hoc with 
immunocytochemistry or single cell RT-PCR, exhibit a long-duration action potential 
and a comparatively slow and regular action potential discharge, both in vitro and in 
vivo (Gorelova and Reiner, 1996; Sotty et al., 2003; Simon et al., 2006).  On the other 
hand, the VGLUT 1 and/or 2 expressing putative glutamatergic neurons and 
GAD65/67 or PV expressing GABAergic medial septal neurons display a wide range 
of firing patterns including fast firing, burst firing, slow firing, and cluster firing 
(Sotty et al., 2003; Huh et al., 2010).  Retrogradely labeled septo-hippocampal 
neurons recorded in vitro also exhibited electrophysiological properties that was 
consistent with the mix identified above (Sotty et al., 2003).   
 
Interestingly, GABAergic neurons, especially fast firing parvalbumin-positive, but not 
parvalbumin-immunonegative neurons, and burst firing GABAergic neurons 
exhibited a ZD7288 sensitive, inward Ih current on hyperpolarization in voltage clamp 
mode (Morris et al., 1999; Sotty et al., 2003; Huh et al., 2010).  The Ih is a 
hyperpolarization-activated current that is implicated in the generation of pacemaker-
like activity in neurons.   
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Indeed, the hyperpolarization-activated, cyclic nucleotide-gated non-selective cation 
(HCN) channel that is involved in the mediation of the Ih-current is expressed in a 
subset of GABAergic neurons.  Using combined immuno-staining and in situ 
hybridization, it was found that all HCN1 immunopositive neurons also express 
GAD67 mRNA.  The population of HCN1 expressing GABAergic neurons overlaps 
in part with parvalbumin containing neurons as around half of HCN1 immunopositive 
neurons were double labeled with parvalbumin (Varga et al., 2008).  Although only 
about 20% of parvalbumin positive neurons were HCN positive. 
 
Cholinergic neurons, on the other hand, do not exhibit Ih current and nor do they 
express HCN channels (Sotty et al., 2003; Varga et al., 2008).  On the other hand, 
they display a calcium-dependent slow afterhyperpolarization (sAHP) (Gorelova and 
Reiner, 1996).  Interestingly, attenuation of the sAHP, either with the spider toxin 
apamin or the monoamine 5-hydroxytryptamine (5-HT), enhanced the instantaneous 
frequency of firing of the cholinergic neurons.   
 
Among the putative glutamatergic neurons, only a population of fast firing putative 
type showed ZD7288 sensitive depolarizing sag during hyperpolarization (Huh et al., 
2010).   
 
1.2.6.1 Physiology of intrinsic septal connections 
Electrophysiological experiments carried out in vitro using MS slices or MS 
organotypic slices that are devoid of external synaptic inputs have provided evidence 
that the three major classes of MS neurons interact with each (i.e. intrinsic interaction).  
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Such investigations have mostly relied on administration of neurotransmitter 
substances to excite MS neurons and antagonists to block neural responses.   
 
For example, the glutamate receptor antagonists, 6-cyano-7-nitroquinoxaline-2,3-
dione (CNQX) and 2-amino-5-phosphonopentanoic acid (AP5), blocked the 
depolarizing synaptic currents induced in MS GABA neurons on application of the 
cholinergic-nicotinic receptor agonist, nicotine, to septal slices (Wu et al., 2003a).  
The nicotine-induced excitation was blocked by tetrodotoxin as well, a blocker of fast 
sodium channels that underpin the generation of action potential.  The sensitivity to 
tetrodotoxin suggested that the nicotinic effect was indirect, and likely involved 
excitation of glutamatergic neurons which, in turn, excited the GABA neurons.  
Likewise, Manseau et al. (2005) reported that application of the mixed cholinergic 
agonist, carbachol, in MS slices evoked glutamatergic EPSPs in MS neurons.  Indeed, 
carbachol excited cluster firing, putative glutamatergic neurons in the septal slices.  
Moreover, Manseau et al. (2005) observed large spontaneous depolarization evoked in 
all the three major classes of neurons in presence of the pro-convulsant agent 4-
Aminopyridine (4-AP), a voltage gated potassium channel blocker, and the GABAA 
receptor antagonist, bicuculline.  The depolarization was antagonized by glutamate 
receptor antagonists and was observed both in medial septal slices and organotypic 
medial septal slice culture.  
 
Alreja (1996) reported that excitation of local GABAergic neurons induced 
bicuculline and tetrodotoxin sensitive IPSPs in both cholinergic and non-cholinergic 
neurons in the region.  In the experiments, a population of GABAergic neurons was 
excited on bath application of 5-hydroxytryptamine (5-HT) in septal slices.  The 
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excitation of GABAergic neurons was tetrodotoxin insensitive, suggesting a direct 
excitation of the population by 5-HT (Alreja, 1996).   
 
The local GABAergic neurons are also excited by cholinergic neurons in the MS, 
presumably via release of acetylcholine by their local collaterals (Alreja et al., 2000; 
Wu et al., 2000; Wu et al., 2003b).  Indeed, a proportion of cholinergic neurons, 
identified by their uptake of fluorescent marker Cy3–192IgG or post hoc by 
immunolabeling, are spontaneously active in MS slice (Alreja et al., 2000).  These 
include septo-hippocampal neurons.  Further, antagonists at muscarinic receptor 
selectively decreased the basal activity of GABAergic neurons, while sparing 
cholinergic neurons, thus suggesting that intrinsic cholinergic drive affects local 
GABAergic neurons (Alreja et al., 2000; Wu et al., 2000).  In line with this, 
application of the muscarinic receptor agonist excited majority of GABAergic 
neurons.  The excitatory effect of muscarine was direct and was observed despite the 
block of local synaptic transmission.  Application of acetylcholinesterase (AChE) 
inhibitors reproduced the effects of muscarine on MS neurons (Wu et al., 2003b).  The 
AChE inhibitors increase the synaptic level of acetylcholine by preventing its 
degradation.  Thus, the electrophysiological effects of AChE support the idea that an 
intrinsic cholinergic tone sustained the activity of the GABAergic neurons.   
 
It is notable that in the preceding experiments, muscarine inhibited a sub-population 
of cholinergic neurons.  The inhibition of cholinergic neurons by muscarine was 
partly blocked by tetrodotoxin suggesting that muscarinic inhibition was mediated 
indirectly, at least in part, by excitation of MS GABAergic neurons (Wu et al., 2000). 
Here it is useful to reiterate that the cholinergic-nicotinic transmission also excites MS 
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glutamatergic neurons (see the 2
nd
 paragraph in this section).  Thus, potentially, 
intrinsic cholinergic transmission affects all three classes of neurons in MS.   
 
However, the physiological pattern of intrinsic interactions amongst the three classes 
of MS neurons is not clearly delineated in vivo.  Nonetheless, indirect evidence 
suggests that manipulation of synaptic transmission through the region affects the 
activity of MS neurons.  For example, the outflow of acetylcholine to hippocampus is 
increased with intraseptal microinjection of bicuculline, the N-Methyl-D-aspartate 
(NMDA) glutamate receptor antagonist, CPP, or the muscarinic antagonist, 
scopolamine.  Notably, the three classes of antagonists attenuate excitation of 
GABAergic network in MS, both in vitro (see above), and in vivo (Giovannini et al., 
1994; Givens and Olton, 1994; Moor et al., 1998; Elvander et al., 2004; Leung and 
Shen, 2004; Elvander and Ögren, 2005; Bland et al., 2007; Li et al., 2007).   
 
1.2.6.2 Septo-hippocampal interactions 
All the three major septo-hippocampal afferents, i.e. cholinergic, GABAergic and 
glutamatergic, modulate the excitability of the hippocampal neurons.  For example, 
Huh et al. (2010) recently showed that electrical stimulation of MS leads to short 
latency EPSP in a population of CA3 pyramidal cell in the septo-hippocampal slice 
preparation.  The EPSP was blocked by an antagonist at AMPA glutamate receptor.  
Likewise, chemical stimulation of the MS also evoked a glutamatergic EPSP in the 
pyramidal neurons.   
 
Relatively earlier investigations showed that tetanic stimulation of septal afferents 
through the stratum oriens of the hippocampus produced a slow depolarization in 
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intracellularly recorded CA1 pyramidal cells in hippocampal slices (Cole and Nicoll, 
1983).  The depolarization was antagonized by the cholinergic-muscarinic receptor 
antagonist, atropine.  Conversely, perfusion of the hippocampal slice with an AChE 
inhibitor, physostigmine, which blocks the degradation of acetylcholine, increased the 
size and duration of the stimulation-evoked depolarization.   
 
In line with in vitro experiments, tetanic stimulation of the MS in anaesthetized rat 
facilitated the Schaffer collateral/commissural afferent stimulation-induced CA1 
somatic population spike in an atropine-dependant fashion (Krnjević and Ropert, 1982; 
Rovira et al., 1983).  The effect of tetanic stimulation was replicated with 
iontophoretic application of acetylcholine in the pyramidal cell layer.  Interestingly, 
intra-hippocampal application of acetylcholine also reduced the size of afferent 
stimulation-induced IPSP evoked in CA1 pyramidal cells (Ben-Ari et al., 1981).  
However, acetylcholine did not affect the hyperpolarization due to direct application 
of the putative inhibitory transmitter, GABA.  Thus, the authors concluded that the 
acetylcholine acted presynaptically and reduced the release of GABA by inhibitory 
interneurons impinging upon pyramidal cells.  Such a disinhibition was suggested to 
partly underlie the facilitatory effect of cholinergic afferents on the somatic 
excitability of CA1 pyramidal cells.   
 
Paradoxically, stimulation of cholinergic afferents reduced the apical dendritic 
synaptic field excitatory postsynaptic potential of hippocampal pyramidal cells 
(Rovira et al., 1983).  Moreover, in hippocampal slices, optogenetic stimulation of 
cholinergic fibers triggered GABA mediated inhibitory postsynaptic currents (IPSC) 
in presence of glutamate receptor antagonists (Nagode et al., 2011).  The IPSC current 
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was blocked by atropine, and partly by cholinergic-nicotinic receptor antagonists, 
suggesting that stimulation evoked a release of acetylcholine that led to excitation of 
hippocampal GABAergic neurons which, in turn, inhibited CA1 pyramidal cells.   
 
In context of septo-hippocampal GABAergic neurons, Tóth et al. (1997) suggested 
that these afferents disinhibit hippocampal pyramidal neurons by inhibiting 
hippocampal interneurons.  In line with this, they showed that septal stimulation 
suppressed spontaneous IPSPs recorded intracellularly from CA3 pyramidal cells in a 
septo-hippocampal slice preparation.  During the experiments both glutamatergic and 
cholinergic synaptic transmissions were blocked suggesting that the effect of septal 
stimulation was mediated by the functionally remnant septo-hippocampal GABAergic 
neurons.  Indeed, the authors observed that septal stimulation inhibited putative 
interneurons in the hippocampus.  In parallel, the pyramidal cell was depolarized.  
The size of septal stimulation-induced postsynaptic depolarization increased in 
parallel with depolarization of the resting membrane potential to a more positive 
holding potential.  Equally, the size of intra-hippocampal afferent stimulation-evoked 
GABAergic IPSPs impinging on the pyramidal cells was increased.  The author 
suggested that the pattern of septal stimulation-induced depolarization reflected a 
rebound of the membrane potential of CA3 pyramidal cells from GABA mediated 
spontaneous hyperpolarization, the size of which increases with depolarization of the 
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1.3 Septo-hippocampal network activity 
1.3.1 Hippocampal theta wave activity 
It is notable that several patterns of relatively large extracellular field activities are 
recorded from the hippocampus (or hippocampal electroencephalogram, EEG).  These 
EEG wave patterns include rhythmical waveforms, such as theta (3–12 Hz), beta (12–
30 Hz), gamma (30–100 Hz) and ripple (100–200 Hz) waves, and non-rhythmic 
waves, such as large irregular activity (LIA) and small irregular activity (SIA).  In 
relation to the present study, this brief review will focus on theta waves in the rat 
hippocampus.   
 
Theta wave rhythm or rhythmic slow activity (RSA) is a regular sinusoidal 
extracellular waveform at a frequency of 3 – 6 Hz in anaesthetized animals and 4 – 12 
Hz in awake behaving animals and reflects the rhythmic oscillations of the 
intracellular membrane potential (Bland, 1986; Buzsáki, 2002).  It is notable that the 
phase of theta recorded from deeper layers of the hippocampus, including the stratum 
radiatum and stratum lacunosum-moleculare, is shifted vis-à-vis the theta recorded 
from stratum oriens-stratum pyramidale.   
 
In the anaesthetized rat, hippocampal theta wave activity may be observed 
spontaneously or elicited experimentally.  Such experimental manipulations include 
peripheral application of a noxious stimulus, and chemical or electrical stimulation of 
various brain regions such as the rostral reticularis pontine oralis (RPO), posterior 
hypothalamus (PH), supramammillary nucleus (SuM) and the medial septum (Vertes, 
1981; Bland et al., 1994; Khanna, 1997; Zheng and Khanna, 2001; Yoder and Pang, 
2005; Jiang and Khanna, 2006).  The theta wave activity in anaesthetized rat is 
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strongly attenuated by systemic administration of the muscarinic antagonists, atropine 
or scopolamine.  Likewise, in the awake rat, theta wave activity observed on sensory 
stimulation during animal immobility is abolished by atropine (Kramis et al., 1975).  
The atropine sensitive theta wave activity is classified as Type 2 theta (Bland, 1986; 
Buzsáki, 2002).  In addition, an atropine-resistant, relatively high frequency theta 
wave activity, also known as Type 1 theta, is recorded from the hippocampus of 
awake animals during voluntary motor behaviors and rapid eye movement (REM) 
sleep (Usui and Iwahara, 1977; Bland, 1986; Buzsáki, 2002).  Although cholinergic 
antagonists do not attenuate Type 1 theta, the antagonists affect the dorso-ventral 
pattern of phase shift of the theta wave in behaving animal suggesting that both 
atropine-sensitive and atropine-resistance components contribute to the theta wave 
activity in the behaving animal (Leung, 1984a).   
 
A dipole theory has been proposed to explain the generation of theta wave activity 
(Leung, 1984b).  According to the proposal, dipoles are generated during theta by 
perisomatic inhibition of pyramidal cells coupled with synaptic excitation at the distal 
dendritic layer of the CA1 pyramidal cells.  The rhythmic generation of current source 
and sink associated with the dipoles leads to fluctuation of the neuronal membrane 
potential that is recorded extracellularly as theta rhythm (Leung, 1984b; Buzsáki et al., 
1986; Smythe et al., 1992; Tóth et al., 1997; Brazhnik and Fox, 1999; Buzsáki, 2002; 
Yoder and Pang, 2005).  Furthermore, the change in the phase of theta along the 
dorso-ventral axis of CA1 is suggested to reflect the vector summation of the two 
dipoles (Leung, 1984b).   
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Interestingly, hippocampal theta can also be recorded in vitro in transverse 
hippocampal brain slices or in unilateral whole septohippocampal preparation 
(Konopacki et al., 1987; Goutagny et al., 2008).  Indeed, the theta wave-like 
oscillations may emerge spontaneously in vitro in field CA1 of the whole 
hippocampal preparation (Goutagny et al., 2009).  These oscillations exhibit 
properties of theta wave recorded in vivo, including (a) oscillatory frequencies in the 
theta range, (b) phase reversal from stratum oriens to stratum radiatum, and (c) 
source-sink alternation between stratum pyramidale and stratum radiatum.   
 
Single cell recordings, both in vivo and in vitro, support the two dipole hypothesis of 
the generation of theta waves.  For example, pyramidal cells depolarize during theta 
and, in addition, theta rhythmic intracellular membrane potential oscillations are 
recorded from the soma and the dendrites of the CA1 pyramidal cells, both in vivo and 
in vitro (Leung and Chi Yiu, 1986; Soltesz and Deschenes, 1993; Ylinen et al., 1995; 
Kamondi et al., 1998; Bland et al., 2002; Goutagny et al., 2009).  In line with the 
dipole theory, rhythmic IPSPs mediate, at least in part, the intracellular theta at the 
pyramidal cell soma, while correspondingly cyclic depolarization is observed in the 
apical dendrites.  Indeed, hippocampal CA1 interneurons that innervate the 
perisomatic region of pyramidal cells, especially parvalbumin positive basket cells 
and axo-axonic cells, show cyclic discharge during theta wave activity with the peak 
discharge around the positive phase of the extracellular theta recorded from the CA1 
pyramidal cell layer (Somogyi and Klausberger, 2005).  The positive phase of the 
theta wave recorded from the pyramidal cell layer corresponds temporally to the 
somatic hyperpolarization of the pyramidal cells.   
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It has been proposed that the medial septum and entorhinal cortex contribute to the 
two dipoles with the former mediating somatic inhibition via the hippocampal 
interneurons (see below), whereas the latter providing the excitatory drive, at least in 
part, at the apical dendrites.  In context of the latter, current-source density analysis of 
extracellular current flow indicates that lesion of the entorhinal cortex leads to a loss 
of a sink in the distal dendrites in parallel with loss of dendritic theta (Ylinen et al., 
1995; Kamondi et al., 1998).   
 
However, the intrinsic theta activity recorded in vitro in whole hippocampus is 
suggested to be generated by a feedback loop between CA1 pyramidal cells and 
inhibitory interneurons such that pyramidal cells excite interneurons via release of 
glutamate and, in turn, are inhibited by interneurons through GABAA receptor 
mechanism leading to generation of rhythmic potentials that reflect as extracellular 
theta (Goutagny et al., 2009).  In this regard, the intrinsic theta wave activity recorded 
in vitro from the whole hippocampus preparation is blocked by application of the 
AMPA receptor antagonist, 6,7-dinitroquinoxaline-2,3-dione (DNQX) or the GABAA 
receptor antagonist bicuculline, and is insensitive to atropine (Goutagny et al., 2009).   
 
1.3.2 Role of the medial septum in hippocampal theta generation 
Several lines of evidence implicate the medial septum in the generation of 
hippocampal theta rhythm, both in anaesthetized and behaving animals.  The evidence 
suggests that the medial septal neurons influence both the amplitude and the 
frequency of the hippocampal theta.  The evidences from anaesthetized and behaving 
animals include the following: 
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A) medial septal neurons in the anaesthetized animal discharge rhythmically in 
parallel with hippocampal theta wave activity generated spontaneously, on electrical 
stimulation of the reticular formation or tail pinch (Bland et al., 1994; Bland and 
Oddie, 1998; Bland et al., 1999),   
B) electrical stimulation (6 – 10 Hz) of the medial septum in awake animal drives 
hippocampal theta wave activity at the stimulation frequency (Gray and Ball, 1970), 
while in anaesthetized animal it resets the frequency (either increase or decrease to 
that of the frequency elicited by MS stimulation alone) and increases the amplitude of 
theta triggered by stimulation of the posterior hypothalamus (PH) or the region of the 
reticularis pontis oralis (RPO or reticular stimulation)(Jackson and Bland, 2006), 
C) MS inactivation with the local anesthetic lidocaine reduced the spontaneous firing 
rate of single unit hippocampal CA1 neurons which were classified as theta cells 
according to their firing properties.  These neurons discharge rhythmically in parallel 
to theta activity (Ranck Jr, 1973; Mizumori et al., 1989). 
D) inactivation of the medial septum with the local anesthetic, procaine, or the 
GABAA agonist, muscimol, attenuated the spontaneous or intracerebral stimulation-
evoked hippocampal theta wave activity (Smythe et al., 1991; Bland et al., 1996; 
Jiang and Khanna, 2004).  Likewise, lesion or inactivation of the medial septum in the 
behaving rat attenuated Type 1 and 2 theta, including hippocampal theta evoked 
during PH stimulation-induced wheel running behavior (Allen and Crawford, 1984; 
Lawson and Bland, 1993; Oddie et al., 1996), 
E) selective destruction of medial septal cholinergic or the GABAergic neurons by 
intraseptal microinjection of the neural-selective toxins attenuated the amplitude of 
Type 1 and 2 theta (Zheng and Khanna, 2001; Yoder and Pang, 2005).  The lesion did 
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not affect the frequency of theta.  Moreover, the destruction of both neuronal types 
eliminated theta altogether (Yoder and Pang, 2005), 
F) iontophoretic application of atropine attenuated theta-rhythmic discharge of 
putative interneurons in field CA1 of the anaesthetized rat (Stewart et al., 1992).  This 
is consistent with the evidence that stimulation of cholinergic septo-hippocampal 
afferents excite hippocampal interneurons (see section 1.2.6.2), 
G) intraseptal administration of ZD7288, a blocker of hyperpolarization-activated 
cation currents or Ih, attenuated the frequency of Type 1 and 2 theta (Kocsis and Li, 
2004).  Interestingly, the effect of the drug was more pronounced on the higher theta 
frequencies evoked on relatively high intensity reticular stimulation.  Indeed, the drug 
abolished the ability to induce the atropine-resistant high frequency theta on reticular 
stimulation (Kocsis and Li, 2004), and  
H) intraseptal administration of N-methyl-D-aspartate (NMDA) receptor antagonist, 
AP5, into the medial septum attenuated the amplitude of both Type 1 and 2 theta 
(Leung and Shen, 2004; Bland et al., 2007). 
 
Interestingly, the evidence, that intraseptal ZD7288 attenuates hippocampal theta 
frequency (see point G, above, Kocis and Li, 2004), underscores a crucial role of the 
Ih carrying neurons in the medial septum in the generation of hippocampal theta.  The 
Ih current is carried by HCN1/2 channels.  Notably, the HCN immunopositive neurons 
are GABAergic and exhibit theta rhythmic burst firing in parallel with tail-pinch-
induced theta in anaesthetized rat (Simon et al., 2006; Varga et al., 2008).  A 
proportion (~50%) of these also exhibited theta rhythmic burst discharge during non-
theta period.  Conversely, non HCN neurons are non-bursting and only a low 
percentage exhibited theta rhythmic discharge.   
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By analyzing the temporal sequence of activity between the medial septal 
GABAergic/HCN containing neurons and hippocampal local field activity, Hangya et 
al. (2009) observed that the medial septal GABAergic/HCN neuronal firing precedes 
the shift of hippocampal EEG state from large irregular activity to the synchronized 
theta state in the urethane anaesthetized rat (Hangya et al., 2009).  In contrast, the 
increase in discharge of putative cholinergic neurons in MS, and the corresponding 
release of acetylcholine in the hippocampus, is slower than the onset of tail pinch-
induced hippocampal theta (Zhang et al., 2010).  This suggests that MS cholinergic 
neurons are not essential for theta initiation.   
 
A model has been proposed that integrates the hippocampal effects of GABAergic 
and cholinergic septo-hippocampal neurons in the generation of hippocampal theta 
wave activity.  In the proposed model the septo-hippocampal GABAergic neurons 
sculpt the activity of hippocampal inhibitory interneurons into theta rhythm against 
the background of tonic excitation by the cholinergic septo-hippocampal neurons 
(Bland, 1986; Stewart and Fox, 1990; Buzsáki, 2002).  In turn, the hippocampal 
interneurons evoke theta rhythmic IPSPs in the pyramidal cells.  Strikingly, a 
population of CA1 pyramidal cells depolarizes during theta (Bland et al., 2002).  Here 
it is also notable that among the multiple and paradoxical effect, the septo-
hippocampal cholinergic neurons depolarize CA1 pyramidal cells.  However, at 
present the role of septohippocampal cholinergic input, if any, remains unclear. 
 
The role of the septo-hippocampal glutamatergic in hippocampal theta activation is 
less well studied.  Though, as pointed out in section 1.2.6, a population of fast firing 
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and Ih-current carrying neurons is glutamatergic in nature and, analogous to 
GABAergic neurons, might convey a theta rhythmic signal to the hippocampus (Huh 
et al., 2010).  Interestingly, microinfusion of NMDA into hippocampal pyramidal cell 
apical dendrites have been shown to induce theta which was blocked by intra-
hippocampal AP5 in the urethane anaesthetized rat (Bland et al., 2007).  
 
1.3.3 Role of the medial septum and theta in affect-motivation  
From a neurophysiological perspective, the MS plays a crucial role in processing of 
information by the hippocampus.  For example, in context of field CA1, Freund and 
Buzsaki (1996) have proposed that the rhythmic inhibition, facilitated by MS, affects 
spatially distributed population of CA1 pyramidal cells during theta and groups them 
into a coherent ensemble of neurons during biologically relevant events.  The 
inhibition may function to pre-empt the excitation of most pyramidal neurons whereas 
a select population of pyramidal cells that show a high spontaneous discharge are 
selectively excited by the event (i.e. ‘signal-to-noise’ processing) (Buzsáki, 1989; 
Thompson and Best, 1989; Khanna, 1997).  At the same time, the rhythmic 
hyperpolarization help demarcate the intensity of cell excitation such that cell 
excitation to strong excitatory inputs advances temporally towards the peak of the 
local theta wave which corresponds to intracellular hyperpolarization of CA1 
pyramidal cell (Magee, 2001; Harris et al., 2002; Mehta et al., 2002; Gasparini and 
Magee, 2006).   
 
Along with the above, it has been proposed that the inhibition of intrinsic Schaffer-
collateral excitatory input from CA3 to CA1 pyramidal cells by the septo-
hippocampal cholinergic neurons also plays a role in encoding of information during 
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theta activation, albeit indirectly (Hasselmo and McGaughy, 2004).  These authors 
have proposed that the cholinergic mediated inhibition facilitates encoding to external 
sensory input to biologically relevant stimulus by suppressing irrelevant intrinsic 
information in the hippocampus (Leung and Vanderwolf, 1980; Khanna, 1997; 
Hasselmo and McGaughy, 2004).   
 
Behaviorally, both theta activation and MS are implicated in affect-motivation.  In 
this context, there are several evidences that support the role of theta and medial 
septum including the following:  
 
A) Oddie et al. (1997) observed that intraseptal atropine attenuated dodging 
movement made by a hungry rat in response to another rat attempting to steal its food 
(Oddie et al., 1997).  Concomitantly, atropine sensitive, Type 2 theta was abolished, 
though the Type 1 movement related theta was spared (Oddie et al., 1997),   
B) posterior hypothalamus (PH) stimulation-induced wheel running behavior and 
hippocampal theta activation were attenuated concomitantly on inactivation of medial 
septum (Oddie et al., 1996).  Further, the recovery of wheel running speed paralleled 
the recovery of hippocampal theta frequency,   
C) likewise, desynchronizing stimulation of median raphe (MR) that attenuated 
hippocampal theta activity blocked PH stimulation-induced wheel running behavior 
which recovered, together with theta activation, on stopping the MR stimulation 
(Bland, 2009),  
D) knockout of phospholipase C β4 (PLC-β4) in MS neurons increased anxiety-like 
behavior in mice accompanied by a decreased hippocampal theta activation (Shin et 
al., 2009).  The increased anxiety was marked by decreased exploration of the 
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environment, especially the open arm of the apparatus.  Augmenting the cholinergic 
transmission in the septohippocampal pathway by systemic injection of rivastigmine, 
an acetylcholinesterase inhibitor, restored hippocampal theta and decreased anxiety 
behavior marked by increased exploration of the environment (Shin et al., 2009), and 
E) in rats trained to jump out of box, the frequency of theta varied with behavior 
(Bland et al., 2006).  Thus, Type2 theta was observed during immobility.  Such theta 
exhibited an incremental increase in frequency just prior to jump leading to a 
relatively high frequency theta with the jump (i.e. Type 1 movement related theta).  
An analysis of the jump indicated that the speed of initiation of the jump was 
associated with the frequency of the theta. 
 
Overlaying the behavioral observation with the neurophysiological findings, Bland 
and colleagues have proposed a sensory-motor integration function of the septo-
hippocampus network (Bland, 1986; Bland and Oddie, 2001; Bland, 2009).  Broadly, 
in the model proposed by Bland and colleagues, hippocampal information during 
Type 2 theta, triggered by sensory stimulation, is relayed to motor areas.  The 
frequency of action potential discharge during theta-rhythmic bursting of hippocampal 
neurons signals the intensity of hippocampal response to the change.  Such intensity 
coded hippocampal response relayed during Type 2 theta is used by the motor 
network as a ‘readiness’ signal and/or an ‘intensity’ signal that primes the motor 
system to generate movements at the desired intensity.  During Type 1 theta, which is 
observed in parallel with voluntary motor activity and occurs at higher frequency than 
Type 2 theta, the hippocampal neural activity integrates sensory information with 
motor information.  For example, the frequency of cell discharge per theta rhythmic 
burst during voluntary behavior may increase over that seen during type 2 activity 
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alone.  The increase reflects the input from the motor systems against the background 
of sensory information.  The cell discharges per rhythmic burst during Type 1 
movement codes for both the speed of initiation of the motor program and/or the 
changes in intensity of any ongoing motor program.  In turn, the integrated 
information from the hippocampus then feeds back continually to the motor regions 
providing these region with information on their performance relative to sensory 
conditions.  Here it is notable that septo-hippocampal network is functional linked 
with motor areas.  For example, stimulation in motor areas, especially the red nucleus 
and the basal ganglia evokes hippocampal theta via the medial septum (Dypvik and 
Bland, 2004; Hallworth and Bland, 2004).  Indeed, theta related cells are observed in 
these motor areas. 
 
It follows from the theory that interruption of septo-hippocampal during Type 2 
and/or Type 1 theta will affect the execution of voluntary behaviors as observed in 
experiments cited above (points A and D above).  Interestingly, Bland et al. (2006) 
noted that during animal jump (point E) for the highest jump height, the movement 
initiation occurred around the trough of theta recorded from the stratum moleculare.  
Notably, the trough of stratum moleculare theta corresponds to the peak of CA1 
pyramidal cell layer theta.  The highest frequency of pyramidal cell discharge during 
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1.4 Pain and the septo-hippocampal system  
1.4.1 Pain: general description 
Pain is defined by the International Association for the Study of Pain (IASP) as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage or described in terms of such damage” (Loeser and Treede, 2008) and serves 
an important biological role in directing attention to the bodily damage in order to 
facilitate recuperation and prevent further tissue damage.  Tissue damage can be 
caused by a variety of noxious stimuli, including chemical, mechanical or thermal, 
and is detected by specialized peripheral high-threshold sensory receptors called 
nociceptors.  The transduction of noxious stimulus by nociceptors leads to encoding 
of the properties of noxious stimuli or nociception (Loeser and Treede, 2008).  While 
nociception is readily studied in animals, the emotional aspect of pain, which is 
subjective, is difficult to quantify in animal studies.  Nonetheless, it is assumed that 
animals experience unpleasantness similar to humans upon tissue damage.  The 
unpleasantness is quantified in animals using (1) behavioral responses such as 
vocalization and guarding of the injured area (Mogil and Crager, 2004), and (2) 
physiological responses, such as changes in heart rate and respiratory rate. 
 
Pain has been conceptualized to comprise of three components: sensory-
discriminative, affective-motivational and cognitive-evaluative (Melzack and Casey, 
1968).  The sensory-discriminative component refers to the location, intensity, quality 
and duration of a noxious stimulus and functions to provide the spatial and temporal 
map of the noxious stimulus.  The affective-motivational component reflects the 
aversive and negative feelings that are associated with the perception of pain and the 
drive to seek pain relief.  The negative feelings may be expressed overtly by facial 
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grimaces, flinching and withdrawal from the noxious stimulus that enables one to 
recognize that someone is in pain (Craig, 1995).  The cognitive-evaluative component 
refers to the influence on pain by the “higher central nervous system” or cognitive 
activities, that is, the ability of past experiences or present environmental 
circumstances to affect pain behavior.  Indeed, anticipation of pain and anxiety 
appears to enhance pain in general, whereas fear decrease pain reactivity in human 
studies (Rhudy and Meagher, 2000; Rodriguez-Raecke et al., 2010).  
 
In general, the cortical processing of the noxious signal is suggested to underpin the 
different dimensions of pain.  Indeed, patients with frontal lobotomy rarely complain 
about severe clinical pain or ask for pain relief (Freeman and Watts, 1948).  The 
cortex receives pain information via ascending pathways arising from the spinal cord.  
Broadly, tissue damage activates nociceptors, which are free unmyelinated nerve 
endings innervating tissues.  This initiates the propagation of nociceptive signals via 
Aδ- and C-primary afferent fibers (Almeida et al., 2004; Willis et al., 2004).  The 
information carried by the nociceptors reaches the spinal cord where the nociceptors 
synapse with and relay the information to second-order neurons in the dorsal horn.  
Second order neurons include (a) nociceptive specific (NS) neurons which receive 
input only from Aδ- and C-fibers, and (b) wide dynamic range (WDR) neurons (also 
known as multireceptive neurons) that receive non-nociceptive input from Aβ fibers 
which is in addition to noxious information conveyed to the WDR neurons by the two 
nociceptive afferents (Almeida et al., 2004).  It has been proposed that the NS neurons 
code for the localization and quality of the noxious stimulus, while the intensity of the 
stimulus is enoded by the WDR neurons (Almeida et al., 2004).  The spinal neurons in 
turn relay the nociceptive information via a number of ascending tracts, such as the 
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spinothalamic tract, spinoreticular tract and the spinomesencephalic tract, to different 
supraspinal regions.  The information eventually reaches the cortex via the thalamus 
(Almeida et al., 2004). 
 
Apkarian et al. (2005) carried out a comprehensive review of human brain areas 
activated with pain.  Indeed, a variety of different forebrain areas are activated with 
application of peripheral noxious stimulation as detected by scanning techniques such 
as positron emission tomography (PET) and functional magnetic resonance imaging 
(fMRI). For example, contact heat and cold induced pain activated areas such as the 
anterior cingulate cortex (ACC), primary somatosensory cortex (S1), insular cortex 
(IC), thalamus (Th), and prefrontal cortex (PFC).  Interestingly, the ACC stands out as 
the cortical region that is most often activated with peripheral application of noxious 
stimuli in humans (Apkarian et al., 2005).  This region is implicated in the affective 
processing of nociception.  A number of animal studies also support this view.  In this 
regard, excitotoxic lesion of the anterior cingulate cortex (ACC) blocked the formalin-
induced conditioned place avoidance in behaving rats without affecting the 
nociceptive behaviors.  Normally, sham lesioned animals spent significantly less time 
in the formalin-paired compartment as compared with the preconditioning test day 
indicating that the animals avoid the pain-paired compartment.  The place avoidance 
was attenuated by lesion of ACC (Johansen et al., 2001; Gao et al., 2004).   
 
1.4.2 Supraspinal regulation of pain 
Nociceptive information arriving at the dorsal horn of the spinal cord is integrated 
before ascending up to higher brain centres where the neural activity is linked to pain.  
In this regard, several cortical region can affect pain perception.  These areas include, 
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but not limited to, the prefrontal cortex, anterior cingulate cortex (ACC) and the 
insular cortex (Tracey and Mantyh, 2007).  For example, animal studies indicate that 
the ACC is involved in the affective component of pain since manipulation of the 
ACC, either by muscimol microinjection into the region or lesion, suppressed 
formalin-induced conditioned place avoidance behaviors (Johansen et al., 2001; Gao 
et al., 2004; Wang et al., 2005).  An increased activity in prefrontal cortex was also 
found in certain human pain conditions (Tracey and Mantyh, 2007).  Indeed, immune-
related genes in the prefrontal cortex were found to be upregulated during 
inflammatory pain and injection of a peptide, identical to the C terminus of murine 
S100A9 protein, into the region resulted in decreased facial hypersensitivity evoked 
by carrageenan injection (Poh et al., 2012).  Ascending nociceptive information is also 
subjected to modulation in the form of inhibition or facilitation of the nociceptive 
processing.  In this regard, several supraspinal structures, some of which send 
monosynaptic projections to the spinal cord, are crucial to this network of descending 
modulatory pathways.  These supraspinal structures include the hypothalamus, 
rostroventromedial medulla (RVM), dorsal reticular nucleus of the medulla (DRt) and 
the periaqueductal grey (PAG). 
 
The hypothalamus receives projection from laminae I, V and X of the spinal cord via 
the spinohypothalamic tract (Almeida et al., 2004) and also sends monosynaptic 
projections to the spinal cord.  In this context, hypocretin positive containing neurons 
of the lateral hypothalamus innervate all 10 laminae of the spinal cord, with stronger 
innervation of the dorsal horn, especially lamina 1 of the dorsal horn (van den Pol, 
1999).  Indeed, studies in both humans and animals indicated that the hypothalamus is 
activated during noxious stimulation (Dafny et al., 1996; Hsieh et al., 1996) and 
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electrical stimulation or application of morphine into the lateral hypothalamus evokes 
antinociception in the nociceptive tail flick test in awake rat (Dafny et al., 1996).  
Additionally, deep brain stimulation of the hypothalamic region resulted in an 
increase in the pain threshold for cold in cluster headache patients (Jürgens et al., 
2009).  
 
One of the most well-known pain modulatory system proceeds via the PAG-RVM 
pathway.  Indeed, the PAG is reciprocally connected with the spinal cord, directly or 
indirectly.  In this context, retrograde and anterograde tract tracer studies indicate that 
the PAG receives direct projections from neurons in the spinal laminae I (Craig, 1995; 
Mouton et al., 2001; Spike et al., 2003).  Conversely, experiments with anterograde 
tracers indicate that the neurons in PAG, especially ventrolateral PAG, project to the 
RVM.  These projections make contacts with reticulospinal neurons retrogradely 
labeled by the injection of fluorogold into the spinal cord (Morgan et al., 2008).  
Furthermore, PAG electrical stimulation-induced analgesia is attenuated by an 
anesthetic blockage of the RVM such that the microinjection of lidocaine in the RVM 
significantly increased the PAG stimulation threshold required to evoke an inhibition 
of the tail flick reflex in the anaesthetized rat (Sandkühler and Gebhart, 1984).  Direct 
projections from the PAG to the spinal cord exists but contributes only a minor 
proportion of the overall projections from the PAG and appears to only arise from the 
lateral PAG in the monkey (Castiglioi et al., 1978; Mantyh, 1983).  
 
In humans intractable pain is relieved by electrical stimulation of the PAG 
(Hosobuchi et al., 1977; Richardson and Akil, 1977).  Likewise, PAG activation is 
observed with imaging techniques during a cued self-distraction condition where 
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human subjects gave lower pain intensity ratings (Tracey et al., 2002).  Interestingly, 
analgesia elicited by electrical stimulation of the PAG in both animals and humans is 
blocked by the narcotic antagonist, naloxone, suggesting that, at least in part, 
opioidergic mechanisms are involved in the PAG mediated analgesia/antinociception 
(Akil et al., 1976; Hosobuchi et al., 1977).   
 
With regard to RVM, two different populations of neurons in the RVM, termed the 
ON-cells and the OFF-cells, have been shown to be crucial in the descending 
modulation of nociception (Millan, 2002).  ON-cells are suggested to be pro-
nociceptive and facilitate spinal nociceptive transmission while OFF-cells are 
proposed to be antinociceptive and inhibit spinal nociceptive transmission when 
active.  In this regard, the former exhibit an increase in firing while the latter 
decreased firing just prior to the nociceptive tail flick reflex (Fields et al., 1983; Fields 
et al., 1988; Heinricher et al., 1989; Fields et al., 1991; Morgan and Fields, 1994).  In 
addition, injection of formalin into the hind paw, a model of persistent inflammatory 
pain, increased the firing responses of the ON-cells of the RVM (Vanegas and 
Schaible, 2004).  Further proof that the RVM is involved in both descending 
inhibition and facilitation comes from evidences that show that opioids directly inhibit 
ON-cells and activate OFF-cells possibly through disinhibition (Heinricher and 
Tortorici, 1994), and that microinjection of cholecystokinin (CCK) resulted in thermal 
hyperalgesia from the selective activation of RVM ON-cells (Heinricher and Neubert, 
2004). 
 
Lastly, the medullary dorsal reticular nucleus (DRt) appears to facilitate nociceptive 
behavior.  Retrograde tracing with wheat germ agglutinin-horseradish peroxidase 
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(WGA-HRP) or cholera toxin subunit B (CTb) microinjected into the DRt 
predominantly labeled neurons in lamina I and lamina X of the rat spinal cord 
indicating that spinal neurons project to the DRt (Lima, 1990).  In the context of 
facilitation, quinolinic acid lesion of the DRt increased the tail flick latencies and 
hotplate response temperature in behaving rats.  Similarly, electrolytic lesion or 
quinolinic acid lesion of the DRt decreased the hind paw formalin-induced 
nociceptive behaviors such as licking and flinching of the injured paw (Almeida et al., 
1999).  Number of cells expressing the proto-oncogene c-fos, commonly used as a 
marker of spinal nociceptive processing in the dorsal horn (lamina I-VI) of the spinal 
cord, was also correspondingly reduced.  Conversely, tail flick latency was decreased 
with chemical stimulation of the DRt by the injection of glutamate into the region 
(Almeida et al., 1996; Almeida et al., 1999; Lima and Almeida, 2002).  All in all, these 
findings suggest a role of the DRt, at least in part, in facilitating nociception. 
 
1.4.3 Formalin test – a model of persistent pain 
The formalin test is a commonly used model of persistent pain due to tissue injury 
(Dubuisson and Dennis, 1977; Tjølsen et al., 1992).  Formalin is an aqueous solution 
typically made by diluting 37% formaldehyde (w/w) with water.  In the formalin test, 
a small volume (20 to 150 µl) of dilute formalin (1 to 5%) is injected subcutaneously 
into the paw (dorsal or plantar surface) of a manually restrained animal (Tjølsen et al., 
1992).  Compared with other noxious chemical agents such as acetic acid, 
carrageenan and topical mustard oil, the spontaneous behaviors induced by 
subcutaneous formalin injection into the paw is more robust and reproducible 
(Wheeler-Aceto et al., 1990).  The formalin-induced change in behavior is 
spontaneous and sustained thus differing from other traditional nociceptive test that 
 - 47 - 
involve the application of an acute painful stimulus such as application of strong 
pressure or thermal stimulus that elicits short-lasting nociception.  In addition, 5% 
formalin injection into human skin results in an intense burning pain followed by a 
steady, throbbing ache with a time course that mirrors the characteristic biphasic 
behavioral response observed in animals (Dubuisson and Dennis, 1977).   
 
The nociceptive behavioral responses observed after injection of formalin into the 
animal’s hind paw include easily identifiable behaviors such as lifting, licking and 
flinching or shaking of the affected paw (Dubuisson and Dennis, 1977).  Moreover, 
autonomic changes such as an increase in blood pressure and heart rate are also 
observed (Taylor et al., 1995).  The formalin-induced nociceptive behavioral and 
cardiovascular responses follow a biphasic pattern with an acute phase (1st phase) 
lasting between 5 to 10 minutes, followed by a quiescent period (interphase) of about 
5 to 10 minutes, and subsequently a tonic phase (2nd phase) generally lasting up to 60 
to 90 minutes after injection (Sawynok and Liu, 2004). 
 
Nociceptive behavior evoked upon injection of formalin into the paw is evaluated 
either by way of recording individual parameters of licking, shaking and favoring of 
the injured paw or by using a composite scale of weighted scores derived from the 
individual parameters.  The weighted pain scores method involves the assigning of 
different weights to distinct categories of pain behaviors: 0 = injected paw is not 
favored, 1 = injected paw has little or no weight on it, 2 = injected paw is elevated and 
not in contact with any surface, 3 = injected paw is licked, bitten, or shaken.  A 
weighted average pain intensity score is then calculated by the adding the duration 
spent in each category multiplied by its weight, and then dividing the sum by the total 
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time.  The weighted score method was proposed to be reflective of the overall pain 
experience of the animal (Dubuisson and Dennis, 1977; Coderre et al., 1993). 
 
The other method of recording individual parameters of licking and flinching without 
assigning any weight has the advantage of being continuous scores from which time 
course and cumulative scores can be analyzed (Sawynok and Liu, 2004).  In addition, 
this method does not assume that a behavioral category represents twice or three times 
as much pain as the other behavior as is implicit in the case of the weighted scores 
method (Tjølsen et al., 1992).  Indeed, licking and flinching may involve distinct 
mechanisms as they are differentially modulated by different drugs and procedures 
(Sawynok and Liu, 2004).  In this context, injection of saline via a chronically 
implanted intrathecal cannula has been found to completely abolish licking/biting 
behavior induced by 1.5%, 2.5% or 5% formalin.  Flinching behavior was unaffected 
at the lower formalin concentrations but was increased at 5% formalin with the 
chronic intrathecal cannula (Sawynok and Reid, 2001, 2003).  Additionally, naloxone, 
an opioid receptor antagonist, and the tricyclic antidepressant (TCA) amitriptyline 
simultaneously augment flinching while attenuating licking when administered 
systemically (Wheeler-Aceto and Cowan, 1993; Sawynok and Reid, 2001).  In 
contrast, other TCAs such as imipramine, nortriptyline and desipramine decreased 
licking behavior without affecting flinching behavior (Sawynok and Reid, 2001). 
 
Electrophysiological studies have demonstrated the activation of A and C type 
nociceptive fibers and spinal dorsal horn neurons with the subcutaneous injection of 
formalin into the hind paw.  In this context, recordings from physiologically identified 
A, C or Aβ type single fiber of the anaesthetized rat saphenous nerve indicated that 
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subcutaneous injection of formalin, but not saline, into the receptive field of the fiber 
in the paw evoked long lasting and biphasic action potential discharges in A and C 
fibers that persisted till at least 40min.  In contrast, Aβ fibers were transiently 
activated and that too only in the 1st phase (McCall et al., 1996; Puig and Sorkin, 
1996).   
 
Recent evidence has revealed the potential cellular mechanism by which formalin 
excites nociceptive neurons, at least in part.  TRPA1, a member of the transient 
receptor potential (TRP) family of ion channels expressed in nociceptive neurons, has 
been shown to be activated directly by formalin.  In this context, calcium imaging 
studies indicated that formalin evokes calcium influx in cells expressing cloned 
TRPA1 or in isolated dorsal root ganglia sensory neurons containing TRPA1, which 
was blocked by application of a TRPA1 antagonist (Macpherson et al., 2007; 
McNamara et al., 2007).  Similarly, activation of the TRPA1 channel was also 
confirmed electrophysiologically with an inside-out patch of TRPA1 on cloned cells 
(Macpherson et al., 2007).  Furthermore, formalin-induced nociceptive behavior 
(flinching) in both phases was attenuated with systemic administration of the TRPA1 
antagonist in rats, and mutant TRPA1-deficient mice displayed significantly 
diminished responses in both phases of the formalin test as compared to wild-type 
mice (Macpherson et al., 2007; McNamara et al., 2007). 
 
Like sensory fibers, the convergent dorsal horn neurons, recorded mainly from the 
superficial and deep dorsal region in the anaesthetized rat, also exhibit biphasic 
excitation following formalin injection into their receptive field in the ipsilateral hind 
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paw.  This formalin-evoked excitatory response persisted till around 60 minutes after 
formalin injection (Dickenson and Sullivan, 1987).   
 
Based on the foregoing, a direct activation of sensory afferents by formalin appears to 
play a role in both phases of nociceptive behavior induced by formalin injection into 
the paw.  However, the 2nd phase also appears to involve more than just ongoing 
afferent activation.  Non-steroidal anti-inflammatory drugs (indomethacin, naproxen 
etc.) and steroids (dexamethasone, hydrocortisone etc.) selectively inhibited the 2nd 
phase responses without affecting 1st phase responses thus indicating that the 2nd 
phase involves inflammatory processes (Hunskaar et al., 1986; Hunskaar and Hole, 
1987; Sawynok and Liu, 2004).   
 
In addition, central sensitization in the spinal cord resulting from the 1st phase 
afferent activity was also shown to contribute to the 2nd phase nociceptive responses.  
In this regard, intrathecal administration of the opioid agonist, Tyr-D-Ala-Gly-
MePhe-Gly-ol-enkephalin (DAGO), inhibited the 2nd peak of dorsal horn activity 
more strongly when applied before vs. 2 minutes after formalin injection (Dickenson 
and Sullivan, 1987).  The inhibition with pre-administration of DAGO was not 
antagonized by intrathecal naloxone administered two minutes post formalin injection 
thus suggesting that the decrease in discharge in the 2
nd
 phase was not due to the 
sustained effect of the opioid agonist but might reflect a carryover of the effect of the 
drug on events in the 1
st
 phase.  Likewise, the late phase behaviors in the formalin test, 
measured 30 – 60 minutes post formalin, were attenuated by a) intrathecal 
administration of the local anesthetic, lidocaine, prior to, but not after formalin 
injection (Coderre et al., 1990) and b) injection of the local anesthetic, bupivacaine, 
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into the formalin injected paw at 5 minutes before and 25minutes after, but not only 
after formalin injection, attenuated nociception.  Hence events occurring in the first 
phase may initiate neural changes in the spinal cord that influence the development of 
the second phase.     
 
Along this line, the NMDA antagonists, AP5 and MK801, administered intrathecally 
decreased formalin induced nociceptive responses in the second phase but not the first 
phase.  Furthermore, this analgesic-like effect was only observed when the NMDA 
antagonist was given before the formalin injection but not after the first phase of the 
formalin test (Coderre and Melzack, 1992; Yamamoto and Yaksh, 1992).  This 
suggests that activation of NMDA receptors is important, at least in part, for the 
sustained facilitation of central nociceptive mechanisms initiated during the first 
phase.  Electrophysiological results also supported this view whereby pretreatment 
with intrathecal AP5 significantly reduced formalin-induced 2
nd
 peak of activity of 
deep dorsal horn multireceptive neurons but not the first peak of activity.   
 
1.4.3.1 Fos as a spinal nociceptive marker 
The immediate early gene, c-Fos, is rapidly and transiently expressed when neurons 
are excited (Morgan and Curran, 1989).  Fos, the phosphoprotein product of c-Fos, is 
a transcription factor that binds to the AP-1 (activator protein 1) DNA site, after 
forming a heterodimeric complex with other nuclear proteins of the Jun family, where 
it acts to regulate the “downstream” expression of target genes.  Hence Fos is 
involved in the signal transduction cascade that couples extracellular signals to long-
term intracellular adaptations (Morgan and Curran, 1989).   
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In context of sensory stimulation, Hunt et al. (1987) found that both noxious and non-
noxious stimulation results in the induction of c-Fos expression in the spinal cord, 
although the induction was not co-extensive.  Noxious stimulus typically evoked 
extensive FLI in laminae I, II and V of the dorsal horn whereas tactile stimulation 
evokes FLI in laminae II to IV.  This pattern of induction parallels the pattern of 
spinal termination of nociceptors and low threshold mechanoreceptors that are excited 
by the noxious and non-noxious stimuli, respectively.  Accordingly, nociceptive 
primary afferents such as Aδ and C fibers terminate mostly in superficial laminae I 
and II, and the deeper laminae V whereas Aβ fibers, which respond to non-noxious 
stimulus, terminate in lamina III, IV, V and VI (Woolf, 1994; Sorkin and Yaksh, 1998; 
Basbaum and Jessell, 2000).  This connection between nociception and c-Fos 
expression in the spinal cord is supported by other studies that show that procedures 
that affect nociceptive behavior also affect the induced expression of c-Fos.  For 
example, (a) behavioral conditioning, which reduced animal nociceptive responses to 
formalin, reduced spinal expression of Fos protein (Harris et al., 1995), and (b) prior 
administration of the narcotic analgesic, morphine, that reduces formalin-induced 
nociceptive behaviors, also suppressed the induction of FLI by formalin injection 
(Presley et al., 1990).   
 
The functional implication of the induction of the Fos protein remains unclear.  
However, potentially Fos, via effect on expression on downstream genes, may alter 
spinal nociceptive circuits that result in hyperalgesia or allodynia as it has been shown 
that c-Fos is expressed highly in spinal neurons following manipulations that cause 
hyperalgesia and allodynia (Harris, 1997).  Fos may also be important in the 
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development of an adaptive response in the spinal cord to ongoing or subsequent 
nociceptive insult (Munglani and Hunt, 1995). 
 
1.4.4 Role of the medial septum in pain 
The role of the medial septum region in nociception (pain) remains undefined though 
there is evidence to link the region to nociception in animals and pain in humans.  In 
context of the latter, electrical stimulation of the septal area in humans provided 
dramatic relief from chronic pain in some instances (Gol, 1967; Scavarez, 1993).  
Likewise, in rat, carbachol microinjection into the septal area evoked an 
antinociceptive effect in some instances in the tail flick test and the calibrated-pinch 
test (Klamt and Prado, 1991).  Further, septo-hippocampal neurons are activated on 
noxious peripheral stimulation in anaesthetized rat (Dutar et al., 1985).  Overall, 
however, the effects of MS stimulation on nociceptive behaviors is very variable and 
ranges from no change, to increase or decrease in such behaviors (Schmidek et al., 
1971; Jacquet and Lajtha, 1973; Lico et al., 1974; Mayer and Liebeskind, 1974; 
Abbott and Melzack, 1978; Klamt and Prado, 1991).  Indeed, simulation of different 
sites within the septal area or stimulation of the same site with different frequencies 
augmented or attenuated nociceptive responses (Lico et al., 1974).   
 
Other, indirect evidence, also suggests that MS might play a role in nociception.  For 
example, MS is connected functionally and anatomically with regions that are 
implicated in nociception in both humans and animals.  The regions include the 
hippocampus, the cingulate cortex and the amygdala, and the bed nucleus of the stria 
terminalis (BNST).  In context of the hippocampus, imaging studies have indicated 
that peripheral administration of noxious stimuli results in the activation of 
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hippocampus in humans (Ploghaus et al., 1999; Bingel et al., 2002).  In animals, we 
have reported that injection of formalin in rat hind paw, a model of persistent 
inflammatory pain, excites CA1 pyramidal cells against the background of widespread 
pyramidal cell suppression (i.e. ‘signal-to-noise’ response) in parallel with theta 
activation (Khanna, 1997).  The theta activation is observed in both anesthetized and 
behaving animals (Tai et al., 2006).  Interestingly, the formalin-induced hippocampal 
theta and ‘signal-to-noise’ processing in anesthetized rat were attenuated with lesions 
of the cholinergic neurons of the medial septum (Khanna, 1997; Zheng and Khanna, 
2001).  The hippocampus might be involved in facilitation of nociception, at least in 
part, since manipulations that decrease synaptic transmission through the region 
attenuate formalin-induced nociceptive behaviors in awake rat (McKenna and 
Melzack, 1992).   
 
Likewise, the anterior cingulate cortex, the amygdala (see chapter 1.2.4) and the 
BNST are also implicated in pain perception (Meibach and Siegel, 1977b).  Lesion of 
these regions reduces the unpleasantness of formalin pain without attenuating acute 
pain behaviors.  In these experiments the unpleasantness was measured indirectly 
using the conditioned place avoidance paradigm.  In this paradigm animals avoid the 
compartment where they were paired with hind paw injection of formalin.  A 
summary of the involvement of these regions in different nociceptive paradigms is 
shown in figure 1.2.   
 




Fig. 1.2.  A summary of the effects of manipulations of select forebrain areas on formalin-induced pain behaviors. 
  
 Spontaneous Pain Behavior 
(Formalin Pain) 
Formalin-induced Place Avoidance 
Behavior (F-CPA) 
Other Pain Behavior 
Hippocampus 
Decreased with lidocaine/AP5 
(McKenna and Melzack, 1992, 
2001), and ritaserin (Soleimannejad 
et al., 2006) 
- 
No effect on thermal and mechanical 
nociception with ibotenic lesion (Al 
Amin et al., 2004) 
Amygdala 
Lesion have no effect on formalin 
pain (Tanimoto et al., 2003; Gao et 
al., 2004), but reduced the ability of 
morphine to suppress formalin pain 
(Manning, 1998) 
F-CPA was suppressed by lesion of 
the amygdala (Tanimoto et al., 2003; 
Gao et al., 2004) 
Hind paw mechanical allodynia in 
CCI rats was attenuated with intra-
amygdala muscimol (Pedersen et al., 
2007)   
Cingulate 
Cortex (CC) 
Lesion of the CC have no effect on 
formalin pain (Johansen et al., 2001; 
Gao et al., 2004) or attenuated 
formalin-induced licking behaviour 
(Donahue et al., 2001) 
F-CPA was suppressed by 
microinjection of muscimol into the 
CC (Wang et al., 2005) or lesion of 
the CC (Johansen et al., 2001; Gao et 
al., 2004) 
Lesion of the CC decreased both hot 
plate (Pastoriza et al., 1996) and cold 
plate (Lee et al., 1999) response 
Bed Nucleus 
of the Stria 
Terminalis 
(BNST) 
Lesion of the BNST increased 
formalin-induced nociceptive 
behaviour (Deyama et al., 2007) 
F-CPA was suppressed by 
microinjection of the beta-adrenergic 
receptor antagonist, timolol (Deyama 
et al., 2008) or lesion of the BNST 
(Deyama et al., 2007) 
Shocked-induced hyperalgesia was 
prevented with the lesion of the 
BNST (Crown et al., 2000) 
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1.5 Rationale and purpose of study 
As reviewed in the previous sections, physiological and behavioral evidences support 
a role for the hippocampal formation in nociception (or pain; (McKenna and Melzack, 
1992; Khanna, 1997; McKenna and Melzack, 2001; Khanna et al., 2004).  For 
example, the neurons of the hippocampus are affected by peripheral application of a 
noxious stimulus, while inactivation of the region attenuates nociceptive (pain) 
responses in the formalin model of persistent inflammatory pain (McKenna and 
Melzack, 1992).   
 
Of particular interest here is that formalin injection in the behaving animal induces a 
biphasic pattern of hippocampal theta activation in parallel with the biphasic pattern 
of nociceptive responses (Tai et al., 2006).  The hippocampal theta wave activity is 
strongly affected by the MS.  Indeed, the MS, a subcortical forebrain structure, is 
reciprocally connected to the hippocampus, both anatomically and functionally (Jakab 
and Leranth, 1995; Amaral and Lavenex, 2007).  Besides, the region is also connected, 
both functionally and anatomically, with other regions implicated in nociception in 
both humans and animals.  These regions include the cingulate cortex, the amygdala, 
and the bed nucleus of the stria terminalis (BNST).  However, at present little is 
known about the role of the MS in nociception.   
 
The MS region contains neurochemically diverse populations of neurons.  The MS 
neurons, especially the GABAergic interneurons and septo-hippocampal neurons, are 
implicated in the generation of hippocampal theta.  Furthermore, the region is rich in 
GABA receptors, including the GABAA receptors that are expressed by both the 
cholinergic and parvalbumin positive GABAergic neurons in the MS.  Interestingly, 
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the cholinergic neurons by and large express the GABAA receptors with subunit 
combination α3/β3/γ2, whereas parvalbumin positive GABAergic neurons express the 
subunit combination α1/β2/γ2 or α1/α3/β2/γ2.  That is, the α1 subunit is preferentially 
expressed by parvalbumin positive neurons (>78% neurons) in the MS while the 
majority (more than 84%) of ChAT immunoreactive MS neurons contain the α3-
subunit with only a minority (less than 9%) expressing the α1-subunit (Gao et al., 
1995).  In addition, all medial septal neurons recorded in the urethane anaesthetized 
rat appeared to be extremely sensitive to inhibition by GABA applied ionophoretically 
(Lamour et al., 1984).   
 
The present study explored the role of MS, including the GABAergic mechanisms 
therein, in persistent nociception using the formalin model of pain.  Consequently, it 
was hypothesized that the medial septum modulates nociception and the objectives of 
this study were twofold: 
1)  To investigate the effect of blocking MS neural activity on hindpaw formalin-
induced nociceptive behaviors and spinal nociceptive processing.  The 
GABAA agonist, muscimol, and a positive allosteric modulator of GABAA 
receptor, zolpidem, were used to inhibit MS neural activity.  As mentioned in 
the preceding paragraphs, the MS region is rich in GABAA receptors.  The 
GABAA receptor is a ligand-gated chloride channel and activation of the 
receptor by an agonist such as muscimol leads to the opening of the chloride 
channel resulting in the hyperpolarization of the neuron and thus inhibiting 
neural activity (Kaila, 1994).  In contrast, zolpidem binds to the allosteric site 
of the GABAA receptor, or the benzodiazepines binding site, and enhances the 
effect of GABA at the receptor by facilitating the opening of the chloride 
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channel (Baur and Sigel, 2005).  Zolpidem has selectivity for α1 subunit 
containing GABAA receptors which is expressed preferentially by 
parvalbumin positive septo-hippocampal GABAergic projection neurons (Gao 
et al., 1995). 
2) To investigate the effect of blocking GABAergic inhibition in the MS.  
GABAergic inhibition in the MS was blocked with bicuculline, a competitive 
GABAA receptor antagonist.  Bicuculline competes with GABA for the 
binding site but do not activate the receptor, henceforth blocking GABAergic 
inhibition (Johnston, 1978).  
 
The following experiments were carried out in rat:   
a. Anaesthetized rat: investigated the effect of intraseptal microinjection of 
GABAA receptor antagonist, bicuculline, on hippocampal responses, including 
theta activation, evoked on intracerebral stimulation, hind paw injection of 
formalin and direct activation of MS neurons with intraseptal microinjection 
of the cholinergic agonist, carbachol and, 
b. Awake rat: investigated the effect of altered GABAergic tone in the MS on 
formalin nociception.  The GABAergic tone was manipulated with intraseptal 
microinjections of the following drugs, either alone or in combination: (i) 
bicuculline, (ii) muscimol, a GABAA agonist, and (iii) zolpidem, a positive 
allosteric modulator of GABAA receptor with high selectivity for α1-subunit-
containing GABAA receptors.   
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1. MATERIALS AND METHODS 
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2.1 Animals and general procedures 
Adult male Sprague-Dawley rats (derived from Charles River stock obtained from 
Laboratory Animals Center, National University of Singapore) were used for 
experiments.  The animals were either (a) surgically implanted under pentobarbitone 
anesthesia with a microinjection cannula and/or a twisted metal electrode for 
subsequent investigations in awake condition (see section 2.3; animal weight at time 
of surgery being 270 – 320g) or (b) anaesthetized with urethane for acute 
electrophysiological recordings (see section 2.4; weight of the animals at time of 
experiment was 300 – 380g).    The experiments followed the ethical guidelines of the 
International Association for the Study of Pain (Zimmermann, 1983) and all efforts 
were made to minimize the number of animals used and their suffering.  All 
experimental procedures were approved by the Institutional Animal Care and Use 
Committee of the National University of Singapore.  Behavioral observations were 
conducted blind to the treatment. 
 
2.2 Hind paw injection of formalin 
Dilute formalin was made from 37% formaldehyde (methanol stabilized; Merck, 
Darmstadt, Germany) and injected subcutaneously into the plantar surface of the right 
hind paw at a concentration of 1.25% (0.1ml; behaving animals) or 5% (0.05ml; 
anaesthetized animals) using a 27G needle (Becton Dickinson and Co., Frankin Lakes, 
NJ, USA) (Tai et al., 2006).  For behaving animals, the rat was gently restrained to 
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2.3 Experiments in anaesthetized animals 
2.3.1 Electrophysiological procedures 
For acute electrophysiological recording, the urethane-anaesthetized (1g/kg, i.p.; 
Sigma) animal was mounted onto a stereotaxic frame and burr holes drilled on the 
exposed skull at the selected stereotaxic coordinates to lower recording and 
stimulating electrodes as reported previously (Jiang and Khanna, 2004, 2006; Ariffin 
et al., 2010).  The recording electrode consisted of a carbon fiber microelectrode 
which was made according to the method of Armstrong-James and Millar 
(Armstrong-James and Millar, 1979).  Essentially, a glass capillary containing a 
carbon fiber was pulled conventionally on a vertical microelectrode puller.  The 
resulting carbon fiber that protrudes from the glass tip was etched to a length of 7–
15μm.  The resistance of the electrode generally ranges from 200kΩ to 2MΩ 
(Armstrong-James and Millar, 1979). 
 
2.3.1.1 Extracellular recording 
In vivo extracellular field potential was recorded from CA1 pyramidal cell layer of 
anaesthetized rats using a carbon fiber microelectrode which was lowered into the left 
dorsal hippocampus at an angle of 12° to the vertical (~ P 4.0mm from bregma, ~ L 
2.5mm from midline, ~ V 2.0–3.0mm from cortical surface) (Jiang and Khanna, 2004, 
2006; Paxinos and Watson, 2007).  The signal from the carbon fiber microelectrode 
was split to record both local hippocampal EEG and population spike (PS) in the 
pyramidal CA1 layer. Amplification was set at x500 and the signal was filtered at 1 
Hz to 100 Hz to record EEG and filtered at 1 Hz to 3000 Hz to record the population 
spike (Jiang and Khanna, 2004, 2006).  The CA1 pyramidal cell layer was recognized 
based on physiological criterion, i.e. the presence of characteristic complex spike cell 
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activity and/or the generation of population spike on ipsilateral field CA3 stimulation 
(0.1Hz, 0.01s pulse duration; ~P 3.0 mm, ~L 1.5-2.0 mm, ~V 4.0 mm from cortical 
surface) (Paxinos and Watson, 2007).  The ipsilateral CA3 area was stimulated with a 
concentric bipolar electrode (Model NE-100, David Kopf, U.S.A.) by a constant 
current stimulation isolation unit (Grass S88 Stimulator, Grass technologies, Warwick, 
RI, USA).  Generally, the stimulus voltage was adjusted to evoke 70% of maximal PS 
amplitude (Ariffin et al., 2010). 
 
2.3.1.2 Intracerebral stimulation 
In some experiments performed on anaesthetized rats, hippocampal theta wave 
activity was evoked on stimulation in the region of the left rostral reticularis pontine 
oralis (RPO; ~P 8.0mm from Bregma, ~L 0.8 from midline, ~V 9.0mm from cortical 
surface) (Paxinos and Watson, 2007).  The RPO was stimulated every 10 seconds for 
a duration of 2.56 seconds with a train of electrical pulses (i.e. phasic stimulation 
using 0.01ms pulse duration at 100Hz; stainless steel concentric bipolar electrode, 
Model NE-100, David Kopf).  Generally, the RPO stimulation voltage was adjusted to 
evoke theta wave activity at about 4-5Hz frequency (Jiang and Khanna, 2004).  Single 
pulse CA3 stimulation to elicit CA1 PS (see above) was paired with RPO stimulation 
in some experiments.  The CA3 stimulation was applied at an interval of 10ms from 
the end of the RPO stimulation (Jiang and Khanna, 2004). 
 
2.3.2 Drugs and microinjection 
Intraseptal drug microinjection in anaesthetized rat was carried out using a double 
barreled stainless steel cannula assembly which was made in-house by fusing two 
33G stainless steel cannula (Plastic One) together using cyanoacrylate adhesive.  The 
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average external diameter of the resultant product at its widest was about 500μm.  A 
fine bore polyethylene tubing (internal diameter of 0.28mm; Portex, UK) was attached 
to the external end of each cannula.  The free end of the tubing was connected to a 
10μl Exmire microsyringe (Ito Corporation) that was used to microinject discrete 
volumes of 0.5μl.  Because of space constraint on the recording side, the medial septal 
region was approached by lowering the double barreled cannula into the brain 
contralateral to the recording side.  The double barreled cannula was inclined at an 
angle of 14° to the vertical and lowered 1.5mm lateral from midline on the 
contralateral side (~P 0.5mm from Bregma; (Paxinos and Watson, 2007). The two 
barrels of the assembly were oriented along the rostral-caudal axis.  The drugs that 
were microinjected included bicuculline methiodide (Sigma) and carbachol (Sigma) 
which were dissolved in alcian blue-dye-saline (0.5% w/v, Sigma) and saline (0.9% 
NaCl), respectively.  0.5μl of carbachol (0.156μg/μl; (Jiang and Khanna, 2006) or 
saline (0.9% NaCl) was microinjected via the anterior cannula and bicuculline 
methiodide (0.125g or 0.25g in 0.5l solution; (Chrobak and Napier, 1992) was 
microinjected through the posterior cannula. 
 
2.3.3 Experimental protocol 
The overview of the experimental protocol for the experiments in anaesthetized rat is 
depicted in figure 2.1.  A series of investigations (see sections 2.3.3.1, 2.3.3.2 and 
2.3.3.3) was performed to characterize the effect of intraseptal microinjection of the 
GABAA receptor antagonist, bicuculline (0.125g in 0.5l solution), on hippocampal 
CA1 neural responses.  The CA1 responses were evoked on RPO stimulation, 
intraseptal carbachol or hind paw injection of formalin.  Although disparate, each of 
the triad of stimuli evokes CA1 theta activity and also suppresses CA1 PS.  For 
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example, RPO stimulation and hind paw injection of formalin induces hippocampal 
theta and suppresses CA1 PS via an ascending relay involving the excitation of 
neurons in the hypothalamic supramammillary nucleus and the MS (Kirk and 
McNaughton, 1993; Zheng and Khanna, 2001; Jiang and Khanna, 2004; Pan and 
McNaughton, 2004; Ariffin et al., 2010).  While intraseptal carbachol directly affects 
the MS relay to the hippocampus (Zheng and Khanna, 2001).  Indeed, in vitro 
investigations indicate that cholinergic agonists directly excite septohippocampal 
GABAergic neurons (Alreja et al., 2000; Wu et al., 2000).  It was hypothesized that 
intraseptal bicuculline will selectively effect theta activation since MS GABAergic 
mechanisms are implicated in generation of hippocampal theta (see introduction).  On 
the other hand, the PS suppression is mediated via the septo-hippocampal cholinergic 
neurons (e.g. Zheng and Khanna, 2001). 
 
2.3.3.1 Effect of intra-septal bicuculline on intracerebral stimulation evoked CA1 
responses 
 
During the experiment, the CA1 PS was first recorded under the condition of 
hippocampal large irregular EEG activity (LIA) for 2 minutes and then paired with 
RPO stimulation for next 11 minutes.  At the end of 11
th
 minute, 0.5l of saline (0.9% 
NaCl) was microinjected followed by 5 minutes of additional recording.  The 
microinjection of the saline served as control for the microinjection procedure.  
Subsequently, bicuculline was microinjected and the effects on RPO stimulation was 




 minute.  
 
It is notable that CA3 was stimulated using twin (paired) pulse stimulation at inter-
pulse interval 50-200 msec to evoke a pair of PSs.  The 2
nd
 of the pair was suppressed 
compared to 1
st
 PS, the suppression being due to recruitment of CA1 inhibitory 
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mechanisms with the first PS (see introduction chapter 1.1.3).  The stimulation 
intensity was adjusted so that the amplitude of the second PS was around 50% of the 
first PS, the first PS being around 70% of maximal.   
 
2.3.3.2 Effect of intra-septal bicuculline on sensory stimulation evoked CA1 
responses 
 
Sensory stimulation was applied in the form of subcutaneous injection of formalin 
(5%, 0.05ml) into the plantar surface of the right hind paw.  As in section 2.3.3.1, 
CA1 PS was first recorded during hippocampal LIA for 2 minutes.  Saline was then 
microinjected into the septal region via the double barreled stainless steel cannula 
assembly and recording was made for another 5 minutes following which formalin 
(5%. 0.05ml) was injected into the right hind paw.  Five minutes following formalin 
injection, bicuculline was microinjected into the septum and the effect on hind paw 
formalin-induced changes in hippocampal CA1 was recorded for a further 25 minutes 




 minute (Fig. 2.1).   
 
Here it is notable that the animals used in this part of the study were also used to 
investigate the effect of bicuculline on RPO-elicited CA1 responses (see section 
2.3.3.1).  Generally, investigations with formalin injection were performed first 
followed by experiments with RPO stimulation.  In one instance investigation with 
formalin followed the experimental investigation with RPO stimulation.  A gap of 1 
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2.3.3.3 Effect of intra-septal bicuculline on intra-septal carbachol induced 
hippocampal responses 
 
Each experiment consisted of 3 microinjections of carbachol, each at least 1 hour 
apart.  Carbachol was microinjected after 2 minutes of recording of large irregular 
EEG activity (LIA).  Following each microinjection of carbachol, hippocampal 





 minute.  Bicuculline was microinjected five minutes before the 2
nd
 microinjection 
of carbachol during LIA (Fig. 2.1).  The concentration of carbachol selected was the 
lowest concentration required to induce robust hippocampal theta wave activity when 
microinjected into the SUM.  At this dose, theta activity was reproducibly elicited at a 
threshold frequency of 4 – 5 Hz, similar to that obtained with RPO stimulation, and 
lasted about 40 minutes (Jiang and Khanna, 2006). 
 
- 67 - 
 
 
This page is intentionally left blank 
- 68 - 
 
Figure 2.1.  The experimental protocol used to investigate the effects of bicuculline 
methiodide, a competitive antagonist at GABAA receptors, on hippocampal CA1 
responses evoked on (A) reticular (RPO) stimulation, (B) hindpaw injection of 
formalin, or (C) intraseptal microinjection of carbachol.  The number below each 
vertical tick on the horizontal line represents the time point with respect to the 
intraseptal microinjection of bicuculline (A and B) or carbachol (C).  The time of 
microinjection was taken as 0 minute.  In all cases, CA1 field potential evoked by 
ipsilateral CA3 stimulation (single pulse; 0.01 ms; 0.1 Hz) was first recorded under 
large irregular activity (LIA) of the hippocampal electroencephalogram.  All the drugs 
were microinjected via the double barreled stainless steel cannula assembly which 
was orientated along the rostro-caudal axis of the medial septum.  The anterior 
cannula was filled with vehicle (A and B) or carbachol (C) and the posterior cannula 
filled with bicuculline (dissolved in 0.5% w/v alcian blue dye saline). 
 
(A) shows the protocol used to evaluate the effect of intra-septal bicuculline on 
hippocampal CA1 responses evoked by stimulation of the RPO.  The RPO was 
stimulated every 10 seconds for a duration of 2.56 seconds (0.01ms pulse duration; 
100 Hz).  Stimulation of the RPO was initiated 2 minutes after the recording of CA1 
PS during LIA EEG (-18 to -16 minute time point).  Vehicle was microinjected into 
the septum 11 minutes after the initiation of RPO stimulation.  At time point 0 minute, 
bicuculline (0.125g or 0.25g in 0.5l solution) was microinjected into the septum. 
 
(B) shows the protocol used to investigate the effect of intraseptal bicuculline on 
formalin (5% formalin, 0.05ml, s.c.)- induced hippocampal responses.  Here, after 
recording CA1 PS during LIA EEG (-12 to -10 minute time point), vehicle was 
microinjected (-10 minute time point) into the septal area.  Formalin was injected into 
the plantar region of the right hindpaw 5min following vehicle microinjection.  
Bicuculline (0.125g in 0.5l solution) was microinjected into the septal region 5 
minutes after formalin injection (0 minute time point).  Hippocampal responses were 







(C) shows the protocol used to investigate the effect of intraseptal bicuculline 
(0.125g in 0.5l solution) on hippocampal responses evoked on intraseptal 
microinjection carbachol (0.5 μ1, 0.156μg/μl).  Carbachol was microinjected 3 times 
into the septum with gap of about 1 hour between microinjections.  Carbachol was 
microinjected after 2 minutes recording of basal LIA EEG (time point 0 minute, upper 
panel).  Hippocampal responses were continually recorded for 20 minutes after 
microinjection and again for 1 minute at the 40
th
 and the 60
th
 minute.  To investigate 
the effect of bicuculline on intraseptal carbachol-induced hippocampal responses, 
bicuculline was microinjected 5 minutes before the 2
nd
 microinjection of carbachol (-5 
minute time point; C, lower panel). 
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2.4 Experiments in behaving awake animals 
2.4.1 Surgical procedure 
The animal was anaesthetized with sodium pentobarbitone (60mg/kg, i.p.) and 
secured in a stereotaxic frame for the implantation of a stainless steel depth wire 
electrode and/or a microinjection cannula under aseptic conditions.  Alignment of the 
skull was ensured by the planarity of the bregma and lambda.  A burr hole was drilled 
at 4.0mm posterior from the bregma and 2.2mm lateral on left from the midline 
(Paxinos and Watson, 2007) for lowering of the recording electrode to record 
extracellular field activity from dorsal hippocampal field CA1 (V 3.2mm from skull 
surface).  Seven additional burr holes were drilled, two on the frontal bones (1 on each 
side) and five on the parietal bones (2 ipsilateral to the recording electrode and 3 on 
the contralateral side), to facilitate the insertion of the indifferent/ground screw 
electrode (contralateral parietal bone) and 6 miniature screws for anchoring the dental 
cement onto the skull (see below).   
 
The depth recording electrode was constructed by twisting together a pair of stainless 
steel wires (A-M Systems, Carlsborg, WA, USA).  Each wire was approximately 
0.125mm in diameter and 40mm in length.  The wires were insulated with Teflon 
except at the tips.  The two tips of the electrode that were lowered into the brain were 
spaced 0.5 – 1mm apart in the vertical direction.  Separate gold-plated male connector 
pins (A-M Systems) were soldered onto the other end of the wires.  The screw 
electrode, used as indifferent/ground electrode, consisted of a miniature stainless steel 
bone screw (Fine Science Tools Inc., North Vancouver, BC, Canada) soldered to a 
40mm long Teflon – insulated silver wire of approximately 0.25mm in diameter (A-M 
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Systems).  The free end of the silver wire was soldered onto a gold-plated male 
connector pin (A-M Systems).   
 
The recording electrode was lowered to a depth of 3.2mm from the skull surface.  
After securing the electrode to a neighboring anchor screw with dental cement 
(Stoelting Co., USA), the male connector pins of all the electrodes were pushed into a 
9-pin ABS plug (Ginder Scientific, Nepean, ON, Canada) which was then secured 
onto the skull with dental cement.   
 
Similarly, a burr hole was drilled for implanting the microinjection cannula which 
consisted of a stainless steel guide cannula (26G; Plastic One, Roanoke, VA, USA) 
that was directed towards the medial septum (~ A 0.5mm from bregma, ~ M 0.0mm, 
~ V 5.4mm from skull surface; (Paxinos and Watson, 2007)) and secured on the skull 
with dental cement with the aid of 6 miniature screws inserted into holes made on the 
frontal bones (2 holes, 1 on each side) and the parietal bones (4 holes, 2 on each side).  
A dummy cannula (33G; Plastic One) was inserted into the implanted guide cannula 
to prevent tissue entry into the bottom of the cannula. 
 
2.4.2 Habituation 
Animals were housed individually after surgical implantation and allowed to recover 
from surgery in the animal holding unit for 6 to 8 days before habituation and 
experimentation.  During habituation, the animals were exposed to the experimental 
setup for at least 5 to 7 days in the observation room.  The latter consisted of either the 
laboratory where the animals had undergone surgery or a behavior room that was one 
room away from the laboratory.  The animal was habituated in a clear plastic chamber 
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whose dimensions and location varied depending upon the type of experiment (see 
immediately below).  The plastic chamber also served as the observation chamber 
during the formalin test on the day of the experiment in the observation room.   
 
For experiments involving electrophysiological recording along with the formalin test, 
the clear plastic chamber (48cm x 27cm x 20cm, L x W x H) was placed on top of an 
animal activity monitor (Automex-II-2SD, Columbus Instruments, USA) in the 
laboratory.  The sensitivity of the activity monitor was adjusted to detect movements 
during exploration of the environment by the animal (Tai et al., 2006).  No event was 
recorded during animal still-alert behavior at the settings used.  In other experiments 
that involved investigating the effects of drug microinjection on behavior alone, the 
animals were habituated to a clear plastic chamber (43cm x 21cm x 30cm, L x W x H) 
of an open-field activity monitor (model ENV-515, Med Associates Inc, Georgia, VT, 
USA) in the behavior room. 
 
2.4.3 Drug microinjection 
For microinjection in behaving rat, the animal was gently restrained and a 33G 
internal cannula (Plastics One) was inserted into the implanted guide cannula.  The 
internal cannula extended by 1.0mm from the tip of the guide cannula within the brain.  
The external tip of the internal cannula was connected via a polyethylene cannula 
connector assembly system (Plastics One) to a 10μl Exmire microsyringe (Ito 
Corporation, Japan).  A volume of 0.5ul of the solution was microinjected over a span 
of 30 seconds via the internal cannula during an experiment.  Following 
microinjection, the internal cannula was left in place for an additional 1 minute to 
allow the diffusion of the drug before taking it out.  Checks were performed by 
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pushing out some solution just before insertion of the inner cannula and also on 
removal of the internal cannula after microinjection so as to ensure that the 
microinjection assembly system was functioning properly.  In some cases the drug 
solutions for microinjection were prepared in alcian blue-dye-vehicle (0.5% w/v, 
Sigma, St. Louis, MO, USA) for marking the microinjection site.  In other instances, 
an additional 0.5ul of alcian blue dye-saline (0.5% w/v, Sigma) was microinjected at 
the end of the experiments to mark the microinjection site. 
 
2.4.4 Drugs 
The drugs used included zolpidem (Tocris Bioscience, Bristol, UK), muscimol 
hydrobromide (Sigma), bicuculline methiodide (Sigma) and morphine sulfate (RBI, 
Natick, MS, USA).  Zolpidem was administered either intraperitoneally (1mg/kg, 
0.1ml/100g) or microinjected (8 or 12g in 0.5l solution) into the septum.  In context 
of the former, the drug was dissolved in acidified saline while for microinjection the 
drug solution was prepared in acidified alcian blue dye solution (0.5% w/v, Sigma) in 
saline.  On the other hand, morphine (5mg/kg, i.p., 0.1ml/100g), muscimol (1or 2g 
in 0.5l solution microinjected into septum) or bicuculline (0.125g in 0.5l solution 
microinjected into septum) were dissolved in saline.  The corresponding vehicles were 
used in control experiments.  At the selected doses/concentrations, the drugs are 
known to affect indices of septo-hippocampal neural activity (Chrobak and Napier, 
1992; Khanna and Zheng, 1999; Herzog et al., 2000; Ma et al., 2002; van Lier et al., 
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2.4.5 Electrophysiological recording 
The electrophysiological recording from behaving rat was performed as described 
previously (Tai et al., 2006).  Briefly, hippocampal field activity signal was recorded 
via a 9-pin ABS socket (Ginder Scientific) with gold-plated pins that was screwed 
onto the matching headstage on the animal’s head before the experiment.  The other 
end of the socket was connected to a flexible wire which was held suspended above 
the animal thus allowing free movement of the animal.  The free end of the wires was 
connected to the recording amplifier (Grass amplifier, Astromed Inc., USA) to record 
the electroencephalogram (EEG) signals (amplified X500 and filtered at 1 Hz to 100 
Hz).  The hippocampal EEG was digitized at 256 Hz using an A/D converter (Power 
1401, Cambridge Electronic Design (CED), Cambridge, England) and Spike 2 
program (Spike 2 v.6, CED) and stored on a computer for later analysis. 
 
2.4.6 Behavioral monitoring 
Nociceptive behaviors were monitored for a period of 90 minutes after hind paw 
injection of formalin.  Licking and flinching of the injected paw were taken as 
behavioral indices of formalin nociception (Sawynok and Liu, 2004).  Licking was 
measured as the time spent licking the injured paw at both the dorsal and plantar 
surface.  Flinching was the number of shakes and jerks of the injured hind paw.  The 
formalin test was performed in a clear plastic chamber (see section 2.4.2).  The above 
two behaviors were monitored by the observer in all experiments with injection of 
formalin.  In some instances formalin-induced animal agitation was also measured by 
monitoring animal ambulatory movements using the open field activity monitor (Lee 
et al., 2008); Model ENV-515, Med Associates Inc.).  The open field activity monitor 
tracks animal movements using 16 evenly spaced infrared (IR) transmitters and 
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receivers positioned along the sides of the chamber.  Animal ambulation was defined 
as movements of the animal that exceeded a pre-set square box area of 4 x 4 IR 
transmitters (approximately 8cm x 8 cm) in 50 ms duration.   
 
2.4.7 Experimental protocol 
Several behavioral investigations were carried out but each animal was subjected only 
to a single test.  The various investigations were: 
 
(a) Effect of systemic administration of drugs on animal behavior: In this study 
we examined the effect of systemic zolpidem (1mg/kg) or morphine (5mg/kg) on 
formalin-induced nociceptive behaviors.  These experiments facilitated a comparison 
with behavioral studies involving microinjection of the drugs (see below).  
Hippocampal field activity was also monitored during the formalin test via the 
recording electrodes implanted in the hippocampus.  Prior to the formalin test, the 
EEG was first recorded during individual spontaneous animal behaviors (exploration 
and still-alert behavior) for a total of one minute each after which a continuous record 
of the EEG was obtained for 30 minutes.  Following that, either zolpidem, morphine 
or the corresponding vehicle was administered intraperitoneally followed immediately 
by subcutaneous injection of formalin (1.25%, 0.1ml) into the plantar surface of the 
right hind paw.  The drugs were administered as pretreatment keeping in mind the 
relatively rapid onset of effect of zolpidem observed in the anaesthetized rat, and also 
to maximize the drug influence on the progression of nociceptive responses (Lee et al., 
2011).  The EEG was recorded for another 90 minutes subsequent to formalin 
injection together with the animal nociceptive behaviors, especially licking and 
flinching of the injected paw. 
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(b) Effect of intra-septal microinjection of drugs on animal behavior: In this study, 
formalin test was performed on animals implanted with only the microinjection 
cannula that was targeted towards the septum.  On the day of the formalin test, the 
animal was first acclimatized to the observation chamber (L x W x H, 43.2 cm x 21.7 
cm x 30.5cm of an open field activity monitor, Model ENV-515, Med Associates Inc., 
USA) for 15 minutes.  Subsequently, 0.5ul of vehicle, zolpidem, muscimol or 
bicuculline was microinjected through the internal cannula followed by hind paw 
injection of formalin while the rat was gently restrained.  Similar to (a), animal 
nociceptive behaviors were monitored for 90 minutes.  At the end of the experiment, 
0.5μl of alcian blue dye-saline (0.5% w/v, Sigma) was microinjected to mark the 
microinjection site. 
 
(c) Effect of intra-septal zolpidem on hippocampal field activity in the formalin 
test:  Separate experiments were performed to investigate the effect of intra-septal 
zolpidem on hippocampal field activity.  Here, animals were implanted with both a 
hippocampal recording electrode and a microinjection guide cannula targeted towards 
the septum.  The experimental protocol was similar to the one used in (a) but with the 
difference that 0.5μl of zolpidem or the corresponding vehicle was microinjected into 
the septal region instead of being injected intraperitoneally.  Nociceptive behaviors 
were also monitored and are combined with those from (d) below as the experimental 
conditions were entirely similar. 
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(d) Effect of intraseptal bicuculline on intraseptal zolpidem induced 
antinociception in the formalin test:  The aim of these experiments was to 
investigate whether the antinociceptive effect of intramedial septal zolpidem is 
sensitive to antagonism by the competitive GABAA receptor antagonist bicuculline.  
The experimental protocol used was similar to the one used in (c).  However, a drug 
mixture solution (0.5μl) consisting of zolpidem (8μg) and bicuculline (0.125μg), or 
zolpidem (8μg in 0.5μl) as control, was microinjected into the septal region.  Animal 
nociceptive behaviors were subsequently monitored for 90 minutes.  As mentioned 
previously, the behavioral results were combined with those from (c) as the conditions 
of both sets of experiments were entirely similar.  Hippocampal field activity was also 
recorded during the experiments but is not reported here. 
 
2.5 Histology 
Arising from trends in the behavioral results, spinal nociceptive processing was 
investigated in some behavioral experiments.  Here, the induction of the transcription 
protein, c-Fos, was used as a marker of spinal nociceptive information processing 
(Presley et al., 1990).   
 
In other behavioral experiments not involving c-Fos immunohistochemistry, and in 
experiments in the anaesthetized rat, Nissl staining of the brain sections was 
performed to histologically identify the placement site of the microinjection cannula 
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2.5.1 c-Fos immunohistochemistry 
The effect of systemic zolpidem, intra-septal zolpidem, muscimol and bicuculline on 
spinal nociceptive processing was investigated using c-Fos immunohistochemistry.  In 
these experiments, the animal was deeply anaesthetized with urethane (1.5 g/kg, i.p.; 
Sigma) 2 hours after hind paw injection of formalin.  Subsequently, the animal was 
transcardially perfused with 1% sodium nitrite solution (Merck), followed by 4% 
paraformaldehyde solution (400ml; Merck) in 0.1 M sodium phosphate buffer 
(Merck).  The spinal cord was then dissected out and post-fixed in the above fixative 
for approximately 6 hour at 4°C.  A notch was made on the ventral surface of the left 
side (contralateral to the injection site) to facilitate identification of the sides on the 
sections.  Coronal 60 μm were then taken through the lumbar spinal cord on a 
vibratome (Leica VT1200 semi-automatic vibrating blade microtome, Leica 
Microsystems GmbH, Wetzlar, Germany) and collected in 0.05 M Tris-buffered 
saline (TBS). 
 
Alternate sections of the lumbar L4 region were immunolabeled for c-Fos protein and 
the Avidin-Biotin Complex (ABC) method was used to detect the antigen as described 
previously (Khanna et al., 2004; Lee et al., 2008).  All procedures were carried out at 
4°C unless otherwise specified.  Sections were incubated in wells of a 24-well cell 
culture plate (2 sections/well, 250μl /well).  Unless specified, the sections were rinsed 
in-between different steps with TBS for 15 minutes.   
 
Tissue sections were first incubated with 0.3% hydrogen peroxide in TBS 
(Perhydrol®, Merck, Germany) for 20 minutes at room temperature to inhibit any 
endogenous peroxidase activity that may be present and then rinsed with TBS (2 x 15 
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min).  Following that, unwanted protein interactions were blocked by incubation for 2 
hour at room temperature in 3% bovine serum albumin (BSA) (Sigma) in 0.05 M TBS 
with 0.3% Triton® X-100 (Bio-Rad Labs, USA).  Subsequently, the tissues were 
incubated for 70 hour with the primary antibody (1:2000 rabbit anti-Fos (Ab-5) 
polyclonal antibody, Calbiochem), followed by 3 hour incubation at room temperature 
with the secondary antibody (1:1000 biotinylated goat anti-rabbit antibody, 
Calbiochem).  All antibodies were diluted in 0.05 M TBS containing 3% BSA and 
0.3% Trition® X-100.  Sections were next treated with the avidin-biotin-peroxidase 
complex (Vectastain Elite ABC Kit, Vector Labs, U.S.A.) for 3 hour at room 
temperature.  Incubation at room temperature was carried out on a constant shaking 
mini orbital shaker (Stuart Scientific, UK).  Following a 10min incubation with 
diaminobenzidine (DAB) (0.05% in 0.05 M TBS; Sigma), the tissue-bound 
peroxidase was visualized by a DAB reaction on adding a fresh solution consisting of 
0.05% DAB and 0.009% hydrogen peroxide in 0.05 M TBS to the wells containing 
the tissues.  Once the brown immunolabel had developed, the reaction was stopped by 
rinsing the sections in TBS in a Petri dish and mounted on chrome alum gelatin-
coated slides, air dried, dehydrated via ethanol (100%, absolute; BDH Lab Supplies, 
England) for 2 minutes, and 100% xylene (J.T. Baker.)/ethanol (50:50) for 1 minute 
and cleared with 100% xylene (1 minute).  Slides were then cover-slipped with 
DePeX mounting medium (BDH Lab Supplies, England).  The Fos-like 
immunoreactivity (FLI) was visualized as brown reaction product.  Omission of the 




- 80 - 
 
2.5.2 Nissl stain 
In other experiments not involving c-Fos immunocytochemistry, animals were 
transcardially perfused with 0.9% sodium chloride (BDH Laboratory Supplies) 
followed by 5% formalin (Merck).  The brain was removed and post-fixed overnight 
in the above fixative.  Coronal sections were taken through the septal region (60 μm) 
and/or the hippocampus (100 μm) on a vibratome (Leica VT1200 Semi-Automatic 
Vibrating Blade Microtome, Leica Microsystems) and collected in 0.1 M phosphate 
buffer (Merck).  Cresyl Violet (0.5% w/v; Sigma) was used to stain the sections for 
identification of the microinjection site and electrode placement. 
 
2.6 Data Analyses 
2.6.1 Analysis of electrophysiological data 
Electrophysiological data were digitized (EEG at 256Hz and PS at 10kHz) and 
collected using Spike2 software (CED) for off-line analyses.  The analysis of theta 
wave activity and PS followed the previous convention from the laboratory (Jiang and 
Khanna, 2004, 2006; Tai et al., 2006; Ariffin et al., 2010; Lee et al., 2011). 
 
2.6.1.1 Analysis of electrophysiological data for anaesthetized experiments 
The data obtained from anaesthetized rats were analyzed offline for the following 
measures: i) time course of change in PS amplitude (mV), ii) time course of duration 
of theta wave activity (s/min) following hind paw injection of formalin and intra-
septal  microinjection of carbachol, iii) time course of change in fast-Fourier 
transform (FFT) peak power in the theta range (3–6 Hz; FFT theta peak power in 
mV
2
), iv) average FFT theta peak power (mV
2
) at select time-points, and v) average 
FFT theta peak frequency (Hz) at select time-points.  Population spike was averaged 
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in 1 minute blocks (six sweeps per minute) using the software.  The average of the 
negative peak from the 2 positive peaks around it was taken as the amplitude of the 
PS (Jiang and Khanna, 2004, 2006; Ariffin et al., 2010).  The amplitude of the 
population spike reflects the almost synchronous discharge of a population of CA1 
pyramidal cells and an increase in the PS amplitude signifies an increase in the 
number of neurons firing.   
 
The duration of theta was calculated by computing the time period (seconds per 1 
minute block) for which the hippocampal field activity displayed rhythmic slow wave 
activity at 3 to 6 cycles per second (3 – 6 Hz) in the EEG trace.  FFT analyses 
(frequency resolution of 0.5 Hz) of carbachol- or sensory stimulus–induced field 
activity were performed only on theta wave activity.  In the anaesthetized rat, theta 
waves, taken from 10-second block of the EEG (band pass filtered at 1-10 Hz; Finite 
Impulse Response (FIR) filter) between consecutive CA3 stimulation, were analyzed 
and averaged for six such blocks to give the average value of theta peak power and 
theta peak frequency per 1-minute block.   
 
In context of RPO stimulation-induced theta, FFT analyses were performed on 2-
second segments of theta activity from the onset of reticular (RPO) stimulation and 
averaged for six such stimulations.  FFT theta peak power was presented as units of 
mV
2
 by the program which was divided by 0.08581 to give the power (peak-to-peak 
amplitude square in mV
2
) of the EEG at the peak frequency(Tai et al., 2006).  The 
value of 0.08581 was the Spike2-units that corresponded to a 1 mV peak-to-peak 
sinusoidal wave at 10 Hz sine wave that was used to calibrate the software output.  
Because of inaccuracy in the conversion between time and frequency domains, the 
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estimate of amplitude of the sinusoidal (in the time domain) using peak power (single-
frequency measure) is only approximate.   
 
The theta peak power was further normalized to facilitate statistical analysis.  Thus, in 
experiments involving hind paw injection of formalin, the FFT theta peak power was 
normalized against the average theta peak power during the first 5 minutes after 
injection but before any drug treatment.  The RPO stimulation-induced theta peak 
power was normalized against the average theta peak power during the first 11 
minutes of RPO stimulation before any drug treatment.   
 
Average FFT theta peak power and average FFT peak frequency at select time-points 
during the course of an experiment was the average FFT theta peak power and 
average FFT theta peak frequency in two 1-minute blocks, respectively. 
 
2.6.1.2 Analysis of electrophysiological data for behaving experiments 
The EEG data from behaving animals were analyzed off-line for the following 
measures: i) time course of change in duration of theta wave activity (s/5min) , ii) the 
duration of theta wave activity in the first (0-5 minutes) and second (11-40 minutes) 
theta states of the formalin test (Tai et al., 2006), iii) the time course of change in FFT 
peak power in the theta range (4–12 Hz), iv) average FFT peak power in the theta 
range (4–12 Hz) during the first and second theta states of the formalin test, v) the 
time course of change in the FFT theta peak frequency (Hz), and vi) average FFT 
theta peak frequency during the first and second theta states of the formalin test. 
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During analysis, the EEG trace was digitally band pass filtered at 1-40 Hz (FIR filter).  
Duration of theta was calculated by computing the period of time (seconds per 5 
minute block) for which theta was visually identified in an artifact-free EEG trace as a 
continuous sinusoidal oscillation of at least 1 second duration at frequencies of 4-12 
Hz.  The duration of theta wave activity in the first and second theta state was the total 
duration of theta in 0-5 minutes and 11-40 minutes after the injection of formalin.   
 
FFT analyses (frequency resolution of 0.5 Hz) were also performed on theta wave 
activity (minimum of 2 seconds of visually identified theta wave activity) in artifact 
free segments of EEG data recorded from 30 minutes before and till 60 minutes after 
formalin injection and averaged in blocks of 5 minutes.  FFT peak power (in 5 
minutes block) in the theta range (4–12 Hz) and FFT theta peak frequency, calculated 
in five minutes block, were averaged for the period of 11–40 minutes to give the 
average FFT theta peak power and frequency in the second theta state of the formalin 
test.  
 
As mentioned above, the FFT theta peak power, presented as units of mV
2
 by the 
program, was divided by 0.08581 to give the power (peak-to-peak amplitude square in 
mV
2
 unit) of the EEG at the peak frequency.  For statistical analyses, the formalin-
induced theta peak power in behaving rat was normalized against the theta peak 
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2.6.2 Analysis of behavior 
In the formalin test, the duration of licking and the number of flinches of the injected 
paw were quantified in 5min blocks over the 90min observation period.  Further, the 
licking and flinching of the injected hind paw and the concomitant ambulatory 
distance were also computed for the first phase (0–5min) and the second phase (11–
60min) of the formalin test and used for statistical analysis. 
 
2.6.3 Quantification of c-Fos-like immunoreactivity (FLI) 
The method for c-Fos quantification was as described previously (Lee et al., 2008).  
Sections of the lumbar L4 spinal cord were digitized at 750dpi with Montage Explorer 
(Synoptics Ltd.) using a Nikon Eclipse E408 microscope (Nikon Corp., Japan) at 4 x.  
The Fos-positive cells were counted for the right side (ipsilateral to the injection site) 
of the sections using a commercial software (AIS™ Image Analysis Software; 
Imaging Research Inc., Canada).  Briefly, the average intensity of each spinal region 
was determined and Fos-positive cells in that region were detected as stained nuclei 
that were at least 300% more intense as compared to the average intensity of the 
region.  Additional target criteria were set: 1) an area of greater than or equal to 5 
units (of the software), and 2) a form factor of greater than 0.8.  The form factor is a 
measure of the degree of roundness and a form factor of one is perfectly round.  The 
conditions were set based on comparisons with manual counts of the FLI.   
 
The total count was averaged for L4 sections of each animal and then for the 
experimental group.  In addition, laminar specific counts were made for four regions 
following the approach by Khanna et al. (2004).  Spinal segmental level and laminar 
subdivisions were identified based on the configuration of the gray matter (Molander 
- 85 - 
 
et al., 1984; Presley et al., 1990).  The regions with the corresponding laminae were: 
A) superficial dorsal horn (laminae I – II), B) nucleus proprius (laminae III – IV), C) 
neck of the dorsal horn (laminae V – VI) and D) the ventral gray (laminae VII – X).  
The counts from all L4 sections were also averaged for each region. Generally, around 
15 – 18 lumbar L4 spinal sections were analyzed for FLI cells. 
 
2.6.4 Statistical analysis 
Results are expressed as mean ± S.E.M.  The time course of change in 
electrophysiological parameters was analyzed using repeated measure one-way 
ANOVA.  The time course of behavioral change among different groups was 
compared using two-way ANOVA.  The comparison of averaged or selected data 
between different groups, including the behavioral phase data, was analyzed using 
one-way ANOVA.  Since the behavioral groups were of unequal size, the data were 
first validated for homogeneity of variance using Bartlett’s test.  In some instances, 
where the Bartlett’s test showed unequal variance, the data was normalized by log 
transform followed by ANOVA.  .  In all instances, post hoc comparisons following 
one-way and two-way ANOVA were performed using Newman–Keul’s test and 
Bonferroni correction respectively.  Some statistical analyses were performed using 
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3.1 Effect of intraseptal bicuculline on reticularly-elicited hippocampal 
activity 
 
In these experiments, we examined the effect of intraseptal microinjection of 
bicuculline, a GABAA receptor antagonist, on hippocampal theta activation and 
suppression of CA1 population spike (PS) to phasic RPO stimulation (2.56 sec of 
100Hz tetanus applied every 10 seconds).  During the experiments, a discrete volume 
(0.5μl) of the drug (0.125μg) was microinjected into the medial septum while 
following the protocol as described in Fig. 2.1.  The microinjection sites are shown in 
Fig. 3.1.   
 
3.1.1 Effect of reticular stimulation on hippocampal theta activation and PS 
amplitude 
 
As previously (Jiang and Khanna, 2004), stimulation of the reticularis pontis oralis 
(RPO) on the background of LIA hippocampal EEG evoked stable theta activation 
and robust suppression of the CA1 PS.  Compared to FFT peak power and frequency 
in the theta range during LIA, RPO stimulation increased both FFT theta peak power 
(Fig. 3.2; time, F12, 48 = 6.13, P < 0.0001) and FFT theta peak frequency (Fig. 3.2; 
time, F12, 48 = 12.53, P < 0.0001).  The amplitude of the 1
st
 PS evoked on twin pulse 
CA3 stimulation was decreased with RPO stimulation as compared to the amplitude 
during LIA, while the amplitude of the corresponding 2
nd
 PS increased in parallel (Fig. 
3.2; time, F12, 48 = 7.54, P < 0.0001).  Indeed, the ratio of the amplitude of the 2
nd
 PS 
to the amplitude of the 1
st
 PS significantly increased from 0.43 ± 0.06 in 2min during 
LIA to 1.47 ± 0.46 (t4=2.96, P < 0.05, n = 5) in the 2min following the onset of RPO 
stimulation. 





























Fig. 3.1.  Diagrammatic representation of hemi-sections of the brain through the 
medial septum illustrating the bicuculline microinjection sites in the region (inverted 
triangles).  Bicuculline (0.125µg/0.5µl) was microinjected using a double cannula 
assembly in urethane anaesthetized rat.  The double cannula assembly was oriented 
along the rostral-caudal axis of the medial septum.  The anterior cannula contained 
saline (0.9% NaCl) while the posterior cannula contained bicuculline solution 
prepared in alcian blue dye-saline.  The microinjection sites were identified by the 
presence of the blue dye spot in the Nissl stained brain sections.  Diagrams are 
adapted from Paxinos and Watson (2007), with the anterior-posterior coordinates 
















































Fig. 3.2. Stimulation of the reticularis pontis oralis (RPO) induced hippocampal CA1 
theta activation and the suppression of the population spike (PS).  The RPO 
stimulation (100Hz tetanus for 2.56s repeated every 10s) was applied on the 
background of LIA.  The intensity of RPO stimulation was adjusted to evoke CA1 
theta wave activity at 4-5Hz.  Hippocampal field CA3 was stimulated at a delay of 
10ms from the end of RPO tetanus.  The CA3 was stimulated using twin pulses 
(0.01ms pulse duration) at inter-pulse interval of 50-200ms to evoke a pair of PS, the 
1
st
 of two being larger in amplitude.  The amplitude of the 1
st
 PS was about 70% of 
maximal during LIA.  The 2
nd
 PS of the pair was suppressed compared to the 1
st
, 
presumably due to paired-pulse inhibition.  The experimental protocol followed is as 
described in Fig. 2.1.  The CA1 PSs was first recorded during LIA for 2 minutes and 
then paired with RPO stimulation (from time point -16min onwards on the graph).  
Since time point -18 and -17min was during LIA and have no theta, FFT analysis was 
performed on the recorded EEG during the entire 1min period and the theta power and 
frequency were represented by the FFT peak power and FFT peak frequency in the 
theta range.  Plots shows that from a low FFT peak power and FFT peak frequency in 
the theta range during LIA, RPO stimulation induced a robust and stable increase in 
the FFT theta peak power (upper left panel) and FFT theta peak frequency (upper 
right panel) that was accompanied by a decrease in the amplitude of the 1
st
 population 
spike and a parallel increase in the amplitude of the 2
nd
 PS.  The FFT theta peak 
power was normalized against the average theta peak power during the first 11 
minutes of RPO stimulation.  Data are mean ± SEM.  Significant difference: *P < 
0.05, vs. -18 minutes and -17 minutes (repeated measure 1-way ANOVA). 
 
Theta Peak Power









































































* * * * * * * *
* *















 - 90 - 
3.1.2 Differential effects of intraseptal bicuculline on RPO stimulation-induced 
hippocampal responses 
 
Eleven minutes following the initiation of the phasic RPO stimulation (see Fig. 2.1 
and section 3.1.1.) saline (0.5μl) was microinjected into the medial septum followed 
5min later by microinjection of bicuculline.   Microinjection of bicuculline 
(0.125μg/0.5μl), but not saline, attenuated the RPO stimulation-induced hippocampal 
theta power compared to the preceding control values (Figs. 3.3 and 3.4;  saline- -
7min and -6min vs. -5 to -1min, time, F6, 24 = 0.83, P > 0.5, Fig. 3.4A; bicuculline- -
2min and -1min vs. 1 to 30min, time, F31, 124 = 7.25, P < 0.0001, Fig. 3.4A).  Here it is 
notable that where there was little or no theta wave activity with RPO stimulation 
after bicuculline injection, the theta power and frequency were represented by the FFT 
peak power and FFT peak frequency in the theta range obtained on FFT analysis of 
the 2s of the non-theta segment during RPO stimulation.   
 
Neither saline nor bicuculline microinjection affected the FFT theta peak frequency 
(Fig. 3.4B; saline- 7min and -6min vs. -5 to -1min, time, F6, 24 = 1.12, P > 0.3; 
bicuculline- -2min and -1min vs. 1 to 30min, time, F31, 124 = 1.41, P > 0.09).  Likewise, 
analysis of selected time points indicated a robust decrease in theta power (Fig. 3.5A; 
groups F3, 15 = 16.94, P < 0.0001) with bicuculline microinjection which, however, 
did not affect theta frequency (Fig. 3.5B; groups F4, 18 = 0.13, P > 0.9).   
 
However, neither saline nor bicuculline affected the RPO stimulation-evoked 
suppression of the 1
st
 PS (Fig. 3.3 and 3.4; saline- -7min and -6min vs. -5 to -1min, 
time, F6, 24 = 0.70, P > 0.6, Fig. 3.4C; bicuculline- -2min and -1min vs. 1 to 30min, 
time, F31, 124 = 0.41, P > 0.9, Fig. 3.4C).  The facilitation of the 2
nd
 PS was also not 
affected by microinjection of vehicle (Fig. 3.4C; -7min and -6min vs. -5 to -1min, 
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time, F6, 24 = 1.00, P > 0.4).  Even though ANOVA showed a significant effect of 
bicuculline on facilitation of the 2
nd
 PS (Fig. 3.4C; bicuculline- -2min and -1min vs. 1 
to 30min, time, F31, 124 = 1.59, P < 0.04), post hoc analysis did not show a difference 
between the individual time points.   




































Fig. 3.3. Microinjection of bicuculline (0.125µg/ 0.5µl) into the medial septum 
attenuates reticularis pontis oralis (RPO) stimulation-induced power of theta wave 
activity (middle and right column).  The time of bicuculline microinjection is given by 
the horizontal arrow on the left and was taken as 0min while the time points -1min 
and 1min to 20min correspond to time before and after bicuculline microinjection.  
Time point -17min shows the recordings before the initiation of RPO stimulation.  
The traces in the left column represent the average PS amplitude in 1-min blocks 
where the stimulus artifact is indicated by the vertical arrow.  The traces in the middle 
column represent the hippocampal EEG while those in the right column are the fast 
Fourier transforms (FFT; frequency resolution of 0.5Hz) of the 2s of the EEG activity 
induced on RPO stimulation.  The FFT peak power is shown on right of each FFT 
trace.  Notice that RPO stimulation induced theta wave activity that was strongly 





 min post microinjection.  However, the RPO stimulation induced 
suppression of PS amplitude was not affected following bicuculline microinjection.
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Fig. 3.4. The time course of effect of bicuculline (0.125µg/ 0.5µl), microinjected into 
the medial septum, on RPO-elicited FFT theta peak power (A), FFT theta peak 
frequency (B), and population spike (PS) suppression (C).  The RPO was stimulated 
as explained in the figure 3.2.  Saline was microinjected at time point -5min which 
was 11min after the onset of RPO stimulation (see fig. 3.2).  Bicuculline was 




 minutes post 
RPO stimulation, which corresponds to -7min and -6min on the plot, are illustrated 
here.  Theta peak power was normalized against the average theta peak power during 
the first 11 minutes of RPO stimulation.  Intraseptal microinjection of bicuculline 
evoked an immediate decrease in the power of theta wave activity.  In contrast, both 
the frequency of theta wave activity, suppression of the 1
st
 and the facilitation of the 
2
nd
 PS were unaffected.  Data are mean ± SEM.  Significant difference: *P < 0.05, vs. 





























































































































Fig. 3.5. Intraseptal bicuculline (0.125µg/ 0.5µl) attenuated RPO-elicited theta power 
(A) but not the corresponding frequency (B).  In A and B, the values ‘pre sal’, ‘post 
sal’ and ‘pre Bic’ represent the average values in 2min periods before saline 
microinjection, after sal microinjection, and before bicuculline microinjection, 
respectively.  ‘Post bic’ in A represent the average value in the 2min after bicuculline 
microinjection.  Since theta was almost completely abolished relatively immediately, 
the time points were selected based on visibly identified theta of 1s or more during 
RPO stimulation for the entire 1 minute block during the recovery period.  For B, 
‘50% power’ represent the FFT theta peak frequency during the recovery period when 
FFT theta peak power had recovered to about 45% to 55% of the original before 
bicuculline microinjection.  While, ‘visible theta’ represents the FFT theta peak 
frequency of 2s segments of RPO stimulation-induced field activity that comprised of 
clear theta activity of 1s or more.  Note that intraseptal bicuculline, but not saline 
attenuated FFT theta peak power without affecting FFT theta peak frequency.  Data 
are mean ± SEM.  Significant difference: *P < 0.05, vs. Pre Sal; #P < 0.05, vs. Post 
Sal; @P < 0.05, vs. Pre Bic (1-way ANOVA). 
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3.2 Effect of intraseptal bicuculline on sensory stimulation-induced 
hippocampal activity 
 
The animals used in this part of the study were the same as that used to investigate the 
effect of bicuculline on RPO-elicited CA1 responses (see sections above).  Generally, 
investigations with sensory stimulation, involving subcutaneous injection of formalin 
(5%, 0.05ml) into the right hind paw (Khanna, 1997), were performed first followed 
by experiments with RPO stimulation.  In one instance, investigation with formalin 
followed the experimental investigation with RPO stimulation.  A gap of at least 1 
hour separated the two set of experiments.   
 
Bicuculline was microinjected into the medial septum 5min after hind paw injection 
of formalin.  Since the animals in this study were same as that reported above, the 
microinjection sites are the same as shown in Fig. 3.1. 
 
As previously (Khanna, 1997), injection of formalin into the hind paw elicited 
hippocampal theta activation (Fig. 3.6).  Both the theta duration (time, F11, 44 = 23.67, 
P < 0.0001) and FFT theta peak power (time, F11, 44 = 13.68, P < 0.0001) were 
significantly increased with hind paw injection of formalin.  Analysis indicated an 
overall significant trend with FFT theta peak frequency (Fig. 3.6; time, F11, 44 = 3.11, 
P < 0.004), though post hoc analysis indicated that individual time points were not 
different from each other.  Hippocampal CA1 PS was also suppressed in parallel with 
theta activation (Fig. 3.6; time, F11, 44 = 7.55, P < 0.0001). 
 
The microinjection of bicuculline (0.125µg/0.5µl) into the medial septum resulted in 
an attenuation of formalin-induced theta activation (Fig. 3.7A; time, F26, 104 = 14.17, P 
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< 0.0001).  The decrease in the duration of theta wave activity was observed within 
the minute of bicuculline microinjection, and it lasted for the duration of the recording 
(Fig. 3.7A).  Repeated measures 1-way ANOVA showed an overall significant effect 
of bicuculline on formalin-induced FFT theta power.  Indeed, a trend towards 
decreased FFT theta peak power was observed post bicuculline, though post hoc 
analysis indicated that the individual time points were not different from each other 
(Fig. 3.7B; time, F26, 104 = 1.84, P < 0.02).  However, analysis of select time points 
indicate that the FFT theta peak power in the 2 minutes before bicuculline 
microinjection (1.05 ± 0.03) was significantly higher than that around the peak of 
effect within 5 minutes (4 – 5 minutes; 0.22 ± 0.07; t4=9.19, P < 0.0009, n = 5). 
 
Intraseptal bicuculline, however, did not affect formalin-induced FFT theta peak 
frequency (Fig. 3.7C; time, F26, 104 = 0.82, P > 0.7) and PS suppression (Fig. 3.7D; 































Fig. 3.6. Injection of formalin (5%, 0.05ml) into the right hindpaw of the urethane 
anaesthetized rat induced hippocampal CA1 theta activation and the suppression of 
CA1 population spike (PS).  Formalin was injected into the right hindpaw just after 
time point -6min on the plot.  The experimental protocol followed is as described in 
Fig. 2.1.  Plots show the time course of effect of hindpaw formalin injection on the 
duration (A), FFT peak power (B), FFT peak frequency (C) of hippocampal CA1 
theta wave activity and on the amplitude (D) of hippocampal CA1 PS.  The 
hippocampal EEG was dominantly LIA with no clear theta wave activity prior to 
injection of formalin field.  Thus, the duration of theta prior to injection of formalin 
was zero.  The theta power and frequency in that period are represented by the FFT 
peak power and FFT peak frequency in the theta range.  The power and frequency 
post injection are the FFT theta peak power and FFT theta peak frequency of the theta 
wave activity observed following injection of formalin.  Theta peak power was 
normalized against the average theta peak power during the first 5 minutes after 
injection of formalin.  Data are mean ± SEM.  Significant difference: *P < 0.05, vs. -7 
















































































































































Fig. 3.7. The time course of effect of bicuculline (0.125µg/ 0.5µl), microinjected into 
the medial septum, on hindpaw formalin-induced theta duration (A), FFT theta peak 
power (B), FFT theta peak frequency (C), and suppression of CA1 population spike 
(PS; D).  The experimental protocol is detailed in Fig. 3.2.  Bicuculline was 
microinjected at time point 0min which was 5 minutes after hindpaw formalin 




 minutes post formalin 
injection, which corresponds to -2min and -1min on the plot, are illustrated here.  FFT 
analysis was performed on segments of theta wave activity selected from the recorded 
EEG except where there was little or no clear theta wave activity.  Under that 
situation FFT analysis was performed in an un-biased fashion on the recorded EEG 
and the theta power and frequency were represented by the FFT peak power and FFT 
peak frequency in the theta range.  Theta peak power was normalized against the 
average theta peak power during the first 5 minutes of formalin injection.  Note that 
the robust theta activation induced by hindpaw formalin injection was attenuated 
within the minute of bicuculline microinjection (A).  Data are mean ± SEM.  
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3.3 Effect of intraseptal bicuculline on carbachol-induced hippocampal 
activity 
 
These experiments were performed so as to investigate the effect of intraseptal 
bicuculline on carbachol-induced hippocampal theta activity induced on direct 
activation of MS neurons with intraseptal of the cholinergic agonist, carbachol 
(Lawson and Bland, 1993; Zheng and Khanna, 2001).  A discrete volume (0.5µl) of 
carbachol (0.156µg/µl) was microinjected every 60 minutes for 3 times during LIA 
EEG.  Bicuculline (0.125µg/0.5µl in alcian blue dye-solution) was microinjected 5 
minutes before the 2
nd





were denoted as C1 and C3 respectively while the 2
nd
 microinjection, which was 
preceded by the microinjection of bicuculline, was denoted as Bic-C2.  The 
microinjection sites are depicted in Fig. 3.8.  
 
Carbachol, microinjected into the medial septum, induced robust and stable increase 
in hippocampal theta wave activity that reached a peak at around 10 minutes post 
microinjection.  Prophylactic microinjection of bicuculline significantly attenuated the 
duration of hippocampal theta (Fig. 3.9A; treatment, F2, 276 = 17.21, P < 0.0004, 2-
way ANOVA) as compared to that observed with C1 and C2.  Further, an overall 
significant effect of the bicuculline treatment was observed on carbachol-induced FFT 
theta peak power (Fig. 3.9B; treatment, F2, 276 = 5.26, P < 0.03, 2-way ANOVA), 
though post hoc analysis indicated that individual time points were not different from 
each other.  Nonetheless, an analysis of the FFT theta peak power at the plateau phase 
of maximal theta activity from 11 to 15 minutes showed that bicuculline pretreatment 
significantly attenuate the average theta peak power compared to control 
microinjection of carbachol (Fig. 3.9D; groups, F2, 12 = 4.63, P < 0.04).  In context of 
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theta frequency, bicuculline pretreatment did not affect the FFT theta peak frequency 
(Fig. 3.9C; treatment, F2, 276 = 0.86, P > 0.44, 2-way ANOVA).   
 
Here, it is notable to point out that the dose of carbachol microinjected (0.078g 
[0.5µl of 0.156µg/µl]) was lower than that used previously (Zheng and Khanna, 2001; 
4µg).  Unlike that reported by (Zheng and Khanna (2001) with the higher dose, the 
lower dose did not affect PS amplitude clearly.  Repeated measures ANOVA show a 
significant effect of carbachol on PS amplitude even though post hoc analysis 
indicated that the PS amplitude at the individual timepoints after carbachol injection 
were not different from that before injection (time, F23, 92 = 2.82, P < 0.0003; data not 
shown).  Indeed, the average PS amplitude in the 2min before carbachol injection 
(6.30 ± 0.43mV) was not different from the corresponding value during 2min of peak 
of theta activation after carbachol injection (4.68 ± 0.61mV; t8=2.16, P > 0.06, n = 5). 
 






























Fig. 3.8.  Diagrammatic representation of hemi-sections of the brain through the 
medial septum illustrating the bicuculline microinjection sites in the region (inverted 






































Fig. 3.9. Bicuculline (0.125µg/0.5µl), microinjected into the medial septum, 
attenuated intraseptal carbachol-induced hippocampal theta activation.  (A-C) shows 
the time course of effect of bicuculline on carbachol-induced theta duration, FFT theta 
peak power and FFT theta peak frequency respectively.  Carbachol (0.5l of 
0.156µg/µl solution) was microinjected into the medial septum at time point 0min 
every 60 minutes for 3 times.  Bicuculline was microinjected 5 minutes before the 2
nd
 




 microinjection of carbachol is denoted as 
C1 and C3 respectively while Bic-C2 denotes the 2
nd
 microinjection of carbachol that 
was preceded by the bicuculline microinjection.  FFT analysis was performed on 
segments of theta wave activity selected from the recorded EEG except where there 
was little or no clear theta wave activity.  Under that situation FFT analysis was 
performed in an un-biased fashion on the recorded EEG and the theta power and 
frequency were represented by the FFT peak power and FFT peak frequency in the 
theta range.  (D) The effect of bicuculline on the average theta peak power at the peak 
of the hippocampal theta activity post carbachol microinjection.  The average theta 
peak power is the average of FFT theta peak power (or FFT peak power in the theta 
range) from 11-15min after carbachol microinjection.  FFT Theta peak power was 
normalized against the average of the FFT theta peak power during the first 5 minutes 
of the 1
st
 microinjection of carbachol (C1).  Data are mean ± SEM.  Significant 
difference: (A) *P < 0.05, vs. C1 and C2 (2-way ANOVA), (D) *P < 0.05, vs. C1; # P 
< 0.05, vs. C3 (1-way ANOVA).   
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3.4 Effect of systemic zolpidem and morphine on formalin-induced 
hippocampal theta activation in the awake rat 
 
These experiments were performed to correlate the system level effect of 
intraperitoneal drugs on septo-hippocampal theta activation vis-a-vis their influence 
on nociceptive behaviors.  The effects of the drugs on nociceptive behaviors are 
reported in the section 3.7.   
 
The theta wave activity was recorded from the stratum radiatum (n = 8; e.g. Fig. 3.10) 
or the stratum lacunosum-moleculare/fissure (n = 4) of the awake rat.  Only animals 
with implants that gave clear and large theta wave activity during exploration (theta 
amplitude of ≥ 0.2mV2 peak-to-peak) were used so as to facilitate analysis (Tai et al, 
2006).   
 
Hind paw injection of formalin in vehicle pre-treated animals evoked an increase in 
duration of theta (Fig. 3.11A; time, F13, 39 = 4.55, P < 0.0002).  In these experiments, 
vehicle, as also zolpidem and morphine in separate animals, was administered as pre-
treatment just before hind paw injection of formalin.  Such an administration of 
zolpidem prevented an increase in the duration of theta following injection of 
formalin (Fig. 3.11A; time, F13, 39 = 1.18, P > 0.3).  Repeated measure ANOVA 
showed an overall significance in animals pretreated with morphine, though none of 
the time points following injection of formalin were different from the pre-injection 
controls (Fig. 3.11A; time, F13, 39 = 2.35, P < 0.02). 
  
Indeed, the formalin-induced duration of theta wave activity, both during the first 
theta state and the second theta state of the behaving rat, was significantly higher in 
vehicle pre-treated animals as compared to those that were administered 
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intraperitoneal zolpidem or morphine (1
st
 theta state, groups, F2, 9 = 7.36, P < 0.02; 2
nd
 
theta state, groups, F2, 9 = 7.63, P < 0.02; n = 4 per group). Thus, in the first theta state 
the duration of theta for the three groups, i.e. vehicle vs. zolpidem vs. morphine, were 
112.1 ± 22.5s vs. 18.9 ± 13.0s vs. 51.7 ± 15.5s. The duration of theta during the 
second theta state for the three groups was 750.8 ± 49.3s vs. 367.8 ± 107.0s vs. 370.9 
± 72.2s. The duration of theta wave activity was not different between the zolpidem 
and morphine treated animals. 
 
Systemic administration of zolpidem attenuated frequency of theta wave activity in 
formalin test in behaving animal (Figs. 3.10 and 3.11). Here, the FFT theta peak 
frequency was calculated for the 20 min period following zolpidem that corresponds 
to the duration of the strongest effect of the drug in the anaesthetized rat (Lee et al., 
2011).  Interestingly, the frequency of theta wave activity was increased in morphine 
treated animals as compared to the vehicle control group (Fig. 3.11B; groups, F2, 9 = 
13.67, P < 0.002). 
 
However, unlike the FFT theta peak frequency, the corresponding power of the theta 
wave activity was no different among the three.  It is notable that the amplitude of the 
theta wave activity, which reflects power, varies with relative location within the 
hippocampus along the dorsal-ventral axis.  Thus, to minimize the effect of the depth, 
the FFT theta peak power in the three groups was normalized against the exploratory 
theta power.  The normalized FFT theta peak power in vehicle vs. zolpidem vs. 
morphine treated animals was 0.44 ± 0.09 vs. 0.53 ± 0.14 vs. 0.40 ± 0.08 (groups, F2, 9 
= 0.39, P > 0.6, n = 4 per group).  In general, the three groups of behaving animals 
were similar in physiological background insofar that the frequencies of theta wave 
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activity during exploration were not different among the three (FFT theta peak 
frequency for vehicle, zolpidem and morphine groups being 6.88 ± 0.13, 7.25 ± 0.14 
and 7.33 ± 0.31Hz; groups, F2, 9 = 1.32, P > 0.3, n = 4 per group). 
 

















Fig. 3.10. Illustration of recording sites (A) and electroencephalogram traces (EEG; 
B, C) recorded from hippocampal field CA1 in a behaving animal.  In A, the top left 
panel is the digital image of a Nissl-stained coronal section taken through the 
hippocampus showing the electrode track (arrow), while the corresponding 
diagrammatic representation, adapted from Paxinos and Watson (2007), is on the 
right.  The dark intense band labeled Py on the digital image is the pyramidal cell 
layer whereas hf is the hippocampal fissure. The filled circle and filled square on the 
diagrammatic representation correspond to the ventral (to the py) and the dorsal (to 
the py) recording sites, respectively. The ventral recording site was in the stratum 
radiatum (st. rad on figure) while the dorsal site was estimated to be in the corpus 
callosum (cc on the figure). The EEG waveforms in B and C were recorded from 
ventral sites and are taken from the first five minutes following hind paw injection of 
formalin (1.25%, 0.1ml) in animals administered vehicle (B) or zolpidem (C; 1mg/kg, 
i.p.) immediately before formalin injection. Clear theta wave activity was observed in 
B and, in line with visual observation, the peak frequency of the associated fast 
Fourier transform (FFT; frequency resolution 0.5Hz) of the EEG trace was in the theta 
range (4–12 Hz) and was clearly demarcated from other frequencies around the region 
of the peak. Compared to B, a mixture of theta and non-theta EEG was observed in C 
and FFT analyses revealed peaks in theta and non-theta ranges. Furthermore, the FFT 
peak frequency in the theta range was lower compared to B, although of similar 
power (peak-to-peak amplitude square in mV
2
 unit).   
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Fig. 3.11.  Differing effects of systemic zolpidem (Zol) and morphine (Mor) on 
formalin-induced theta activity in the behaving rat.  The animal was acclimatized for 
30min in the recording chamber before the start of the experiment.  Either zolpidem 
(1mg/kg), morphine (5mg/kg) or vehicle was administered intraperitoneally at end of 
acclimatization followed immediately by hind paw injection of formalin (1.25%, 
0.1ml).  The time of formalin injection was taken as 0min (A).  The data was 
calculated in blocks of 5min such that -10min and -5min on the plot correspond to the 
10min of acclimatization preceding formalin injection while the other time points 
reflect the period following the injection (A).  Theta was identified visually as 
sinusoidal oscillations between 4–12 Hz frequencies of at least 1s duration, and the 
duration of theta per 5min blocks (A) was the number of seconds that theta wave 
activity was observed in that block.  Fast Fourier Transform (FFT) analysis was 
performed on visually identified theta segments, each of at least 2s duration, in each 
5min block after injection of formalin in vehicle or drug treated animals and then 
averaged for the first 20min to give FFT theta peak frequency (B).  The first 20min 
were targeted for comparative analysis since the effect of zolpidem was most robust in 
this period in anaesthetized rat (Lee et al., 2011).  Note the decrease in theta duration 
with injection of zolpidem or morphine.  However, the FFT theta peak frequency was 
higher with morphine while it decreased following administration of zolpidem.  The 
data are mean + SEM.  Significant difference: (A) * P < 0.05, vs. -10 min and -5min 
(repeated measure 1-way ANOVA); (B) *P < 0.05, vs. vehicle; #P < 0.05, vs. 
zolpidem (1-way ANOVA). 
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3.5 Effect of intraseptal zolpidem on formalin-induced hippocampal theta 
generation in the awake rat 
 
Theta wave activity was recorded around the stratum radiatum (n = 6) or the stratum 
lacunosum-moleculare/fissure (n = 4) of the awake rats that showed clear and large 
theta wave activity during exploration (theta amplitude of ≥ 0.2mV2 peak-to-peak).  
Zolpidem or its vehicle was microinjected just before hind paw injection of formalin 
(1.25%, 0.1ml).  The animal behavior was also monitored.  The animal behaviors and 
the location of the intraseptal microinjection sites are reported in section 3.9 and Figs. 
3.21, 3.22.   
 
Hind paw injection of formalin in animals pretreated with vehicle evoked the typical 
biphasic increase in theta activation (Fig. 3.12A).  Microinjection of zolpidem 




 theta state) 
even though an overall significant effect was not observed with 2-way ANOVA (Fig. 
3.12A; treatment, F1, 136 = 0.06, P > 0.8).  However, phase analysis of the theta 
duration during the 1
st
 theta state and the 2
nd
 theta state indicates that intraseptal 
zolpidem significantly attenuate theta activity in the 1
st
 theta state (Fig. 3.12D; groups, 
t8 = 3.72, P < 0.006, two-tailed unpaired t test) but not the 2
nd
 theta state (Fig. 3.12D; 
groups, t8 = 0.89, P > 0.3, two-tailed unpaired t test).  This is consistent with a brief 
effect of intramedial septum zolpidem on formalin-induced theta activation in the 
urethane anaesthetized animal (Lee et al., 2011).   
 
A significant effect of treatment was not observed on theta peak power (Fig. 3.12B; 
treatment, F1, 136 = 1.88, P > 0.2) or frequency (Fig. 3.12C; treatment, F1, 136 = 1.09, 
P > 0.3).  Similarly, analysis of the averaged data for the two theta states indicated 
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that microinjection of zolpidem into the medial septum had no effect on average theta 
peak power in both the 1
st
 theta state (Veh. vs. Zol.: 0.67 ± 0.14 vs 0.44 ± 0.09, t8 = 
1.40, P > 0.02, n=5, two-tailed unpaired t test) and 2
nd
 theta state (Veh vs. Zol; 0.53 ± 
0.06 vs. 0.40 ± 0.08 , t8 = 0.25, P > 0.2, n=5, two-tailed unpaired t test), or on the 
average theta peak frequency in both the 1
st
 theta state (Veh. vs. Zol.: 7.50 ± 0.16Hz 
vs. 7.60 ± 0.19Hz, t8 = 0.41, P > 0.6, n=5, two-tailed unpaired t test) and 2
nd
 theta 
state (Veh. vs. Zol.: 7.12 ± 0.07Hz vs. 7.12 ± 0.13Hz, t8 = 0, P > 0.9, n=5, two-tailed 
unpaired t test).   



























Fig. 3.12. Intraseptal zolpidem (Zol; 8µg/0.5µl) attenuated the duration of hind paw 
formalin-induced hippocampal theta activity in the first phase.  Formalin (1.25%, 
0.1ml) was injected into the right hind paw immediately after microinjection of 
zolpidem or vehicle (Veh).  A, B and C are the time course of the effect of intraseptal 
zolpidem on theta duration, FFT theta peak power, and FFT theta peak frequency, 
respectively.  Formalin was injected at time 0min and the data was calculated in 
blocks of 5min such that -10min and -5min on the plot correspond to the 10min of 
acclimatization preceding formalin injection while the other time points reflect the 
period following the injection. Theta was identified visually as sinusoidal oscillations 
between 4–12 Hz frequencies of at least 1s duration, and the duration of theta per 
5min blocks (A) was the number of seconds that theta wave activity was observed in 
that block.  Fast Fourier Transform (FFT) analysis was performed on visually 
identified theta segments, each of at least 2s duration, in each 5min block after 
injection of formalin to give the theta peak power (B) and theta peak frequency (C).  
Theta peak power was normalized with exploratory theta recorded before the formalin 
test.  (D) Histogram plots illustrating the cumulative duration of theta wave activity in 
the 1
st
 (0-5min) and 2
nd
 (11-40min) theta state.  Data are mean + SEM.  Significant 
difference: (D) *P < 0.05, vs. corresponding vehicle (two-tailed unpaired t test). 
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3.6 Effect of intraseptal injection of the GABAA antagonist, bicuculline, on 
formalin-induced behaviors 
 
These experiments were performed to test whether disrupting septal GABAergic 
mechanisms with the GABAA receptor antagonist bicuculline has an effect on 
nociception.  The dose of bicuculline used (0.125μg in 0.5μl) was sub-maximal and 
did not provoke epileptic behaviors or hippocampal epileptic after-discharges though 
it sufficed to attenuate septo-hippocampal network activity, i.e. theta activation, in 
anaesthetized rat (see sections 3.1 – 3.3).  The microinjection sites are illustrated in 
Fig. 3.13. 
 
3.6.1 Intraseptal bicuculline did not affect formalin-induced licking and 
flinching behaviors 
 
Formalin (1.25%, 0.1ml) was injected into the right hind paw within a minute or so 
after the microinjection of bicuculline (0.125μg in 0.5μl) or the corresponding vehicle.  
The injection of formalin overlapped with the peak effect of intraseptal bicuculline on 
RPO stimulation-induced septo-hippocampal theta activation (see Fig. 3.4).  Formalin 
injection evoked the typical biphasic increase in licking and flinching behaviors (Fig. 
3.14A).  Intraseptal microinjection of bicuculline did not affect the time course of 
either licking (Fig. 3.14A; treatment, F2, 357 = 0.46, P > 0.6, 2-way ANOVA) or 
flinching behaviors (Fig. 3.14A; treatment, F2, 357 = 0.08, P > 0.9, 2-way ANOVA), 
as compared to vehicle microinjected animals.  Consistently, intraseptal 
microinjection of bicuculline did not significantly affect the first phase licking 
(intraseptal Vehicle vs. MS bicuculline vs. LS bicuculline; 106.6 ± 9.8s vs. 63.6 ± 
16.7s vs. 82.0 ± 24.9s; groups, F2, 21 = 2.42, P > 0.10) and flinching (intraseptal 
Vehicle vs. MS bicuculline vs. LS bicuculline; 98.9 ± 14.6 vs. 107.7 ± 11.4 vs. 104.4 
± 23.0; groups, F2, 21 = 0.09, P > 0.90) behaviors.  Likewise, the phase 2 behaviors 
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were also not significantly affected compared to vehicle microinjected animals (Fig. 
3.14B; licking- groups, F2, 21 = 1.49, P > 0.20) and flinching (Fig. 3.14B; flinching- 
groups, F2, 21 = 0.08, P > 0.90) with intraseptal bicuculline.     
 






















Fig. 3.13. Diagrammatic representation of brain hemi-sections through the septal 
region illustrating bicuculline (filled inverted triangles) and vehicle (filled circles) 
microinjection sites in the medial septum (A) and the lateral septum (B) of the 
behaving animal.  The drug or vehicle were microinjected (volume of 0.5µl) using a 
33G internal cannula.  The diagrams represented are adapted from Paxinos and 
Watson (2007) with the anterior-posterior coordinates indicated on the right below 
each figure.    
 








































































































Fig. 3.14. Microinjection of bicuculline (Bic) into the medial septum (MS) or the 
lateral septum (LS) did not affect hind paw formalin-induced nociceptive behaviors.  
These experiments were performed on animals implanted with only the microinjection 
cannula.  Formalin (1.25%, 0.1ml) was injected immediately following the 
microinjection.  (A) Time course of licking (left panel) and flinching (right panel) of 
the injured paw after formalin injection.  Formalin was injected at time 0min and the 
duration of licking (s) and the numbers of flinches were counted for blocks of 5min.  
The vehicle (Veh) group comprised of animals with vehicle microinjected into the MS 
(n = 7) and LS (n = 5).  Note the typical biphasic increase in the two nociceptive 
behaviors following injection of formalin.  (B) Histogram plots illustrating the 
cumulative licking (left panel) and flinching (right panel) behaviors in the second 
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3.7 Effect of systemic zolpidem and morphine on formalin-induced behaviors 
 
These experiments, with intraperitoneal administration of zolpidem or morphine, were 
performed so as to build a background against which to evaluate and compare the 
findings with intraseptal microinjection of GABA mimetics (zolpidem and muscimol).   
 
Intraperitoneal administration of both zolpidem (1mg/kg) and morphine (5mg/kg) 
prior to injection of formalin attenuated formalin-induced licking as compared to 
vehicle administered animals (Fig. 3.15A; treatment, F2, 510 = 13.15, P < 0.0001, 2-
way ANOVA).  Similarly, an overall effect of the drug treatments was observed on 
formalin-induced flinching behavior (Fig. 3.15A; treatment, F2, 510 = 14.04, P < 
0.0001, 2-way ANOVA); however, post hoc analysis indicated that morphine, but not 
zolpidem, attenuated flinching compared to the vehicle group (Fig. 3.15A).  The 
vehicle group was a composite of animals that were administered vehicle used to 
dissolve morphine or zolpidem.  The animals in the two vehicle control groups 
exhibited an overlapping behavioral profile following hind paw injection of formalin 
and were thus combined.   
 
Analysis of phase 1 and 2 behaviors also indicated that both drugs affected licking in 
phase 1 (groups, F2, 30 = 8.28, P < 0.002; Vehicle vs. Zolpidem vs. Morphine, 86.0 ± 
11.2s vs. 45.0 ± 6.1s* vs. 39.6 ± 8.0*; * P < 0.01 vs. vehicle) and phase 2 (Fig. 3.15B; 
groups, F2, 30 = 9.43, P < 0.0008), but only morphine affected flinching.  In this 
context, morphine decreased flinching both in phase 1 (groups, F2, 30 = 6.43, P < 0.005; 
Vehicle vs. Zolpidem vs. Morphine, 96.2 ± 14.0 vs. 99.4 ± 12.8 vs. 35.8 ± 7.7*; * P < 
0.01 vs. vehicle and zolpidem) and phase 2 (Fig. 3.15B; groups, F2, 30 = 11.93, P < 
0.0003).

























Fig. 3.15. Differing effects of systemic zolpidem (Zol) and morphine (Mor) on hind 
paw formalin-induced nociceptive behaviors.  These experiments were performed on 
animals implanted with only the recording electrode.  Hippocampal field activity was 
also recorded concurrently (see section 3.4).  Formalin (1.25%, 0.1ml) was injected 
immediately following the intraperitoneal injection of a drug or vehicle (Veh).  (A) 
Time course of licking (left panel) and flinching (right panel) of the injured paw after 
formalin injection.  Formalin was injected at time 0min and the duration of licking (s) 
and the numbers of flinches were counted for blocks of 5min.  Note the typical 
biphasic increase in the nociceptive behaviors following injection of formalin in 
vehicle treated animals.  However, treatment with zolpidem (1mg/kg) selectively 
attenuated licking behavior in both phases whereas morphine attenuated both licking 
and flinching behaviors in the two phases.  (B) Histogram plots illustrating the 
cumulative licking (left panel) and flinching (right panel) behaviors in the second 
phase (11-60min).  Data are mean + SEM.  Significant difference: (A) P < 0.05; * 
zolpidem vs. vehicle; # morphine vs. vehicle (2-way ANOVA); (B) * P < 0.05 vs. 
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3.8 Effect of intraseptal microinjection of GABA-mimetics on formalin-
induced behavior and spinal c-Fos-like immunoreactivity 
 
The experiments were performed to test whether neural inactivation in the MS by the 
two GABAergic drugs influences indices of nociception.  The drugs (muscimol, 1μg 
or 2μg in 0.5μl; zolpidem, 8μg or 12μg in 0.5μl) or the corresponding vehicles were 
microinjected just prior to hind paw injection of formalin (1.25%, 0.1ml; Lee et al., 
2011).  The microinjection sites are shown in Fig. 3.16.  Microinjection of the 
different concentrations of a given drug into a region, i.e. either the medial septum or 
the lateral septum, evoked similar pattern of responses.  Thus, the data for the two 
concentrations of a drug were combined for the same region (Figs. 3.16, 3.17 and 
3.19).  Along similar lines, microinjection of the two vehicles, whether in MS or LS, 
evoked comparable responses and therefore all the vehicle experiments were grouped 
together (n = 12 in total; n = 4, vehicle for zolpidem microinjected into MS; n = 3, 
vehicle for zolpidem microinjected into LS; n = 2, vehicle for muscimol microinjected 
into MS; n = 3, vehicle for muscimol microinjected into LS). 
 
3.8.1 Intraseptal muscimol attenuate formalin-induced nociceptive behaviors 
and spinal c-Fos-like immunoreactivity 
 
Hind paw injection of formalin in animals pre-treated with vehicle evoked the typical 
biphasic increase in both licking and flinching behaviors (Fig. 3.17A).  Intraseptal 
microinjection of muscimol evoked an overall significant effect on both licking (Fig. 
3.17A; treatment, F2, 425 = 5.46, P < 0.02, 2-way ANOVA) and flinching behaviors 
(Fig. 3.17A; treatment, F2, 425 = 8.17, P < 0.002, 2-way ANOVA), as compared to 
vehicle microinjected animals.  Post hoc analysis indicated that muscimol 
microinjection into MS attenuated both the rising and declining phases of the formalin 
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test during the 2
nd
 phase while sparing the phase 1 behaviors.  In comparison, the 
strongest effect of muscimol microinjected into LS was seen on the declining phase of 
the 2
nd
 phase behaviors (Fig. 3.17A).  This was most evident on the flinching behavior 
that exhibited an extended time course as compared to licking (Fig. 3.17A).   
 
Consistently, one-way ANOVA of the phase 2 behavioral responses indicated that 
intraseptal muscimol attenuated both licking (Fig. 3.17B; groups, F2, 25 = 5.53, P < 
0.02) and flinching (Fig. 3.17B; groups, F2, 25 = 14.23, P < 0.0001) with a stronger 
effect of MS muscimol on flinching as compared to the lateral septum microinjection 
of the drug.  Intraseptal microinjection of muscimol did not significantly affect the 
first phase licking (Vehicle vs. MS muscimol vs. LS muscimol; 101.9 ± 6.9s vs. 92.4 
± 5.2s vs. 111.3 ± 8.1s; groups, F2, 25 = 1.47, P > 0.20) and flinching (Vehicle vs. MS 
muscimol vs. LS muscimol; 100.5 ± 11.4 vs. 91.7 ± 20.9 vs. 87.4 ± 5.9; groups, F2, 25 
= 0.30, P > 0.70) behaviors.  Indeed, minute to minute analysis in the first 5 min 
indicated that intraseptal microinjection of muscimol had no significant effect on 
licking (treatment, F2, 100 = 1.53, P > 0.2, 2-way ANOVA) and flinching (treatment, 
F2, 100 = 0.31, P > 0.7, 2-way ANOVA) compared to control animals. 
 
Interestingly, the effect of microinjection of muscimol into MS was comparable with 
the effect of systemic morphine.  Second phase flinching and licking behaviors with 
systemic morphine or MS muscimol were on average 30% to 60% of that observed in 
control animals and were no different from each other (two-tailed unpaired t-test, P > 
0.2). 
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In line with the behavioral effects, intraseptal microinjection of muscimol also 
attenuated the formalin-induced expression of spinal FLI (Fig. 3.18).  The total 
number of FLI positive cells per L4 spinal section in the vehicle group was 69.6 ± 
10.5 (n = 6) which was significantly higher (groups, F2, 15 = 4.45, P < 0.04) than the 
corresponding values in animals microinjected with muscimol into the medial septum 
(40.5 ± 4.1, n = 5) and the lateral septum (43.9 ± 5.8, n = 7).  Laminar specific counts 
(Fig. 3.18B) also revealed that microinjection of muscimol into MS and LS evoked a 
statistically significant reduction of FLI in regions B (laminae III-IV; groups, F2, 15 = 
4.33, P < 0.04, 1-way ANOVA), C (laminae V-VI; groups, F2, 15 = 5.76, P < 0.02, 1-
way ANOVA) and D (laminae VII-X; groups, F2, 15 = 4.29, P < 0.04, 1-way ANOVA).  
There was no significant difference in FLI in region A (Fig. 3.18B; laminae I-II, F2, 15 
= 2.53, P > 0.1, 1-way ANOVA), although the values in the muscimol treated groups 
were low as compared to control.   

















Fig. 3.16.  Diagrammatic representation of brain hemi-sections illustrating the 
microinjection sites in the medial septum (A) and the lateral septum (B) in the 
behaving animal.  The drugs or vehicle were microinjected (volume of 0.5l) using a 
33G internal cannula.  The diagrams represented are adapted from Paxinos and 
Watson (2007) with the anterior-posterior coordinates indicated on the right below 
each figure.  In A filled circles, filled triangles and filled diamonds on the hemi-
sections correspond to vehicle (n = 6), zolpidem (n = 10; 8μg in 6 animals and 12μg in 
4 animals) and muscimol (n = 7; 1μg in 4 animals and 2μg in 3 animals) 
microinjection sites in the medial septum, respectively.  The microinjection sites in 
the adjacent lateral septum are shown on hemi-sections in B and include that for 
vehicle (filled circles, n = 5), zolpidem (filled triangles, n = 9; 3 animals with 8μg and 
6 animals with 12μg) and muscimol (filled diamonds, n = 9; 6 animals with 1μg and 3 
animals with 2μg).  The most dorsal and the most lateral microinjections in the lateral 
septum were 600m and 400m away from the corresponding MS boundaries in the 
same plane.  








































































































































Fig. 3.17. Intraseptal (MS) muscimol (Mus; 1μg in 4 animals and 2μg in 3 animals, 
0.5μl) attenuated animal nociceptive behavior in the 2nd phase of the formalin test.  
These experiments were performed on behaving animals implanted with only the 
microinjection cannula.  Formalin (1.25%, 0.1ml) was injected into right hind paw 
immediately following microinjection of muscimol or vehicle (Veh) via a 33G 
cannula.  (A) Time course of licking (left panel) and flinching (right panel) of the 
injured paw after formalin injection.  Formalin was injected at time 0min and the 
duration of licking (s) and the numbers of flinches were counted for blocks of 5min.  
Note the difference in the pattern of the drug effect upon microinjection into the MS 
vs. the lateral septum (LS, 1μg in 6 animals and 2μg in 3 animals, 0.5μl) on the 
behaviors in the second phase of the formalin test.  Thus, MS microinjection 
attenuated the nociceptive behaviors both on the rising and the falling phase whereas 
LS microinjection strongly affected the falling phase of the behaviors.  However, the 
behaviors in the 1st phase were not affected by the microinjections.  (B) Histogram 
plots illustrating the cumulative licking (left panel) and flinching (right panel) 
behaviors in the second phase (11-60min).  Data are mean + SEM.  Significant 
difference: (A) P < 0.05; * muscimol (MS) vs. vehicle; # muscimol (LS) vs. vehicle 
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Fig. 3.18. Intraseptal muscimol (1μg or 2μg, 0.5μl) attenuated formalin-induced 
induction of Fos-like immunoreactivity (FLI) in the spinal cord.  (A) On the left are the 
digital images (developed at 750 dpi) of 60µm coronal sections taken through the L4 
lumbar spinal cord, while the diagram on the right illustrates the laminar subdivisions of 
the spinal region (adapted from Molander et al, 1984).  Cells expressing FLI stand out as 
darkly stained relative to the background on the digital images.  Note the relatively high 
level of labeling in the superficial dorsal horn and the neck of the dorsal horn in the 
vehicle (Veh) treated group and the relatively sparse labeling, especially in the neck of 
the dorsal horn of the muscimol-treated group (Mus).  Muscimol or vehicle was 
microinjected into medial septum (MS) or lateral septum (LS).  (B) Histograms 
illustrating the number of FLI cell, counted using a digital imaging system, in the 
different regions of the spinal cord, with regard to laminae I-II (area A), laminae III-IV 
(area B), laminae V-VI (area C) and laminae VII-X (area D).  Data are mean + SEM.  
Significant differences: * p < 0.05 vs. vehicle (1-way ANOVA). 
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The action of intraseptal zolpidem was also both site- and formalin phase-specific, but 
the effect was weaker than seen with muscimol.  Thus, intraseptal microinjection of 
zolpidem evoked an overall significant effect on flinching behavior as compared to 
vehicle microinjected animals (Fig. 3.19A; treatment, F2, 476 = 6.45, P < 0.006, 2-way 
ANOVA).  The flinching was suppressed in the 2
nd
 phase in animals’ microinjected 
with zolpidem into the MS, though post hoc analysis indicated that only a select time 
point was different from vehicle microinjected animals (Fig. 3.19A).  Notwithstanding, 
1-way ANOVA analysis of phase 2 flinching behavior indicated that the flinching 
behavior in animals’ microinjected with zolpidem into the MS was significantly 
suppressed compared to control animals and animals microinjected with zolpidem 
into the LS (Fig. 3.19B; groups, F2, 28 = 8.50, P < 0.002).  The flinching behaviors in 
the last two groups were not different from each other.  The 1
st
 phase flinching 
behavior among the three groups was not different from each other (Vehicle vs. MS 
zolpidem vs. LS zolpidem: 100.5 ± 11.4 vs. 84.4 ± 16.6 vs. 116.7 ± 12.9; groups, F2, 
28 = 1.29, P > 0.2).  Indeed, minute to minute analysis of flinching behaviors in the 
first 5 min showed no difference between the three groups (treatment, F2, 112 = 1.80, 
P > 0.1, 2-way ANOVA). 
 
Unlike muscimol, intraseptal zolpidem did not significantly affect licking behavior, 
although licking was somewhat blunted with microinjection of zolpidem into the 
medial septum (Fig. 3.19A; treatment, F2, 476 = 1.70, P > 0.2, 2-way ANOVA).  
Indeed, phase analysis indicated a statistically non-significant effect of intraseptal 
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zolpidem on both the first phase (Vehicle vs. MS zolpidem vs. LS zolpidem: 101.9 ± 
6.9s vs. 93.5 ± 5.6s vs. 83.7 ± 13.2s; groups, F2, 28 = 1.11, P > 0.3) and second phase 
(Fig. 3.19B; groups, F2, 28 = 1.45, P > 0.2) licking. 
 
That zolpidem was only weakly antinociceptive, as compared to muscimol, was 
further reinforced by lack of effect of zolpidem on the formalin-induced expression of 
spinal FLI (Fig. 3.20).  The total number of FLI positive cells per L4 spinal section in 
the vehicle group was 69.6 ± 10.5 (n = 6) which was not different (groups, F2, 12 = 
0.01, P > 0.9) than the corresponding values in animals microinjected with zolpidem 
into the medial septum (72.4 ± 12.8, n = 5) and the lateral septum (70.5 ± 24.3, n = 4).  
Laminar specific counts (Fig. 3.20) also did not indicate a difference in FLI in regions 
A (laminae I-II, groups, F2, 12 = 0.18, P > 0.8), B (laminae III-IV; groups, F2, 12 = 0.06, 
P > 0.9), C (laminae V-VI; groups, F2, 12 = 0.05, P > 0.9) and D (laminae VII-X; 
groups, F2, 12 = 0.38, P > 0.6). 
 
 


























Fig. 3.19. Intraseptal (medial septum; MS) zolpidem (Zol, 8μg or 12μg; 8μg in 6 
animals and 12μg in 4 animals, 0.5μl) selectively attenuated formalin-induced 
flinching behavior in the 2
nd
 phase.  These experiments were performed on behaving 
animals implanted with only the microinjection cannula.  Formalin (1.25%, 0.1ml) 
was injected immediately following microinjection of zolpidem using an internal 
cannula.  (A) Time course of licking (left panel) and flinching (right panel) of the 
injured paw after formalin injection.  Note the parallel decrease in flinching behavior 
with MS microinjection of zolpidem, as compared to vehicle (Veh) microinjected 
animals.  The effect on licking was relatively mild and only the peak response 
appeared blunted.  However, lateral septum (LS) microinjections (8μg or 12μg, 8μg in 
3 animals and 12μg in 6 animals, 0.5μl) did not evoke any significant decrease.  The 
behaviors in the 1
st
 phase were unaffected by the microinjections.  (B) Histogram 
plots illustrating the cumulative licking (left panel) and flinching (right panel) 
behaviors in the second phase (11-60min).  Data are mean + SEM.  Significant 
difference: (A) P < 0.05; * zolpidem (MS) vs. vehicle; # zolpidem (LS) vs. vehicle (2-
way ANOVA) and (B) * P < 0.05 vs. vehicle; # P < 0.05 vs. zolpidem (MS) (1-way 
ANOVA). 
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Fig. 3.20. Intraseptal zolpidem (Zol; 8μg or 12μg, 0.5μl) did not affect formalin-
induced induction of Fos-like immunoreactivity (FLI) in the spinal cord.  Histograms 
illustrate the number of FLI cell, counted using a digital imaging system, in the 
different regions of the spinal cord following microinjection of vehicle (veh), or 
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3.9 Effect of combined microinjection of bicuculline and zolpidem on 
formalin-induced behaviors 
 
These experiments were performed to test if intraseptal bicuculline, a GABAA 
receptor antagonist, modulates GABAergic mechanisms in behaving rat.  For this 
purpose, MS bicuculline was tested for its ability to antagonize the effect of MS 
zolpidem on formalin-induced nociceptive behaviors.  Zolpidem is a positive 
allosteric modulator at GABAA receptor and potentiates the effect of GABA.   
 
Drugs were microinjected in animals implanted with hippocampal recording 
electrodes.  However, successful EEG was recorded only in few cases and therefore 
this electrophysiological readout is not reported here.  Further, the experiments were 
in parallel to experimental exploration of the effect of bicuculline on formalin-induced 
behavior (see section 3.6).  The two were, however, not combined since the latter 
were performed without field recording.   Nonetheless, it is notable that bicuculline 
alone did not affect formalin-induced nociceptive behaviors (see section 3.6.1).   
 
During the investigations, either a drug mixture solution consisting of zolpidem (8μg) 
and bicuculline (0.125μg), or a single agent, including zolpidem (8μg) or vehicle was 
microinjected followed immediately with hind paw injection of formalin (1.25%, 
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3.9.1 Microinjection of combination of bicuculline and zolpidem precludes the 
antinociceptive effect of zolpidem on flinching behavior 
 
An overall significant effect was observed on flinching behavior (Fig. 3.22A; 
treatment, F2, 272 = 6.60, P < 0.009, 2-way ANOVA) but not licking behavior (Fig. 
3.22A; treatment, F2, 272 = 0.11, P > 0.8, 2-way ANOVA) in the experiments.  Post 
hoc analysis indicated that MS zolpidem attenuated flinching behavior.  This is in line 
with previous results (see section 3.8.2).  However, zolpidem-induced decrease in 
flinching was prevented when the drug was microinjected into MS together with 
bicuculline (Fig. 3.22A).   
 
Consistently, one-way ANOVA of the phase 2 behavioral responses indicated that 
intraseptal zolpidem attenuated flinching behavior (Fig. 3.22B; groups, F2, 16 = 7.56, P 
< 0.005) but not licking behavior (Fig. 3.22B; groups, F2, 16 = 0.08, P > 0.9).  The 
zolpidem-induced attenuation of phase 2 flinching behavior was prevented when the 
drug was microinjected together with bicuculline.   
 
MS microinjection of zolpidem or the drug mixture (zolpidem and bicuculline) did 
not significantly affect the first phase licking (Vehicle vs. MS zolpidem vs. MS 
zolpidem + bicuculline: 76.6 ± 15.0s vs. 86.4 ± 9.1s vs. 68.3 ± 19.3s; groups, F2, 16 = 
0.45, P > 0.6) and flinching (Vehicle vs. MS zolpidem vs. MS zolpidem + bicuculline: 
81.6 ± 11.6 vs. 66.9 ± 6.8 vs. 93.8 ± 7.5; groups, F2, 16 = 2.90, P > 0.08) behaviors. 
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Fig. 3.21.  Diagrammatic representation of brain hemi-sections through the septal 
region illustrating vehicle (filled circles), zolpidem (8ug; filled inverted triangles), and 
zolpidem (8ug) plus bicuculline (0.125ug; filled squares) microinjection sites in the 
medial septum.  The drug(s) or vehicle were microinjected (volume of 0.5µl) using a 
33G internal cannula.  The diagrams represented are adapted from Paxinos and 















































































Fig. 3.22. Microinjection of bicuculline (Bic) into the medial septum (MS) 
antagonized the antinociceptive effect of intraseptal zolpidem (Zol).  The experiments 
were performed on animals implanted with both the microinjection cannula and CA1 
recording electrode.  Formalin (1.25%, 0.1ml) was injected immediately following the 
microinjection.  (A) Time course of licking (left panel) and flinching (right panel) of 
the injured paw after formalin injection.  Formalin was injected at time 0min and the 
duration of licking (s) and the numbers of flinches were counted for blocks of 5min.  
Note the typical biphasic increase in the two nociceptive behaviors following injection 
of formalin in vehicle (Veh) treated animals.  Intraseptal zolpidem per se reduced 
formalin-induced flinching which was prevented when the drug was microinjected 
together with bicuculline (Zol + Bic).  (B) Histogram plots illustrating the cumulative 
licking (left panel) and flinching (right panel) behaviors in the second phase (11-
60min).  Data are mean + SEM.  Significant difference: (A) P < 0.05; * zolpidem 
(MS) vs. vehicle; # zolpidem + bicuculline mixture (MS) vs. zolpidem (MS) (2-way 
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3.10 Effect of intraseptal injection of GABAergic agents on formalin-induced 
agitation  
 
Ambulatory movements of the animal during formalin test were monitored 
concurrently with the help of an activity meter.  A biphasic pattern of agitated 
behaviors (i.e. ambulation) was seen with hind paw injection of formalin (Fig. 3.23 
left panel).  Analysis of time course of change indicated that intraseptal bicuculline 
evoked a robust increase in formalin-induced ambulatory distance in the awake rat, 
both during phase 1 and at different time-points during phase 2 (Fig. 3.23A left panel; 
treatment, F2, 357 = 5.29, P < 0.02, 2-way ANOVA).  The increase was most marked 
with MS microinjection than LS microinjection.  Furthermore, instead of a biphasic 




 phase and a low at 
interphase, formalin-induced ambulation exhibited a robust and sustained increase and 
then a gradual decline.  Unlike bicuculline, formalin-induced ambulatory distance was 
not affected with microinjection of zolpidem (Fig. 3.23B left panel; treatment, F2, 425 = 
1.25, P > 0.3, 2-way ANOVA) or muscimol (Fig. 3.23C left panel; treatment, F2, 408 = 
0.36, P > 0.6, 2-way ANOVA).   
 
Indeed, one-way ANOVA of the phase 2 ambulatory distance indicated that MS 
bicuculline augmented formalin-induced agitation (Fig. 3.23A right panel; groups, F2, 
21 = 5.63, P < 0.02).  The effect with LS was more variable and not as marked.  No 
change was observed with septal microinjection of zolpidem (Fig. 3.23B right panel; 
groups, F2, 25 = 1.45, P > 0.2) or muscimol (Fig. 3.23C right panel; groups, F2, 24 = 
0.69, P > 0.5).   
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Fig. 3.23. Intraseptal (medial septum or MS; lateral septum or LS) bicuculline, but not 
muscimol and zolpidem, significantly increased formalin-induced ambulatory distance.  
These experiments were performed on behaving animals implanted with only the 
microinjection cannula.  Formalin (1.25%, 0.1ml) was injected immediately following the 
microinjection of (A) bicuculline, (B) zolpidem, and (C) muscimol, using an internal 
cannula.  The time course of effect of drug microinjections on ambulation are shown on 
the left whereas the histogram plots of the 2
nd
 phase of the formalin-induced ambulation 
are shown on the right.  Data are mean + SEM.  Significant difference: (A; left panel) P < 
0.05; * bicuculline (MS) vs. vehicle; # bicuculline (LS) vs. vehicle (2-way ANOVA) and 
(A; right panel) * P < 0.05 vs. vehicle; # P < 0.05 vs. bicuculline (MS) (1-way ANOVA). 
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4 DISCUSSION 
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4.1 Medial septum modulates nociception  
 
The present study examined the effect of manipulation of medial septum with the 
GABAergic antagonist, bicuculline, and GABA mimetic, muscimol and zolpidem, on 
behavioral responses and spinal nociceptive processing in the formalin model of 
persistent inflammatory pain.  Experiments in anaesthetized rat indicated that 
microinjection of bicuculline into MS selectively attenuated the theta rhythmic-
synchronized activation of the septohippocampal network while sparing the non-theta 
neural responses of the network.  In this regard, intraseptal bicuculline, but not 
intraseptal vehicle attenuated the power of the reticularly-evoked hippocampal theta 
wave activity.  However, bicuculline did not affect the reticular stimulation-evoked 
suppression of CA1 PS and the accompanying facilitation of the paired PS.  Indeed, in 
this experimental group, bicuculline also attenuated formalin-evoked theta activation 
while also sparing the concomitant suppression of the CA1 PS.  Here it is notable that 
both reticularly- and formalin-evoked theta activation and PS suppression are 
mediated via the medial septum (Khanna, 1997; Zheng and Khanna, 2001; Jiang and 
Khanna, 2004).  Consistently, intraseptal bicuculline also attenuated theta activation 
on relatively direct activation of septohippocampal network with intraseptal 
microinjection of the cholinergic agonist, carbachol.   
 
In awake animals, microinjection of bicuculline into medial septum, at the dose that 
selectively affected septal theta generating neural mechanisms in the anaesthetized 
animal, evoked a robust increase in animal agitation (ambulation) in the formalin test.  
Furthermore, the pattern of formalin-induced ambulation was no longer biphasic.  
Normally, the formalin-induced ambulation shows a peak in the first 5 minutes after 
formalin injection followed by, in order, period of low ambulation (an inter-phase) 
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and a 2
nd
 peak of activity from 20 – 30 minutes post injection (2nd phase; Lee et al., 
2011).  On the other hand, the bicuculline treated animals exhibited a robust and 
sustained increase in ambulation that overlapped with both the 1
st
 phase and the inter-
phase.  High ambulation was also seen in the 2
nd
 phase that gradually declined 
towards control.  Interestingly, the biphasic pattern of nociceptive licking and 
flinching was unaffected by bicuculline.   
 
In contrast to bicuculline, inactivation of the MS with the GABA mimetic muscimol 
selectively attenuated formalin-induced nociceptive licking and flinching while 
sparing the ambulatory response.  Muscimol, an agonist at GABAA receptors, was 
microinjected in a dose that blocks hippocampal theta activation in both anaesthetized 
and behaving animal (Ma et al., 2002; Lee et al., 2011).  The attenuation of theta 
activation by muscimol is robust.   
 
Further, the behavioral effects of muscimol was accompanied by an inhibition of 
spinal expression of the transcription protein, c-Fos.  The induction of c-Fos is a 
measure of spinal nociceptive processing and the decrease in number of FLI neurons 
suggests that the effect of intraseptal muscimol on behavior is accompanied by a 
reduction of spinal nociceptive information processing.   
 
In contrast to muscimol, intraseptal zolpidem, a positive allosteric modulator at 
GABAA receptor, evoked a weak inhibition of MS marked by a relatively weak 
inhibition of theta activity in anaesthetized and behaving animal (Lee et al., 2011; 
present study) and, correspondingly, exhibited a weak antinociceptive effect.  In 
context of the latter, intraseptal zolpidem inhibited only the flinching behavior 
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without affecting nociceptive licking and formalin-induced ambulation.  Moreover, 
intraseptal zolpidem did not affect the formalin-induced expression of spinal c-Fos.  
The effect of zolpidem was precluded with co-administration of bicuculline which is 
consistent with the notion that the antinociceptive effect of zolpidem is mediate via 
GABAA receptors in the medial septum.  
 
Put together, the inhibition of indices of formalin pain by intraseptal muscimol and 
zolpidem suggests that the MS normally facilitates persistent nociception in the 
formalin test.  Furthermore, the selective effect of bicuculline on formalin agitation 
(ambulation) which, otherwise, is not affected by muscimol and zolpidem, suggests 
that the neural mechanisms in medial septum that modulate formalin-agitation are 
distinct from those that facilitate formalin pain.   
 
4.2 Medial septum preferentially affects the second phase 
 
It is notable that in the microinjection experiments, formalin was injected into the 
hind paw of the animals immediately after muscimol or zolpidem microinjection.  
However, the antinociceptive effect of the two drugs was observed on the second 
phase of the formalin test, with no effect on the pain responses in the first phase.  The 
lack of effect on the first phase behaviors is unlikely to be caused by differences in the 
peak effect of the drugs on neural processing in the first versus the second phase.  
Indeed, we have reported that the inhibitory effect of intraseptal muscimol on 
reticularly-evoked hippocampal theta wave activity in anesthetized rats, as an index of 
the drug’s neural affects, reaches a peak within 2 minutes and is sustained for at least 
20 minutes (Lee et al., 2011).  However, the minute-to-minute changes in licking and 
flinching behaviors in muscimol-microinjected animals in the current study were 
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comparable to the corresponding controls in the first 5 minutes (ie, first phase) after 
hind paw injection of the algogen.   
 
Likewise, the effect of intraseptal zolpidem on formalin-induced theta in anesthetized 
rats also reaches a peak in the first minute and is sustained for another couple of 
minutes (Lee et al., 2011).  Interestingly, the effect of zolpidem is brief and recovers 
toward control between 4 and 10 minutes after drug microinjection.  This period 
coincides with the first phase and the inter-phase of the formalin test.  Indeed, we 
show here that microinjection of zolpidem in the awake rat also has a brief but weak 
effect on formalin-induced theta in the first phase only.  In contrast, the formalin-
induced behavior, especially flinching, was blunted nearer to the peak of second phase 
behavior from the 20th minute onward.  This therefore suggests that the neural 
effect(s) of the drugs on their microinjection into the medial septum preferentially 
affected the development of the second-phase behaviors.  Indeed, supraspinal regions 
facilitate pain, including the second-phase pain behaviors and the expression of spinal 
c-Fos in the formalin test (Urban and Gebhart, 1999; Lima and Almeida, 2002; Suzuki 
et al., 2002; Svensson et al., 2006; Wei et al., 2010).  As such, the second phase 
behaviors are more reliant on central plasticity, while first phase behaviors are mostly 
driven by nociceptive inputs (Ji and Rupp, 1997; Ji et al., 1999; Sawynok and Liu, 
2004; Zeitz et al., 2004; Svensson et al., 2005; Liu et al., 2008; Pezet et al., 2008). 
 
4.3 Medial septal, but not lateral septal neurons mediate the effect of the 
GABA agonistic drugs 
 
As with medial septum microinjection, muscimol microinjected into the lateral 
septum also attenuated formalin-induced behaviors in the second phase and decreased 
the spinal expression of c-Fos.  However, the behavioral effect of LS muscimol was 
 - 145 - 
weaker than that seen with microinjection of the drug into the MS.  Indeed, analyses 
of the time course of effect revealed that the effect of lateral microinjection was most 
marked on the falling phase than the rising phase of the second phase of the formalin 
test.  In contrast, microinjection into the adjacent medial septum blunted the behaviors 
both on the rising and falling phase in the second phase.  The difference in the effects 
of the medial versus lateral microinjections makes it unlikely that the effect of medial 
septum muscimol is caused by a spread to more lateral regions.  On the other hand, 
the effect of lateral microinjection of muscimol might be, in part, due to a spread to 
the medial septum.  Thus, the relatively weaker effect on the rising phase with lateral 
microinjection may arise because lower concentration of the drug reaches the 
neuronal population in the medial septum, especially early after microinjection, and 
the behavioral effect of which was accentuated during the declining pain responses.   
 
A central role of medial septum is also highlighted by the finding that zolpidem 
attenuated nociceptive flinching when microinjected into the medial, but not the 
adjacent lateral septum.  The fall-off of effect of zolpidem in lateral septum is 
reminiscent of the demarcation of the zolpidem binding sites, which are low in lateral 
septum but high in MS (Duncan et al., 1995).  Correspondingly, zolpidem potentiates 
the action of GABA within medial, but not lateral septum.   
 
4.4 Diverse mechanisms in the medial septum influence formalin-induced 
nociception vs. agitation 
 
Interestingly, intraseptal bicuculline, in dose that attenuated formalin-induced 
ambulation (agitation) did not affect nociceptive licking and flinching.  The dose of 
bicuculline was sub-maximal and did not did not provoke epileptic behaviors or 
hippocampal epileptic after-discharges that are otherwise seen at higher doses 
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(Chrobak and Napier, 1992).  Nonetheless, the effect of bicuculline on ambulation 
was quite robust.  Unlike bicuculline, intraseptal muscimol attenuated nociceptive 
licking and flinching behaviors without affecting formalin-induced ambulation.  The 
double dissociation in the effect of the drugs on the behaviors suggests that neural 
mechanisms that underpin formalin-induced ambulation are different from that which 
mediates formalin-induced licking and flinching. 
 
It is notable that experiments on anaesthetized animals in the current study indicated 
that bicuculline attenuated hippocampal theta activation without affecting 
hippocampal PS suppression induced on reticular stimulation and peripheral 
application of formalin.  Notably, RPO stimulation induces hippocampal theta and 
suppression of PS via activation of hypothalamic regions and the MS (Bland, 2009).  
Indeed, microinfusion of procaine into the SuM abolished the RPO-elicited theta field 
activity in anaesthetized rat (Kirk and McNaughton, 1993; Oddie et al., 1994).  
Interestingly, the SuM projects to the MS via glutamatergic afferents that innervate 
both the cholinergic and GABAergic neurons of the MS (Swanson and Cowan, 1979; 
Jakab and Leranth, 1995; Leranth and Kiss, 1996; Kiss et al., 2000; Risold, 2004).  
Accordingly, hippocampal theta activity and PS suppression induced by excitation of 
SuM with intra-SuM carbachol is attenuated by inactivation of the MS (Oddie et al., 
1996; Jiang and Khanna, 2006).  
  
The selective attenuation of RPO evoked hippocampal theta, but not PS suppression 
suggests that intraseptal bicuculline affected synchronization in the septo-
hippocampal network, but did not prevent excitation of MS neurons to external inputs.  
Within MS, bicuculline sensitive GABAA receptor-mediated inhibitory mechanisms 
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affect all classes of neurons, whether local interneurons or projecting neurons, of 
different phenotypes (See section 1.2, 1.5 and Fig. 1.1).  Furthermore, the MS 
GABAergic neurons, including local interneurons, discharge rhythmically during 
hippocampal theta activation suggesting that the theta-rhythmic GABAergic 
inhibition impinges on MS neurons during hippocampal theta wave activity (see 
section 1.3).  Thus, the disruptive effect of intraseptal bicuculline on theta likely 
reflects a disinhibition by the drug of GABA-receptive septal neurons, at least in part, 
that attenuates the GABA mediated pacing of the theta rhythm in the network.  On the 
other hand, intraseptal muscimol is likely to attenuate excitation of MS neurons to 
incoming inputs.  Consistent with this, intraseptal muscimol, in doses used in the 
current study, prevents the sensory/behavior-induced release of acetylcholine in the 
hippocampus, which, however, is not the case with intraseptal bicuculline, even at 
doses higher than used in the current study (Moor et al., 1998a; Moor et al., 1998b; 
Roland and Savage, 2009).   
 
Taken together, the foregoing suggests that disrupting GABAergic inhibition, rather 
than blocking information outflow per se from MS, evokes a greater effect on 
ambulation suggesting that MS modulates, rather than drive, the ongoing motor 
behaviors.  Interestingly, ambulation reflects voluntary activity and, indeed, the septo-
hippocampal theta network is postulated to play a role in sensory-motor integration of 
voluntary behaviors (Bland and Oddie, 2001; Hallworth and Bland, 2004; Bland, 
2009; see section 1.3.3).  In this regard, the theta-related input from the MS is 
suggested to facilitate the encoding of sensory information by the hippocampus (see 
section 1.3.3).  Furthermore, the integration of sensory with the motor-related 
information within hippocampus occurs against the background of hippocampal theta 
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activity.  In turn, the hippocampus is proposed to interact with the motor areas, 
priming them to generate movements at the desired intensity on one hand and, on the 
other hand, acting to provide a feedback to the motor areas about their performance in 
relation to sensory inputs (Bland and Oddie, 2001; Hallworth and Bland, 2004; Bland, 
2009).  Earlier, our laboratory had provided evidence that hippocampal theta 
activation in the formalin test was most prominent during formalin-induced agitation 
rather than during licking and flinching behaviors.  Conversely, in the present study, 
bicuculline, in a dose that affected mechanisms underlying hippocampal theta 
generation, selectively disrupted both the degree of agitation and the integration of the 
motor behavior with formalin-induced sensation such that agitation was no longer 
parallel to the biphasic pattern of nociceptive responses that were also unaffected by 
the drug.   
 
While the current evidences suggests a role for MS GABAergic mechanism in 
formalin-induced agitation, the neural mechanism(s) that underpin nociceptive licking 
and flinching remains unclear.  Intraseptal muscimol is likely to non-selectively 
inhibit the activity of the diverse population of neurons in the region.  Interestingly, 
indirect evidence from our laboratory suggests that cholinergic neurons are activated 
by hind paw injection of formalin (Zheng and Khanna, 2001).  In this context, we 
have shown that lesion of the MS cholinergic neurons attenuated formalin-induced 
inhibition of pyramidal neurons in the hippocampal field CA1.  Though, the role of 
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4.5 Physiological role of medial septum in pain 
 
The evidence that inactivation of medial septum with GABA mimetics attenuates 
formalin-induced nociceptive behaviors in the second phase suggests a physiological 
relevance for the region in facilitating pain.  Previously, the region had been 
implicated in affect-motivation but not directly with pain (McNaughton and Gray, 
2000; Bland and Oddie, 2001; Ma et al., 2002).  Indeed, a physiological role in 
persistent nociception is strengthened by the evidence that medial septum affects 
spinal nociceptive processing in the model, especially attenuating the induction of FLI 
in the deep laminae of the dorsal horn.  Strikingly, the induction of c-Fos in the deep 
laminae is correlated with formalin-induced changes in the septo-hippocampal 
network, especially in field CA1 of the hippocampus (Khanna et al., 2004).  The 
induction of c-Fos in the deep dorsal spinal laminae, more so than in the superficial 
laminae, better reflects formalin-induced behaviors in the second phase (Gogas et al., 
1991; Gogas et al., 1996; Bon et al., 2002). 
 
Interestingly, earlier experiments that reported that high frequency stimulation (HFS) 
of MS induced antinociception indirectly reinforce the current findings that the 
disruption of information processing in the MS is antinociceptive (Mayer and 
Liebeskind, 1974; Abbott and Melzack, 1978; Carstens et al., 1982).  Thus, the HFS-
induced antinociceptive effect was accompanied by epileptic after-discharges in the 
septohippocampus, especially in behaving animal, whereas, noxious stimulation 
normally elicits theta activation in the region (Khanna, 1997; Tai et al., 2006).  
Generally, electroencephalographic hippocampal seizures and post-ictal depression 
are accompanied by animal behaviors such as “wet dog shakes” and hyperlocomotion 
(Wishart et al., 1973). Indeed, septal HFS-induced antinociception, especially in the 
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formalin test, is accompanied by “wet dog shakes” and hyper-locomotion, suggesting 
that wider sensory-motor changes accompany HFS (Abbott and Melzack, 1978), 
whereas such behaviors were not observed with intraseptal microinjections of 
muscimol and zolpidem in the present study.  
 
Furthermore: (a) the MS receives spinal input directly from deep dorsal horn 
(Burstein and Giesler Jr, 1989; Cliffer et al., 1991; Li et al., 1997), although indirect 
input via the reticular formation and the posterior hypothalamus is also likely (Lima 
and Almeida, 2002; Leite-Almeida et al., 2006; Sukhotinsky et al., 2007; Ariffin et al., 
2010); (b) many of the neurons in deep laminae of the spinal cord are multireceptive 
or nociceptive specific with large receptive fields, suggesting that they play a role in 
affect-motivation rather than sensory-discrimination (Menetrey et al., 1980; Burstein 
and Giesler Jr, 1989); and (c) similarly, the medial septal neurons are also excited by 
noxious stimuli from widespread peripheral regions (Dutar et al., 1985). 
 
The route through which MS affects pain and spinal nociceptive processing remains 
unclear.  However, direct or indirect projections from the region might affect other 
brain loci that modulate aversive behaviors.  Indeed, as reviewed in the introduction 
(section 1.2.4), MS projects to areas such as the mesopontine rostromedial tegmental 
nucleus, the lateral hypothalamus, and the periaqueductal gray (Swanson and Cowan, 
1979; Gritti et al., 1994; Jhou et al., 2009b; Jhou et al., 2009a; Ariffin et al., 2010) 
Some of these regions are key components of the descending pain modulatory 
pathways (see section 1.4.2).  For example, electrical stimulation of the lateral 
hypothalamus or application of morphine into the region induces antinociception 
(Dafny et al., 1996; Hsieh et al., 1996).  Likewise, electrical stimulation of the PAG in 
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humans elicits analgesia (Hosobuchi et al., 1977; Richardson and Akil, 1977) and 
activation of the region has been shown to be correlated with behavioral paradigms 
that reduce pain in humans (Tracey et al., 2002).  Indeed both regions project to the 
spinal cord, either directly (lateral hypothalamus) or indirectly (PAG via RVM).  Thus, 
potentially MS might modulate nociception via regulation of neural activity in these 
two regions.   
 
Interestingly, the MS also projects directly to midline cortices, especially 
hippocampus, cingulate cortex, and entorhinal cortex, all of which are implicated in 
the affective-motivational dimension of pain/nociception (Leung and Borst, 1987; 
Gaykema et al., 1990; Khanna, 1997; Ploghaus et al., 2001; Vogt, 2005; Zhuo, 2008; 
Young and McNaughton, 2009).  Thus, the present findings, seen in conjunction with 
foregoing information, suggest that the MS is a potential nodal point for integrating 
cortical and subcortical responses to pain/nociception. 
 
The septal circuit that mediate agitation/ambulation also remains undefined, even as 
our findings suggests that it is functionally distinct from the pro-nociceptive circuit of 
the MS.  The behavioral and functional implication of agitation/ambulation and 
related theta activation vis-à-vis formalin pain remains undefined.  A possibility is 
that the agitation is part of an escape drive from the now aversive environment 
triggered by formalin-pain.  Although we have not investigated this angle 
systematically, in aversive and anxiogenic environment there is increased coherence 
between theta in hippocampus and the medial prefrontal cortex, especially so during 
escape when theta power increases, suggesting increased neural synchronization in 
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different cortical regions with implication for animal behavior in the environment 
(Adhikari et al., 2010). 
 
In a broad context, the MS is known to be involved in other neurological processes 
such as learning and memory, anxiety, arousal and attention which are interrelated, at 
least in part, with each other (McNaughton and Gray, 2000; Sharot and Phelps, 2004).  
Interestingly, pathological dysfunction of such processes in humans also appears to 
have an influence on pain, though it is difficult to establish a causal association.  
Furthermore, there are no investigations into the overlap between circuits mediating 
the different roles of the MS.  Nonetheless, some examples where different patho-
physiological states linked with MS affect pain are described below. 
  
One, several lines of evidence suggest a role of the MS in learning and memory.  In 
this regard, lesions or microinjections of muscimol, the benzodiazepine antagonist, 
flumazenil, or lidocaine, affected performance in the radial-arm maze task or the 
Delayed-non-match-to-sample (DNMTS) radial-arm maze procedure, a test of 
working memory (Chrobak et al, 1989; Herzog et al., 1996; Walsh et al., 1996, 1998).  
Moreover, microinjection of tetracaine into the MS which attenuated hippocampal 
theta extinguished learning in the morris water maze which was recovered with 
restoration of hippocampal theta-like rhythmicity by stimulation of the fornix superior 
using theta rhythm present in the SuM after MS blockage (McNaughton et al., 2006).   
 
Accordingly, the medial septum is implicated in Alzheimer’s disease in both humans 
and animal models.  In the former, Alzheimer’s disease patients had reduced 
cholinergic neurons in the medial septum as compared to control subjects and septal 
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forebrain volume was positively associated with recognition memory (Lehéricy et al., 
1993; Butler et al., 2012).  For the latter, cholinergic neurons in the MS was smaller in 
size and there was deafferentation of both cholinergic and GABAergic 
septohippocampal projecting neurons (Bronfman et al., 2000; Rubio et al., 2012).  
Moreover, Tau aggregation was observed in the MS in a Tau transgenic mouse model 
of Alzheimer’s disease, THY-Tau22 (Belarbi et al., 2009).  Pain in Alzheimer’s 
patients has been difficult to study due to a loss of ability to report pain even though 
pain perception was suspected to be altered in these patients (Pickering et al., 2000).  
However, there is evidence that indicate an increase in pain tolerance in Alzheimer’s 
patients even though stimulus detection and pain thresholds were no difference with 
control subjects, showing that the disease did not affect the sensory-discriminatory 
component of pain but the affective-motivational or cognitive-evaluative component 
(Benedetti et al., 1999).   
   
Two, the medial septum is one of the three main regions (including the hippocampus 
and amygdala) implicated in anxiety (Gray and McNaughton, 2003).  Theta activity 
has also been shown to be associated with anxiety behaviors.  In this context, human 
patients with generalized anxiety disorder showed a decreased frontal midline theta 
activity (Suetsugi et al., 2000) and human subjects given anxiolytic drugs showed an 
increase in frontal midline theta activity (Mizuki et al., 1989).  Indeed, anxiolytic 
drugs attenuated the frequency of reticular stimulation induced hippocampal theta 
(McNaughton et al., 2007).  Recently, Shin et al. (2009) showed a connection between 
medial septum, theta and anxiety behavior in mice.  The medial septum phospholipase 
C β4 (PLC-β4) knockout mice exhibited increased anxiety behavior with a decreased 
hippocampal theta activity.  Augmenting the cholinergic transmission in the 
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septohippocampal pathway by systemic injection of rivastigmine, an 
acetylcholinesterase inhibitor, restored hippocampal theta and decreased anxiety 
behavior.   
 
The inter-relationship between anxiety and pain has been clinically reported (Beecher, 
1969; Grachev et al., 2001; Ploghaus et al., 2001).  Anxiety may exacerbate or 
decrease the reported pain experience depending on the context of the source of pain.  
In this context, pain is increased when subjects are anxious about the task which will 
elicit pain and decreased when the anxiety is irrelevant to the source of pain (al Absi 
and Rokke, 1991).  Indeed, activity in the hippocampal formation network has been 
proposed to be associated with the exacerbation of pain by anxiety as determined 
using event-related functional magnetic resonance imaging (Ploghaus et al., 2001).  
However, it is suggested that the influence of anxiety on pain may be due to a process 
of attentional focus on the painful stimuli, at least in experimental settings, but the 
attribution of the role of anxiety on pain cannot be excluded (Arntz et al., 1994).   
 
Interestingly, the MS also projects to the olfactory cortex (Gaykema et al., 1990; also 
see introduction chapter 1.2.4) and alternative therapy such as aromatherapy has been 
proposed to alleviate anxiety and provide pain relief (Fellowes et al., 2004).  However, 
there is insufficient scientific evidence suggesting a positive benefit of such 
alternative therapy on anxiety and pain control (Louis and Kowalski, 2002; Fellowes 
et al., 2004; Wilkinson et al., 2007).  It is notable to point out here that hippocampal 
theta during seemingly sniffing behavior in the rat was due to head movements and 
that no theta was observed during movements of the vibrissae without accompanying 
head movements (Vanderwolf., 1969).   
 - 155 - 
 
In summary, the present study raises the possibility that the medial septum act as a 
potential nodal point for the integration of cortical/subcortical responses to 
pain/nociception.  However, the relationship between MS modulation of pain with 
other functions of the region remains unclear. 
 
4.6 Conclusion and future work 
 
In summary, the results indicate that the medial septum normally facilitates persistent 
nociception in the formalin test since non-selective inhibition of septal neural activity 
with intraseptal application of exogenous GABA mimetics inhibited formalin-induced 
nociceptive behaviors and spinal nociceptive transmission.  Thus, intraseptal 
microinjection of the GABA agonist, muscimol, inhibited both nociceptive licking 
and flinching behaviors.  This was observed in parallel with inhibition of formalin-
induced expression of spinal c-Fos protein, c-Fos being an index of spinal nociceptive 
processing.   
 
On the other hand, GABAergic inhibitory mechanisms intrinsic to MS selectively 
modulate formalin-induced sensorimotor integration.  In this regard, disrupting septal 
mediated hippocampal theta synchronization, but without blocking information 
outflow from MS with intraseptal bicuculline evoked a profound effect on animal 
agitation while sparing nociceptive behaviors.  Both the degree of formalin-induced 
agitation and the integration of motor behavior with formalin-induced sensation were 
disrupted.  In context of the latter, post-bicuculline, the formalin-induced agitation 
was no longer parallel to the biphasic pattern of nociceptive responses.  A summary of 
the findings is illustrated in figure 4.1. 
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However, a number of issues arise from the findings that were not addressed by this 
study.  For example, it remains unclear whether the role of MS in nociception is 
specific to pain phenotype or is more general.  To test this idea, the role of MS in 
other models of pain, including the clinically significant neuropathic pain models (e.g., 
chronic constriction injury), must be evaluated.  Furthermore, the network basis of the 
MS effects on formalin-nociception remains unclear.  Future work should include 
unraveling of the network mechanism(s) that underpin MS role in nociception. 












Fig. 4.1.  Simplified diagram illustrating the summary of findings of this study.  The red 
arrows with the red minus sign indicate the inhibitory actions of muscimol and zolpidem 
on different medial septal neuronal populations.  One red arrow indicates relatively weak 
inhibition while two red arrows indicate a relatively strong inhibition.  The red crosses 
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